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1 Introduction 1.1 Hexaaquaruthenium(II) salts – origin and recent advancements While numerous records of binary aqua complexes of iron can be found, they remain rare for ruthenium and have not been identified for osmium yet.[2-8] In the case of ruthenium two known crystal structures of the hexaaquaruthenium(II) cation have been determined so far, the hexaaquaruthenium tosylate [Ru(H2O)6](tos)2 synthesised by Bernhard et al. (1982) and [Ru(H2O)6][RuCl3(CO)3]2∙2H2O obtained as a side product of a product mixture by Taimisto et al (2003).[9-10] Apart from these two compounds, only a solid but tentatively microcrystalline form of the trifluormethane sulfonate salt of hexaaquaruthenium(II) has been obtained by ion-exchange chromatography, yet.[11] Overall, there have been no synthetic advancements regarding the hexaaquaruthenium(II) cation in almost two decades except for an improved synthesis of the already existent hexaaquaruthenium tosylate in 2010.[12] Nonetheless, since the standard starting material for most ruthenium chemistry in water is the ill-defined RuCl3∙xH2O the hexaaquaruthenium salt as a halogen-free and homogenous compound has gained interest in several fields such as spectroscopy, kinetics, syntheses, computational chemistry and catalytic applications and has been mentioned in an educational study.[13-18] With respect to catalytic methods, hexaaquaruthenium(II) tosylate offers a broad range of reactions from ring-opening metathesis (ROMP), isomerisation of allyl functionalities and isomerisation of olefins (Scheme 1.1).[19-21] Hexaaquaruthenium(II) tosylate as precatalyst in the presence of meta-trisulfonated triphenyl-phosphine (TPPTS) enables the selective decomposition of formic acid into hydrogen and carbon dioxide—a viable step in the direction of a regenerative hydrogen storage system.[17, 22]   Scheme 1.1: Selected examples of reactions with [Ru(H2O)6](tos)2 (1) as catalyst. 
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Recent advances in using hexaaquaruthenium tosylate as a precursor for new coordination compounds succeeded with phosphanes (e.g. dppe, PPh3, tppts), small molecules (e.g. N2, CO, H2), N-heterocycles, arenes and olefines.[14, 23-30] A special case of complexes obtained from ruthenium compounds including hexaaquaruthenium(II)—the sulfonato complexes—are described in the next subchapter. 1.2 Sulfonatoruthenium complexes Sulfonato ligands are valued for their weakly coordinating behaviour and for their good leaving-group abilities.[31-32] Sulfonate ligands coordinate usually labily and tend to be easily replaced by other ligands—a characteristic which is promising for the application in catalysis and synthesis.[33-38] Bailey et al. treated hexaaquaruthenium(II) with phosphane (dppe, PPh3) ligands and predicted correctly that the previous tosylato counterion coordinated to the ruthenium(II) centre.[23] A crystal structure of the dppe complex was obtained by this group in 2018 and confirmed a κ2O,O′ coordination of the tosylato ligand (7).[39] A chelate sulfonate ligand in a mononuclear ruthenium complex proven by a crystal structure is a rarity and is known only for two or more chelate phosphanesulfonate co-ligands (Figure 1.1).[40-42] Nonetheless, tosylato-κ2O,O′ does also appear in dinuclear ruthenium complexes, for example, as bridging ligands.[43-44]   Figure 1.1: ORTEP-3 plot of two examples of phosphanesulfonato complexes with a chelating sulfonate group.[45] Left: [Ru(CH–Ph)Cl(PPh3)(P(Cy)2(-6-SO3–C6H4))]; right: [Ru(H)(PPh3)2(P(Ph)2(-6-SO3–C6H4))].[41-42] In contrast, a monodentate sulfonate is not as rare in ruthenium complexes as its weakly coordinating characteristic suggests. Sulfonatoruthenium complexes—similar to the ones synthesised in this work—are known in several coordination forms.[46-53] A few examples are given in Figure 1.2.  
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 Figure 1.2: ORTEP-3 plot of three examples of complexes with monodentate sulfonato ligands.[45] Left: [Ru(dppm)2(H2O)(OTf)]+; centre: [Os(η5-C5H4PPh2)2Ru(H2O)2(tos)2]; right: [Ru(CF3SO3-κO)(CH3COO-κ2O,O′)(triphos)], triphos = 1,1,1-tris-(diphenylphosphanylmethyl) ethane.[38, 49, 54] The HSAB concept has been the subject of discussion as a possible explanation for the coordination behaviour of aqua and sulfonato ligands.[50, 55] As coordination centres can be described either as hard or soft, a combination of soft organo ligands and relatively hard aqua ligands do not seem to be favoured.[28-29, 56] Jørgensen—commenting on the then recently released HSAB principle of Pearson—emphasized that soft ligands flock together in the same complexes (principle of symbiosis).[57-58] Bjerrum pointed out that mixed complexes of the type MXaYb with moderate pairs of ligands such as water and fluoride or water and ammonia are more frequent than the statistical contribution to the higher entropy suggests.[59] As an example, [Co(NH3)5X]2+ is more stable for X = F than for I, but it is the opposite for [Co(CN)5X]3−.[57] This leads to the question of what standard procedures are used to obtain complexes defying the mentioned observations and principles. The tosylatoruthenium complex with phosphane co-ligands of Peganova et al. shown in Figure 1.2 was obtained—as any tosylato complex in this work—through the treatment of [Ru(H2O)6](tos)2 with the corresponding phosphane. [39, 49] Triflato ruthenium complexes are gained by silver triflate and ruthenium chlorides, ruthenium(II) hydrides and triflic acid and ruthenium(0) derivatives as well as  triflic acid.[38, 52, 60] The ruthenium hydride route is also established for methanesulfonatoruthenium complexes.[54] As mentioned before, not only the hexaaquaruthenium salt is catalytically active, but also the phosphane derivatives.[61] For example, they catalyse the hydrogenation of amides to amines and the transfer hydrohalogenation of organic halides. (C–Cl → CH).[54, 62] As green chemistry and water-as-solvent gain interest in synthesis, the catalysts are ideally tolerant towards water and soluble in water.[51, 63] An example is the Kuntz-Kornils catalyst in Ruhrchemie/Rhône-Poulenc hydroformylation which is a liquid-liquid biphasic catalysis using a water-soluble rhodium catalyst with sulfonated triphenylphosphane co-ligands.[64] Therefore, to obtain phosphane ruthenium catalysts with similar characteristics, [Ru(H2O)6](tos)2 was treated with sulfonated triphenylphosphane derivatives in the group of Kovacs et al..[30] This resulted 
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in catalysts which are capable of formic acid decomposition (HCOOH → CO2 + H2) as previously mentioned in chapter 1.1.[17, 22, 30] 1.3 Phosphanes  Phosphane ligands are used as stabilisers for metal centres of different oxidation states (+IV to –I). Variously substituted chelating phosphanes and polyphosphates can be synthesised. Both their electronic and steric versatility as well as their spectator ligand ability are topics of interest for synthesis and catalysis.[65] A concept to characterise these versatile ligands was established by Tolman.[66-67] A Tolman plot shows the infrared carbonyl shift of the model complex [Ni(CO)3X] (X = monophosphane) coordinated with the respective phosphane solved in dichlormethane on the ordinate (electronic effect) and Tolman’s cone angle of the monophosphane on the abscissa (steric effect) (Figure 1.3). The electron density donated by the phosphane to the metal centre increases the backbond of the carbonyl ligand through a π* orbital population. This weakens the C–O bond (lowering the bond order) resulting in an infrared signal shift to lower wavenumbers. In summary, the higher the electron donation of the phosphane, the lower the (CO) stretching vibration. Nonetheless, phosphanes are also σ*-acceptors due to the empty σ*-orbital. Accordingly, a part of the metal centres’ electron density is withdrawn and the relocation of electron density into a σ*-orbital strengthens the C–O bond ((CO) shift to higher wavenumbers). Therefore, the actual electronic effect is a result of the competitive effects of σ-donation and σ*-back donation. The additivity of the substituent contributions enables the prediction of (CO), even if the phosphane was not measured: For PX1X2X3: (CO) = 2056.1 + ∑  	 Χi (Χ = substituent contribution)   (1.1) The cone angle of a space-filling model of M(PX3) is the basis of Tolman’s steric parameter. The angle 
θ of a symmetrically substituted M(PX3) moiety is obtained from a cylindric cone, which ends in a radius of 2.28 Å from the phosphorus atom. In the presence of internal degrees of freedom, the PR3 moiety will move in such a manner, that the smallest θ is obtained. For asymmetrical M–PX1X2X3 moieties a formula helps to obtain θ due to additivity of the contributions of the different substituents: For PX1X2X3: θ = (2/3)∑ 
	 i/2 (θi = cone angle of the symmetrically substituted phosphane) (1.2) Calculated electronic and steric parameters for the monophosphanes PPh2Bn, PPh2iPr and P H tBu2 are given in Figure 1.3.  
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5   Figure 1.3: Electronic and steric effects of common P donor ligands plotted on a map according to Tolman ( in cm−1).[67] Products obtained in blue: phosphanes, values for PPh2Bn, PPh2iPr and PtBu2H calculated by using the listed equations 1.1 and 1.2.  The Tolman plot is applied for monophosphanes as illustrated in Figure 1.3. However, a classification of bisphosphanes according to the used method is problematic as no reliable electronic parameters could be obtained. Therefore, the bite angle of bisphosphanes with its similar electronic characteristics has proven to be a better classification. An example is given for palladium bisphosphane complexes (dppm, dppe, dppp) by Palenik et al. which will be discussed shortly.[68]   Figure 1.4: Dependency of the orientation of SCN− ligand of the bite angle of the different phosphane ligands (Palenik). ORTEP-3 plot of a) [Pd(dppm)(SCN-κS)2], b) [Pd(dppe)(SCN-κN)(SCN-κS)], c) [Pd(dppp)(SCN-κN)2].[45, 68]  As the ligands vary only in terms of their alkyl chain, similar σ-donor and π-acceptor (actually σ*-acceptor) characteristics are to be expected. There are differences only in steric requirements, as 
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demonstrated in this work. An increase of steric requirements by the elongation of the alkyl chain and therefore, of the P–Pd–P angle, is evident in Figure 1.4. The rigid phenyl rings are pushed towards the SCN ligands, resulting in a turnover of these only by steric effects. The Pd–S–C angle of 110° compared to 180° of Pd–N–C results in larger steric requirements and, consequently, in an isomerisation. The σ*-acceptor characteristics were discussed but ultimately discarded by the comparison of Pd–S, Pd–N and Pd-P bond distances with other complexes.[68] Several structure-reactivity studies followed the shown case.[69-73] One method to predict chelational preferences was shown by Casey and Whitaker. They introduced the “natural bite angle” and a flexibility range of diphosphane ligands which are a result of molecular mechanics. The “natural bite angle” is the preferred chelate angle determined by the backbone alone, not by the metal valence angles. The flexibility (rigidity of the ligand) was obtained by constraining the P–M–P angle and minimising the structure and calculation of the strain energy which was corrected by the strain energy as a result of the bending of the input bite angle. The obtained potential energy diagrams show a bite angle for bisphosphanes between 90 and 120° resulting in a strain difference of less than 3 kcal mol−1.[73-74] Nonetheless, a reliable predictability of complex reactivity coordinated by bisphosphanes is still part of lively research.[75-76] 1.4 Hyponitrite in biology and coordination chemistry The fixation and release of nitrogen-containing species is realised in the nitrogen cycle. In the process of denitrification, nitrate is reduced by several enzymatic steps to elemental nitrogen (NO3 → NO2→ NO → N2O → N2).[77] Not surprisingly, the conversion of the nitrate fertilizer used in agricultural processes is overall unfavourable because of the resulting unavailability of the nutrient for the plants.[78-79] As an enzyme, the nitric-oxide reductase (NOR) is thereby responsible for the conversion of nitric oxide to nitrous oxide—about 70% of that greenhouse gas is a result of bacterial catabolism releasing nitrogen oxides.[80-81] Two enzyme types of the diiron metallozyme NOR can be distinguished, the heme/non-heme reductase (NOR) and the non-heme flavodiiron nitric oxide reductase (FNOR).[82-83] A crystal structure of the nitric oxide reductase (NOR) from Roseobacter denitrificans is shown in Figure 1.5.[84] The forms of bacterial NORs vary, however, all have an electron acceptor for external electron donors (e.g. heme c) and a mediator (e.g. heme b) transporting these electrons to the bimetallic active site (heme b3 and Feb) in common.[80] Conversely, the active site of FNORs is a nonheme dinuclear iron centre in close range to a redox-active flavin mononucleotide.[85-86] The reduction step for pathogens like Neisseria gonorrhoeae or N. meningitidis is essential in order to eliminate the toxic NO molecule which is obtained by the mammalian NO synthase as part of immune defence.[80, 87-88] 
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7    Figure 1.5: CCP4MG plot of the nitric oxide reductase of Roseobacter dentrificans.[89] Left: Overall structure of the RdNorBC complex determined at 2.8 Å resolution. Right: Zoom on the active site heme b3 and Feb, hemebridging calcium, and heme b (mediation of the transfer of electrons) in the large subunit; heme c (accepts electrons from external electron donor) and a unique metal site in the small subunit.[80, 84]  The mechanism of nitrous oxide generation from nitric oxide is still unclear but it is most likely explained through the formation of a reactive hyponitrite intermediate. Hyponitrite is transformed into nitrous oxide over two protonation steps (N2O22 + 2H → N2O + H2O). Scheme 1.2 shows possible reaction mechanisms for the NO reduction.[90]   Scheme 1.2: Proposed mechanisms of hyponitrite formation.[39, 90] A practical approach on EPR-spectroscopic experiments using freeze-quench techniques suggest the trans mechanism to be the most likely. Time-dependent EPR spectral changes show a tentative formation of ferrous Feb–NO and ferrous heme–b3–NO in the same ratio, which would be a trans-mechanism (Scheme 1.2).[91] Nonetheless, mainly theoretical works indicate energetically unfavourable intermediates of the trans mechanism that a so-called cis:b3 mechanism seems to be the reasonable choice. Thus, one NO coordinates to the heme-iron centre (Fe–b3) and gets attacked by a non-coordinating NO. The resulting cis-hyponitrite is coordinated to the non-heme iron centre.[90, 92] Additionally, a theoretical study also supports a cis-intermediate in FNORs.[86] The cis:Feb mechanism was derived from rules of organometallic chemistry and is, today, without any viable indication of Fe FeBFe-heme-b3 Fe FeBFe-heme-b3 Fe FeBFe-heme-b3N ON O N ONO NO NOcis:b3 trans cis:FeB
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existence in the NOR, of historic interest only.[93] Consequently, a lack of structural information makes a final conclusion difficult at the moment, especially in terms of binding modes.    Scheme 1.3: Currently known hyponitrite binding modes.[39] Scheme 1.3 shows that hyponitrite is discussed not only as an intermediate in the enzymatic process of nitric oxide reduction, but is a ligand which attracts attention in other fields of coordination chemistry. So far, eleven coordination modes (except the one from this work) are known for the hyponitrito ligand in its cis and trans form.[94-97] Mononuclear complexes are restricted to the cis type whereby both isomers are found in polynuclear complexes. In general, hyponitrite is able to bind up to all four via each of its atoms.[95, 98-101] It is noteworthy that mononuclear cis-hyponitrito complexes are obtained only with the group 10 metals, nickel and platinum.[98, 102] In contrast, cobalt, copper, iron, ruthenium, yttrium and nickel form polynuclear cis- and trans-hyponitrito complexes.[95-97, 99-101, 103-105] Up to now, only one type of coordinated hydrogenhyponitrite complex has been published. Böttcher et al. synthesised a diruthenium(I) complex, bridged with sterically demanding phosphide ligands, which is capable of reducing nitric oxide to a bridging hyponitrite ligand according to the following equation: [Ru2(CO)4(µ-dppm)(µ-H)(µ-PBut2)] + 2NO → [Ru2(CO)4(µ-dppm)(µ-H)(ONNO-1κN:2κO)(µ-PtBu2)]. Subsequent protonation led to a hydrogenhyponitrito complex which released nitrous oxide 
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upon heating.[39, 99, 105-106] Please note: The content was published in Reference 39.   1.5 Diazoniumdiolates as ligands The name diazoniumdiolate describes the N=N double bond (“diazen”), the formal positive charge (“ium”) and two negatively charged oxygens (“diolate”). Nonetheless, the functional group is known as both diazoniumdiolate (or NONOates) and nitrosohydroxylamine. This is best explained by looking at the resonance forms of these compounds (Scheme 1.4). Additionally, if the compounds were obtained by carbanions and nitric oxide, they are called isonitramines, prepared through the use of nitrosation as nitrosohydroxylamines. To avoid any confusion in nomenclature, the functional group shown in Scheme 1.4 is here referred to only as diazoniumdiolate.[107-108]  Scheme 1.4: Resonance forms of the diazoniumdiolate functional group.  The diazoniumdiolate compounds are distinguished in C-diazoniumdiolates and N-diazoniumdiolates and smaller inorganic subgroups, whereby the name is determined by the substituent at the nitrogen atom. C-Diazoniumdiolate compounds can be prepared by various syntheses, which are—to put it in a nutshell—either a reaction of hydroxylamines or oximes with nitrite or a reaction of nitric oxide in the presence of carbanions. Conversely, N-diazoniumdiolates are synthesised by the direct reaction of an amine with nitric oxide (main route). Nonetheless, alternative routes to these compounds are possible and have been investigated.[107, 109] Beside these two main groups, O-diazoniumdiolates (e.g. Angeli’s salt: Na2N2O3), B-diazoniumdiolates, S-diazoniumdiolates (only known: Pelouze’s salt: O2N2–SO3−) were also investigated even though only on a minor scale (summarised in Scheme 1.5).[107, 110] In biochemistry, C-diazoniumdiolates are most prominent for their enzyme-inhibiting effect in tyronases which are copper-containing enzymes.[111] Further examples are dopastin which is an inhibitor of dopamine-β-monohydroxylase, nitrosoxacin for the 5-lipoxygenase and cupferron for the superoxide dismutase (Scheme 1.6).[112-114] Furthermore, the diazoniumdiolates can be used as antitumor agents or as killing agents for multi-resistent bacteria.[115-117] The diazoniumdiolate chelate cupferron is also used in the colorimetric detection of e.g. Cu, Fe or V.[118-120] In biochemistry, the chelator capability of the diazoniumdiolate function of grambactin—a siderophore of the rhizosphere bacterium Paraburkholderia graminis —succesfully binds iron over the N2O2 moiety.[121]  
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R NHOH NO2 R N N OOR NOH HNO2 R N N OOC-diazoniumdiolateN-diazoniumdiolateCHRR' NO CHRR' N N OOnitrosationNO withcarbanions NHRR' NRR' N N OONO (H+)NO with amines(main route)O-diazoniumdiolateS-diazoniumdiolate  Scheme 1.5: Simplified syntheses of C- and N-diazoniumdiolate compounds and examples for O- and S-diazoniumdiolate anions (Angeli’s salt and Pelouze’s salt). O NH NOH N OdopastinN NHOO nitrosoxacin C ONNO NH4+cupferronNN OO NH4+neocupferron  Scheme 1.6: Various enzyme inhibitors containing the diazoniumdiolate moiety.  Figure 1.6: Ortep-3 plot of the tetranuclear diazoniumdiolatoruthenium complex of Reference 122 on the left. Right: selected fragment around Ru1.[45, 122] Finally, the diazoniumdiolates are capable of releasing nitric oxide (inter alia under physiological conditions) which is a desired property in cancer therapy due to the selective antiproliferative activity in tumor cells.[123] Crystal structures of C-diazoniumdiolates as (chelating) ligands exist for many metals (e.g. Cu, Fe, Rh or Sn), but are also known for N-diazoniumdiolates (Mo, Cu), even though they are not so stable as the corresponding C-compounds.[108, 124-129] At the current state of research, only one 
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diazoniumdiolato complex is known for ruthenium. A selected fragment of this tetranuclear complex is shown in Figure 1.6. The complex was obtained through the treatment of a tetraaryl ruthenium complex with excess nitric oxide.[122] An overview of the possible binding modes of the diazoniumdiolato ligand in general is demonstrated in Figure 1.7 followed by an example for each metal in the references. It is worth noting that for the mononuclear chelate form, the dominant coordination motif is (κO,O′) beside polynuclear and monocoordinating diazoniumdiolato options.  Scheme 1.7: Currently known cis-diazoniumdiolato binding modes (excluding the crystal structures with potassium/sodium).[110, 122, 127-128, 130-154]   
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2 Aim of this work Hence there is only one hexaaquaruthenium salt allowing its effective use in further synthesis, the preparation of alternative hexaaquaruthenium precursors is desired. Intramolecular interactions leading to crystal formation are of special interest, as hydrogen positions were not assigned in the original crystal structure.[10] Subsequently, the question arises whether its solid and solution species are identical. As illustrated in the previous chapter, the application of hexaaquaruthenium as the precursor is common in several syntheses, whereby its phosphane chemistry currently undergoes a vivid development for catalytic approaches. In this work, the development of new phosphane complexes—or reevaluation/crystallisation of the already existing complexes with dppe (diphenylphosphanylethane) and PPh3 (triphenylphosphane)—is a step towards their use as precursors.[23] Furthermore, the collection of good crystallographic data and acceptable yields are intended. The resulting crystal structures will be further contextualised in terms of the ligand’s bite angle. Due to the good leaving group characteristics of the tosylato and aqua ligands, a preferable route towards the synthesis of complexes with rare ligands opens up. The present work focuses on the synthesis of trans-hyponitrito complexes where a preparation is characterised by a particular complexity, being rather defined as a matter of luck in the past than of holistic understanding in its reactivity. Nitric oxide reduction and salt metathesis were attempted in the course of this work. The resulting trans-hyponitrite compounds were then additionally tested by irradiation and computational calculations elucidating the orbital interactions in these compounds.  The use of C- and N-diazoniumdiolato ligands—thereby replacing the explosive cis-sodium hyponitrite—have not recognised apart from one exception.[122] For further analytical investigations, computational calculations were applied on the resulting diazoniumdiolato ruthenium compounds. In general, for the mentioned complexes an overall analysis including X-ray crystallography (main part), IR, UV/VIS and NMR spectroscopy were conducted. Powder-X-ray diffraction (PXRD), elemental analysis (EA) and high-resolution mass spectroscopy (HRMS) were performed as bulk analyses.  Difference-Fourier analysis was further used to assign critical hydrogen positions from crystallographic data.      
Results 
13  
3 Results  3.1 Syntheses of hexaaquaruthenium salts In this work the hexaaquaruthenium salts were synthesised according to an altered synthesis of Bernhard et al. and Fellay et al.[12] New compounds and crystal structures containing the [Ru(H2O)6]2+ cation were obtained with the following counterions: p-toluenesulfonate (tos−) (1), triflate (OTf−) (2), sulfate (SO42−) (3), 1,5-naphthalenedisulfonate (1,5-NaphDS2−) (4), 4,4’-biphenyldisulfonate (4,4’-BiphenDS2−) (5) and mesitylsulfonate (MesSO3−) (6) (Scheme 3.1). tostosylate SOO OFF FOS OO OTftriflate2+ 2+ SOOO O2+SO42sulfateS S O OOOO O 1,5-NaphDS2naphtalenedisulfonate 2+2+ S O OOSOO O 4,4'-BiphenDS2biphenyldisulfonate OSO O2+ 2+2+Mesmesitylsulfonate  Scheme 3.1: Overview of the counterions used. The synthetic route was as follows (Scheme 3.2): RuO2 prepared from RuCl3∙xH2O and sodium hydroxide was oxidised with sodium metaperiodate suspended in water with adding sulfuric acid dropwise. The RuO4 which was poorly soluble in water was transferred by a constant argon flow to a suspension of triflic acid by a constant flow of argon and lead dust resulting in a pink solution of [Ru(H2O)6]2+. The products 1, 3–6 were obtained by the addition of the respective sulfonic acids, subsequent concentration of the solution and preferential crystallisation at 4 °C. Product 2 was obtained only in the absence of counterions other than triflate.   Scheme 3.2: General synthetic procedure for hexaaquaruthenium salts (1–6). X−: monoanionic sulfonates, Y2−: dianionic sulfonates and sulfate. 
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The compounds 1–6 have homogenous crystal habits and colours and were analysed by elemental analysis. 1 was additionally analysed by UV/VIS spectroscopy (solution and solid-state) and 17O NMR spectroscopy (coupled) out of historic context (Figure 3.1 and 3.2). The 17O NMR spectrum shows a highfield signal for the ruthenium complex (−189 ppm) and a downfield signal for the SO3 group of p-toluenesulfonate (174 ppm).[155] The UV/VIS spectra in solution (red: pH 6, green: pH 1) and in solid-state each show two distinctive signals in the region of 390 nm and 529 nm.  Additionally, the crystal structure of [Ru(H2O)6](tos)2 (1) which was originally lacking the exact hydrogen positions of the aqua ligands was reinvestigated by modern methods.[10] The yields of the compounds were as follows: 59% (1), 21% (2), 22% (3), 37% (4), 44% (5), 38% (6).   Figure 3.1: 17O NMR spectrum of [Ru(H2O)6](tos)2 (1). Complex is detectable in the high-field (189.8 ppm), the tosylate counterion in the downfield region (174.3 ppm).  Figure 3.2: UV/VIS spectra of [Ru(H2O)6](tos)2 (1). black: solid-state (388.0, 521.0 nm; y-value (k/s) quadrupled), red: solved in deionised water (pH 6; 391.0, 533.0 nm), green: solved in H-tos solution (pH 1; 392.5, 534.5 nm). In the case of the solid-state spectrum, the Y axis refers to the Kubelka-Munk function (k/s = (1−R)2/2R).[156] Crystal structure of [Ru(H2O)6](tos)2 (1) The structure solution of [Ru(H2O)6](tos)2 (1) succeeded in the monoclinic space group P21/c. The unit cell contains four formula units (CShMOC-6 value: 0.126, asymmetric unit: one molecule). The structure of 1 is shown in Fig. 3.3. The crystal structure can be described as alternate layers of the dicationic complex and the monocationic anion parallel to the a,b plane. The sulfonate groups of the tosylate counterion point alternately to the cation sheet above and below. The orientation of the tosyl moiety is orthogonal to the a,b plane (Figure 3.4). The hexaaquaruthenium complex is coordinated octahedrally and small deviations are presumably attributable to hydrogen bonds and therefore to crystal-packing effects. The average Ru–O distance is 2.108 Å. The crystal data resembles well with given literature.[10] 
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15   Figure 3.3: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(H2O)6](tos)2 (1).[45] Distances (Å) and angles (°): Ru1−O1 2.102(4), Ru1−O2 2.092(4), Ru1−O3 2.109(4), Ru1−O4 2.113(3), Ru1−O5 2.115(4), Ru1−O6 2.114(3), S1−O7 1.462(4); O8−S1−O7 112.8(2), O1−Ru1−O2 85.31(16), O1−Ru1−O4 179.53(14). Figure 3.4: Mercury packing diagram of [Ru(H2O)6](tos)2 (1) in the monoclinic space group P21/c with view along [0 1 0] (on the right side). The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), ruthenium (turquoise), sulphur (yellow).    The hydrogen bonds are listed in Table 3.1. There are seven crystallographically independent hydrogen bonds. The resulting hydrogen-bond network was investigated using a graph-set analysis (Table 3.2). A short definition of the designators is given in Scheme 3.3.[157] In the unary graph set of 1 (looking at one crystallographically independent hydrogen bond) there are four distinguishable ring patterns  NCO RRCchain pattern O HORRSintramolecular hydrogen bondsR O O RHHDfinite pattern R OO ROOHHRring pattern   Scheme 3.3: Illustration of the four possible designator patterns (G). The designator is defined as follows: G ,  a number of hydrogen bond acceptors, d number of hydrogen bond donors, n number of atoms in the pattern called degree of pattern. Example: R(8): ring pattern with two hydrogen bond acceptors, two donors and 8 atoms in total.[157] 
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Table 3.1: Distances (d) and angles (α) of hydrogen bonds in 1. Standard deviations of the last digit are given in parentheses; values without standard deviation are related to hydrogen atoms at calculated positions. D: donor, A: acceptor. Target values of the H∙∙∙H distance and the O–H distance of the water molecules are restrained to 1.31 Å and 0.82 Å. D-H···A d(D–H)/Å d(H···A)/Å d(D–A)/Å α(D–H···A)/° O1–H11∙∙∙O7 0.82 1.91 2.730(5) 174 O1–H12A∙∙∙O8I 0.82 1.97 2.791(5) 172 O2–H21∙∙∙O12II 0.82 2.00 2.818(5) 170 O2–H22A∙∙∙O7I 0.82 1.97 2.766(5) 160 O3–H31∙∙∙O11II 0.82 1.90 2.710(5) 165 O3–H32∙∙∙O12II 0.83 1.95 2.756(5) 162 O4–H41∙∙∙O11III 0.82 1.91 2.734(5) 173 O4–H42∙∙∙O10IV 0.82 1.96 2.768(5) 166 O5–H51∙∙∙O10III 0.82 1.97 2.785(5) 166 O5–H52∙∙∙O9V 0.82 1.95 2.743(5) 159 O6–H61∙∙∙O8V 0.83 1.93 2.758(5) 175 O6–H62∙∙∙O9VI 0.82 1.98 2.808(5) 174 I [x, y+1, z],II [−x, y+1/2, −z+1/2], III [x, −y+1/2, z+1/2], IV [x, −y+3/2, z+1/2], V [−x+1, −y, −z+1], VI [−x+1, −y+1, −z+1].  and three finite patterns. In the binary graph set (two crystallographically independent hydrogen bonds) sixth- or eighth-degree chains are formed with two hydrogen bond acceptors and two donors. A ternary graph set is not possible for 1. The quarternary graph set consists of tenth-degree ring patterns with either three or two hydrogen-bond acceptors and four hydrogen-bond donors.  In summary, the hydrogen-bond donors in 1 are saturated, which means all twelve water hydrogens do form complex hydrogen-bond patterns with the sulfonate groups of the tosylate counterions forming an extended hydrogen-bond network.   
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Table 3.2: Graph set of products 1–6. The unary graph set is completely assigned. For the binary, ternary and quaternary graph set an assignment was made as far as possible and shows examples of the patterns obtained.[157]  N1 N2 N3 N4 1 DR(8)R(8)R(8)DR(8)D C(6), C(8) – R(10), R(10) 2 R(8)DDDD C(6), C(8) – R(10), R(10) 3 R(8)DDDDDDDD C(6), C(8) C(6), C(8) R(10) N6: R(12), R(14) 4 C		(4)R(8)R(8)D C	(6), C(8), C(6) C(6), C(10) – 5 DDDDD C	(6), C(8), C(6) C(8), R(10) R(10) 6 R(10)R	(6)R(12)DDR(8) C(8), C(6) – –  Crystal structure of [Ru(H2O)6](OTf)2 (2) The structure solution of [Ru(H2O)6](OTf)2 (2) succeeded in the monoclinic space group C2/c. The unit cell contains four formula units (CShMOC-6 value: 0.067, asymmetric unit: half molecule). The structure of 2 is shown in Figure 3.5. The [Ru(H2O)6]2+ complex is coordinated octahedrally. Small deviations of the Ru–O distances are a tentative result of crystal-packing effects, in particular hydrogen bonds. The average Ru-O distance is 2.105 Å.  The packing of the unit cell resembles 1 well. Complex and trifluormethanesulfonate each form sheets which alternate parallel to the a,b plane. The OTf− counterions lay in contrast to tos− in 1 on a two-fold screw axis (Figure 3.6). The hydrogen bonds are listed in Table 3.3. There are five crystallographically independent hydrogen bonds. The hydrogen-bond network resembles 1 with identical designators for the binary and ternary graph set and an eighth-degree ring pattern with two hydrogen bond acceptors and donors for the unary graph set (Table 3.2). 
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 Figure 3.5: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 293 K) of [Ru(H2O)6](OTf)2 (2).[45] Distances (Å) and angles (°): Ru1−O1 2.109(2), Ru1−O2 2.111(2), Ru1−O3 2.094(2), S1−O4 1.440(2); O4−S1−O5 114.49(15), O1−Ru1−O2 90.61(10). Symmetry code: i−x+3/2, −y+1/2, −z. Ci site symmetry of the cation. Figure 3.6: Mercury packing diagram of [Ru(H2O)6](OTf)2 (2) in the monoclinic space group C2/c with view along [0 1 0] (on the right side). The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), fluorine (light green), oxygen (red), ruthenium (turquoise), sulphur (yellow).   Table 3.3: Distances (d) and angles (α) of hydrogen bonds in 2. Standard deviations of the last digit are given in parentheses; values without standard deviation are related to hydrogen atoms at calculated positions. D: donor, A: acceptor. Target values of the H∙∙∙H distance and the O–H distance of the water molecules are restrained to 1.31 Å and 0.82 Å. D-H···A d(D–H)/Å d(H···A)/Å d(D–A)/Å α(D–H···A)/° O1–H11∙∙∙O5 0.82 2.05 2.880(3) 174 O1–H12∙∙∙O4I 0.82 2.02 2.843(3) 172 O2–H21∙∙∙O6II 0.83 2.05 2.836(3) 158 O2–H22∙∙∙O5III 0.83 2.04 2.847(3) 163 O3–H31∙∙∙O6IV 0.82 1.95 2.772(3) 172 O3–H32∙∙∙O4 0.82 1.95 2.769(3) 172 I [x−1/2, y−1/2, z], II[−x+1/2, −y+3/2, −z+1], III [−x, −y+1, −z+1], IV [x+1/2, y−1/2, z]  
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Crystal structure of [Ru(H2O)6]SO4 (3) The structure solution of [Ru(H2O)6]SO4 (3) succeeded in the monoclinic space group C2/c. The unit cell contains eight formula units (CShMOC-6 value: 0.109, asymmetric unit: one molecule). The structure of 3 is shown in Figure 3.7. The [Ru(H2O)6]2+ complex is coordinated octahedrally whereby small deviations of angles and distances are tentative results of crystal-packing effects. The average Ru–O distance is 2.117 Å (room-temperature measurement). The packing of the unit cell is similar to 1 and 2 (Figure 3.8) with alternating sheets of complex cations and sulphate anions parallel to the a,b plane.   Figure 3.7: ORTEP-3 plot (50% probability ellipsoids) of [Ru(H2O)6]SO4 (3).[45] Distances (Å) and angles (°): Ru1−O1 2.1289(16), Ru1−O2 2.1056(17), Ru1−O3 2.1137(18), S1−O4 1.4735(19); O4−S1−O6 108.58(12), O1−Ru1−O2 87.49(7). Ci site symmetry of the cation.  Figure 3.8: Mercury packing diagram of [Ru(H2O)6]SO4 (3) in the monoclinic space group C2/c with view along [0 1 0] (on the right side). The symmetry elements of the space group are overlaid. Atoms: hydrogen (white), oxygen (red), ruthenium (turquoise), sulphur (yellow).   The hydrogen bonds are listed in Table 3.4. There are nine crystallographically independent hydrogen bonds. The designators of 1 and 2 are also present in 3. Additionally, the ternary graph set shows a sixth-degree chain pattern with two hydrogen bond acceptors and three donors and an eighth-degree chain pattern with three hydrogen bond acceptors and three donors. The unusual sextary graph set consists of a twelfth-degree ring pattern with three hydrogen bond acceptors and six donors and a fourteenth-degree ring pattern with four hydrogen bond acceptors and six donors. This is a result of the ability of the oxygens of sulphate to accept three instead two hydrogen bonds (Table 3.2). 
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Table 3.4: Distances (d) and angles (α) of hydrogen bonds in 3. Standard deviations of the last digit are given in parentheses; values without standard deviation are related to hydrogen atoms at calculated positions. D: donor, A: acceptor. Target values of the H∙∙∙H distance and the O–H distance of the water molecules are restrained to 1.31 Å and 0.74 Å. D-H···A d(D–H)/Å d(H···A)/Å d(D–A)/Å α(D–H···A)/° O1–H11∙∙∙O6I 0.74 1.94 2.685(2) 180 O1–H12∙∙∙O4II 0.74 2.00 2.741(2) 168 O2–H21∙∙∙O6III 0.73 2.01 2.747(3) 173 O2–H22∙∙∙O1III 0.74 2.11 2.857(2) 175 O3–H31∙∙∙O4IV 0.73 2.33 2.949(3) 143 O3–H32∙∙∙O5 V 0.74 1.98 2.727(3) 175 O8–H81∙∙∙O4IV 0.73 2.00 2.728(3) 170 O8–H82∙∙∙O7 0.74 1.96 2.696(3) 172 O9–H91∙∙∙O5 0.73 2.06 2.780(3) 166 O9–H92∙∙∙O7VI 0.73 2.57 3.065(3) 127 O9–H92∙∙∙O8VII 0.73 2.53 3.186(3) 150 O10–H101∙∙∙O5VI 0.73 2.16 2.877(3) 164 O10–H102∙∙∙O7VI 0.73 1.97 2.696(3) 166 O10–H101∙∙∙O4VIII 0.73 2.61 3.145(3) 131 I [−x+1/2, y+1/2, −z+1/2], II [−x+1, y, −z+1/2], III [−x+1/2, y−1/2, −z+1/2], IV [x−1/2, y−1/2, z], V [x−1/2, y+1/2, z], VI [−x+3/2, −y+1/2, −z+1], VII [x+1/2, y−1/2, z], VIII [−x+1, −y+1, −z+1]. Crystal structure of [Ru(H2O)6](1,5-NaphDS) (4) The structure solution of [Ru(H2O)6](1,5-NaphDS) (4) succeeded in the monoclinic space group P21/c. The unit cell contains two formula units (CShMOC-6 value: 0.172, asymmetric unit: half molecule). The structure of 4 is shown in Figure 3.9. The [Ru(H2O)6]2+ complex is coordinated octahedrally whereby small deviations of angles and distances are tentative results of crystal-packing effects. The average Ru–O distance is 2.109 Å. The packing diagram of 4 shows the layer structure, but the sheets of dicationic complex and dianionic naphthalenedisulfonate alternate parallel to the c,b plane (Figure 3.10).
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 Figure 3.9: ORTEP-3 plot (50% probability ellipsoids) of [Ru(H2O)6](1,5-NaphDS) (4).[45] Distances (Å) and angles (°): Ru1−O1 2.111(3), Ru1−O2 2.101(3), Ru1−O3 2.115(3), S1−O4 1.448(3); O4−S1−O5 113.09(19), O1−Ru1−O2 93.56(12). Ci site symmetry.  Figure 3.10: Mercury packing diagram of [Ru(H2O)6](1,5-NaphDS) (4) in the monoclinic space group P21/c with view along [0 1 0] (on the right side). The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), ruthenium (turquoise), sulphur (yellow). The hydrogen bonds are listed in Table 3.5. There are four crystallographically independent hydrogen bonds. The unary graph set is a fourth-degree chain pattern with one hydrogen bond acceptor and one donor, and two eighth-degree ring patterns with two acceptors and two donors. The binary graph set shows a sixth-degree ring pattern with one acceptor and two donor positions and eighth- and sixth-degree chain patterns with two acceptors and two donors. The ternary graph set consists of sixth-degree chain patterns with two hydrogen bond acceptors and three donors and tenth-degree chain pattern with three acceptors and three donors (Table 3.2).  
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Table 3.5: Distances (d) and angles (α) of hydrogen bonds in 4. Standard deviations of the last digit are given in parentheses; values without standard deviation are related to hydrogen atoms at calculated positions. D: donor, A: acceptor. Target values of the H∙∙∙H distance and the O–H distance of the water molecules are restrained to 1.31 Å and 0.82 Å. D-H···A d(D–H)/Å d(H···A)/Å d(D–A)/Å α(D–H···A)/° O1–H11∙∙∙O3I 0.82 2.05 2.853(4) 163 O1–H12∙∙∙O5II 0.82 2.029 2.841(4) 167 O2–H21∙∙∙O4III 0.83 1.87 2.698(4) 174 O2–H22∙∙∙O6II 0.82 1.86 2.690(4) 175 O3–H31∙∙∙O5III 0.82 1.95 2.780(4) 177 O3–H32∙∙∙O6IV 0.83 1.90 2.726(4) 168 I [−x, y+1/2, −z+1/2], II [−x+1, −y+1, −z+1], III [−x+1, −y, −z+1], IV[−x+1, y+1/2, −z+1/2]. Crystal structure of [Ru(H2O)6](4,4’-BiphenDS)∙2H2O(5)  Figure 3.11: ORTEP-3 plot (50% probability ellipsoids) of [Ru(H2O)6](4,4’-BiphenDS) ∙2H2O (5).[45] The structural disorder of the tilted aromatic rings is omitted. Distances (Å) and angles (°): Ru1−O1 2.1043(18), Ru1−O2 2.1209(18), Ru1−O3 2.095(2), S1−O5 1.4773(19); O5−S1−O6 111.66(12), O1−Ru1−O2 93.47(8). Ci site symmetry. 
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23   Figure 3.12: Mercury packing diagram of [Ru(H2O)6](4,4′-BiphenDS)∙2H2O (5) in the triclinic space group P1 with view along [0 1 0] (on the right). The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), ruthenium (turquoise), sulphur (yellow). The disordered part of the biphenyl moiety is omitted.   The structure solution of [Ru(H2O)6](4,4’-BiphenDS)∙2H2O (5) succeeded in the triclinic space group P1. The unit cell contains one formula unit (CShMOC-6 value: 0.228, asymmetric unit: half molecule). The structure of 5 is shown in Figure 3.11. The [Ru(H2O)6]2+ complex is coordinated octahedrally whereby small deviations of angles and distances are tentative results of crystal-packing effects. The biphenyl moiety is disordered (tilted) around the S–S axis. The average Ru–O distance is 2.106 Å. The packing diagram resembles the former layer structures 1–4, a broad sheet of biphenyldisulfonate and a sheet of [Ru(H2O)6]2+ cations alternating along cp (Figure 3.12). The hydrogen bonds are listed in Table 3.6. Two molecules of crystal water (O4) are included. The unary graph set consists only of finite patterns (D). The binary graph set consists of a sixth-degree chain pattern (one acceptor, two donors), another sixth-degree chain pattern (two acceptors, two donors) and an eighth-degree chain (two acceptors, two donors). The ternary graph set consists of an eighth-degree chain pattern with three acceptors and three donors and a tenth degree ring pattern with three acceptors and three donors. And the quaternary graph set has a tenth-degree ring pattern with two acceptors and four donors (Table 3.2).   
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Table 3.6: Distances (d) and angles (α) of hydrogen bonds in 5. Standard deviations of the last digit are given in parentheses; values without standard deviation are related to hydrogen atoms at calculated positions. D: donor, A: acceptor. Target values of the H∙∙∙H distance and the O–H distance of the water molecules are restrained to 1.31 Å and 0.82 Å. D-H···A d(D–H)/Å d(H···A)/Å d(D–A)/Å α(D–H···A)/° O1–H11∙∙∙O4I 0.83 1.85 2.685(3) 176 O1–H12∙∙∙O5I 0.82 2.07 2.874(3) 164 O2–H21∙∙∙O7II 0.82 1.99 2.819(3) 173 O2–H22∙∙∙O5III 0.82 2.03 2.845(3) 165 O3–H31∙∙∙O5IV 0.82 1.97 2.795(3) 175 O3–H32∙∙∙O4 0.82 1.86 2.689(3) 174 O4–H41∙∙∙O6III 0.82 1.89 2.712(3) 172 O4–H42∙∙∙O7I 0.82 1.96 2.786(3) 173 I [x+1, y, z], II [x+2, y+1, z], III [x+1, y+1, z], IV [−x, −y+1, −z]  Crystal structure of [Ru(H2O)6](MesSO3)2 (6) The structure solution of [Ru(H2O)6](MesSO3)2 (6) succeeded in the monoclinic space group P21/c. The unit cell contains four formula unit (CShMOC-6 value: 0.066, asymmetric unit: one molecule). The structure of 6 is shown in Figure 3.13. The [Ru(H2O)6]2+ complex is coordinated octahedrally whereby small deviations of angles and distances are tentative results of crystal-packing effects as well. The average Ru–O distance is 2.112 Å (room temperature measurement). The packing diagram shows layers of mesitylsulfonate and [Ru(H2O)6]2+ alternating parallel to the a,c plane. The orientation of the mesitylsulfonate counterions is almost parallel to the b,c plane (or orthogonal to the a,c plane) (Figure 3.14). The hydrogen bonds are listed in Table 3.7. There are five crystallographically independent hydrogen bonds. This results in a tenth-degree ring pattern with three hydrogen bond acceptors and four donors, a sixth-degree ring pattern with one acceptor and two donors, a twelfth-degree ring pattern with three acceptors and four donors, and an eighth-degree ring pattern with two hydrogen bond acceptors and two donors for the unary graph set (rest: finite patterns). The binary graph set consists, like 1, of eighth- and sixth-degree chain patterns with two hydrogen acceptors and two donors (Table 3.2). 
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  Figure 3.13: ORTEP-3 plot (50% probability ellipsoids) of [Ru(H2O)6](Mes)2 (6).[45] Distances (Å) and angles (°): Ru1−O1 2.106(2), Ru1−O2 2.112(2), Ru1−O3 2.107(2), S1−O7 1.459(2); O8−S1−O7 111.70(12), O1−Ru1−O2 91.28(8). Ci site symmetry of the cation.  Figure 3.14: Mercury packing diagram of [Ru(H2O)6](MesSO3)2 (6) in the monoclinic space group P21/c with view along [1 0 0] (on the right side). The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), ruthenium (turquoise), sulphur (yellow).       
Results 
26  
Table 3.7: Distances (d) and angles (α) of hydrogen bonds in 6. Standard deviations of the last digit are given in parentheses; values without standard deviation are related to hydrogen atoms at calculated positions. D: donor, A: acceptor. Target values of the H∙∙∙H distance and the O–H distance of the water molecules are restrained to 1.31 Å and 0.82 Å. D-H···A d(D–H)/Å d(H···A)/Å d(D–A)/Å α(D–H···A)/° O1–H111∙∙∙O12I 0.82 1.95 2.772(3) 168 O1–H112∙∙∙O7II 0.82 1.95 2.773(3) 171 O2–H21∙∙∙O8 0.82 1.99 2.810(3) 171 O2–H22∙∙∙O11 0.81 1.98 2.799(3) 171 O3–H31∙∙∙O10IV 0.82 1.86 2.664(3) 163 O3–H32∙∙∙O5II 0.82 2.46 2.878(3) 113 O3–H32∙∙∙O12I 0.82 2.34 3.139(3) 164 O4–H41∙∙∙O10III 0.82 2.57 3.140(3) 127 O4–H41∙∙∙O12III 0.82 2.01 2.819(3) 167 O4–H42∙∙∙O7II 0.82 2.01 2.834(3) 178 O5–H51∙∙∙O8II 0.82 1.90 2.725(3) 177 O5–H52∙∙∙O9 0.82 1.97 2.791(3) 169 O6–H61∙∙∙O11 0.82 2.07 2.853(3) 158 O6–H62∙∙∙O9 0.82 2.00 2.806(3) 163 I [−x+1, −y+1, −z+1], II [−x+1, −y+1, −z], III [−x+2, −y+1, −z+1], IV [x−1, y, z].   
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3.2 Tosylato-κ2O,O′ ruthenium complexes with phosphane co-ligands The synthesis of the tosylatoruthenium complexes in small quantities was accomplished according to a procedure by Bailey et al.for [Ru(dppe)2(tos)](tos).[23] Therefore, a broad screening of phosphanes and bisphosphanes was performed, aiming at high quantity and quality crystal yields (chapter 3.2–3.4). The following phosphanes were used for the syntheses of tosylato-κ2O,O′ ruthenium complexes (Scheme 3.4): dppe, dppp, dppbza (21) and PiPrPh2.   Scheme 3.4: Overview of phosphanes used for tosylato-κ2O,O′ ruthenium complexes 7–12. The synthetic route was as follows (Scheme 3.5): A mixture of [Ru(H2O)6](tos)2 (1) or [Ru(H2O)6](MesSO3)2 (6) and the proper phosphane was suspended in THF and stirred. For crystallisation the crude was solved in DCM layered with diethyl ether (or trichloromethane-diethyl ether). The products [Ru(dppe)2(tos)]BF4 (7), [Ru(dppp)2(tos)]BF4 (8), [Ru(dppbza)2(tos)]BF4 (9), [Ru(dppe)2(MesSO3)]BF4 (11) were obtained by addition of tetrafluoroboric acid (in water), [Ru(PiPrPh2)2(tos)2] (10), and [Ru(PiPrPh2)2(MesSO3)2] (12) without additive.  Scheme 3.5: General synthetic procedure for tosylato-κ2O,O′ ruthenium complexes 7 and 12. The complexes 8–11 were made similarly. 
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The compounds 7–12 had homogenous crystal habits and colours and were analysed by infrared, UV/VIS and NMR spectroscopy (Table 3.8). Mass spectroscopy, elemental analysis and powder-X-ray diffraction for 7 and 8 were performed as bulk analyses. The yields of the compounds 7–12 were as follows: 94% (7a), 82% (7b), 89% (8), 66% (9), 82% (10), 90% (11), 66% (12). Table 3.8: Overview of selected IR, UV/VIS and NMR data of compounds 7a–12 (*7b is almost identical to 7a). ** Expected signals reside in the solvent cut-off region. IR spectrum measured on ATR (attenuated total reflection) unit as solid. NMR spectra measured in CD2Cl2 at RT. UV/VIS measured in DCM. *** NMR spectrum measured in CD2Cl2 at 0°. The  (SO) values were taken from quantum chemical calculations, based on DFT.  IR: S–O/cm−1 IR: S–O/cm−1 calcd. UV/VIS: λmax/nm 13C{1H} NMR: δ/ppm (C–CH3) 31P{1H} NMR: δ/ppm [Ru(dppe)2(tos)]BF4 (7a)* 1205, 993 1220, 999 342, 380 142.3 60.3, 46.9 [Ru(dppp)2(tos)]BF4 (8) 1191, 1025 1200, 1034 317, 400 142.0 23.1, −2.9 [Ru(dppbza)2(tos)]BF4 (9) 1273, 1004  1248, 1004 (945) –** 135.5 87.7, 66.2 [Ru(PiPrPh2)2(tos)2] (10) 1190, 1037, 930 1202, 1042, 935 383, 530 143.3 69.2 [Ru(dppe)2(MesSO3)]BF4 (11) 1191, 940 1186, 939 341, 379 140.9 60.5, 57.8, 51.4, 42.9*** [Ru(PiPrPh2)2(MesSO3)2] (12) ≈1200 (sh), 1055, 935 1207, 1058, 935 379, 519 141.0 70.2  Crystal structure of [Ru(dppe)2(tos)]BF4 (7) The structure solution [Ru(dppe)2(tos)]BF4 (7) succeeded in the triclinic space group P1. The unit cell contains two formula units (CShMOC-6 value: 2.293, asymmetric unit: one molecule). The structure of 7 is shown in Figure 3.15. The coordination polyhedron of the cationic complex is best described as distorted-octahedral. Two bisphosphanes and a tosylato-κ2O,O′ ligand which is part of a four-ring chelate coordinate a ruthenium(II) centre.
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 Figure 3.15: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dppe)2(tos)]+ ion in 7 (on the left side).[45] Selected distances (Å) and angles (°): Ru1−O1 2.267(2), Ru1−O2 2.2914(19), Ru1−P1 2.3815(8), Ru1−P2 2.3031(7), Ru1−P3 2.4481(8), Ru1−P4 2.3034(8), S1−O1 1.486(2), S1−O2 1.489(2), S1−O3 1.441(2); O1−Ru1−O2 62.37(7), O3−S1−O1 112.92(12), O3−S1−O2 115.16(12), O1−S1−O2 105.04(11), S1−O1−Ru1 95.42(10), S1−O2−Ru1 94.33(9). Crystals suitable for X-ray diffraction obtained by layering a chloroform solution with diethyl ether. Crystal solvent (trichloromethane) and tetrafluoridoborate counterion are omitted.[39] The four-ring chelate has an acute angle of 62.37° at the central metal (O1−Ru1−O2) and an obtuse angle of 105.04° at the sulphur (O1−S1−O2). The ruthenium-oxygen distance is with 2.267 Å and 2.2914 Å similar to the sulfato-κ2O,O′ ruthenium complex ([Ru(NO)2(PPh3)2(SO4)]) with Ru–O 2.2126 Å (Table 3.9).[158]  Table 3.9: Overview of selected angles (α) and distances (d) of compounds 7–12 and [Ru(NO)2(PPh3)2(SO4)].[158]   α(O−Ru1−O)/° α(O1−S1−O2)/° d(Ru–O)/Å d(Ru–O′)/Å 7 62.37(7) 105.0(1) 2.267(2) 2.291(2) 8 62.10(7) 105.0(1) 2.311(2) 2.255(2) 9 64.00(8) 104.7(1) 2.209(2) 2.249(2) 10 64.53(4)/64.16(4) 106.11(7)/105.04(7) 2.301(1), 2.143(1) 2.283(1), 2.165(1) 11 61.64(7) 104.5(1) 2.237(2) 2.340(2) 12 64.34(6)/64.12(6) 104.94(1)/104.73(9) 2.303(2), 2.134(2) 2.295(2), 2.127(2) [Ru(NO)2(PPh3)2(SO4)][158] 63.44(9) 100.0(1) 2.212(2) 2.212(2)* * symmetry generated The infrared spectrum of 7 shows two bands which can be confirmed by calculation for a coordinated tosylate at 1205 and 999 cm−1. A visualisation is shown in Figure 3.16. The UV/VIS spectrum has two bands at 342 and 380 nm. The signal of the quaternary carbon (C-CH3) of the tosylate in the 13C{1H} NMR spectrum (in DCM, RT) can be identified in the literature.[159-160] The signal appears at 142.3 ppm. The two triplets of the 31P{1H} NMR spectrum locate at 60.3 and 46.9 ppm and resemble well for cis-
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dppe chelates.[23] Elemental analysis confirmed the formation of the complex 7. The HRMS spectrum shows a peak at [M]+ m/z = 1069.11. The calculated powder pattern of the cryogenic single-crystal diffraction measurement (100 K) and the powder pattern of 7 at room temperature agree. Compound 7 is the precursor for compound 28a, 28b, 35 and 39. Due to the similar characteristics of 8–12 compared to 7 the presentation of the complexes is gathered. Important data is summarised in Table 3.8 and Table 3.9.   Figure 3.16: The two stretching vibrations of tosylato-κ2O,O′ ruthenium complex 7. On the left: S–O stretching vibration of the uncoordinated oxygen, weak symmetrically coupled stretching vibration of the coordinated oxygens. On the right: S–O asymmetrically coupled stretching vibration of both coordinated oxygens. (SO) values were taken from quantum-chemical calculations, based on DFT. Similar vibrations are obtained for 8, 9 and 11.  Crystal structure of [Ru(dppp)2(tos)]BF4 (8), [Ru(dppbza)2(tos)]BF4 (9), [Ru(dppe)2(MesSO3)]BF4 (11) The structure solution of [Ru(dppp)2(tos)]BF4 (8) succeeded in the monoclinic space group P21/c, [Ru(dppbza)2(tos)]BF4 (9) in the orthorhombic space group Fdd2 and [Ru(dppe)2(MesSO3)]BF4 (11) in the triclinic space group P1. The unit cell of 8 contains two formula units, 9 eight and 11 two (CShMOC-6 value: 1.780 (8), 4.018 (9), 2.489 (11) asymmetric unit: one molecule in 8, 9, 11). The structures of compounds 8, 9, 11 are shown in Figures 3.18–3.20. Complexes 8 and 9 are distorted-octahedrally coordinated by two dppp or dppbza chelates and a tosylato ligand. Complex 11 is also distorted-octahedral, but with a mesitylsulfonato ligand and two dppe ligands in cis-configuration. The angles and distances of the resulting four-ring chelate of the complexes are almost identical to 7 (Table 3.9). The bulk purity was confirmed by HRMS ([M]+ m/z = 1027.21 (8), 1310.30 (9), [M]+BF4 1183.28), by a comparison of a calculated powder pattern of a cryogenic single crystal analysis and a powder pattern at room temperature for 8 and by elemental analysis for 9 and 11. The formation of 8, 9, 11 is also confirmed by IR, UV/VIS and NMR spectroscopy (Table 3.8). Although, the 31P{1H} NMR spectrum of 11 had to be measured at 0 °C in DCM to obtain four acceptably sharp signals. Two signals (60.6, 57.8 ppm) 
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in the downfield region can be assigned for the cis-standing P atoms. The remaining P atoms have a large trans-coupling with roof effect. These signals were analysed as shown in Figure 3.17. The two highfield signals lay at A = 51.0 and B = 42.6 ppm (each two singuletts) with a coupling constant of JAB = 291.6 Hz (trans-coupling).  Figure 3.17: 31P{1H} NMR spectrum of [Ru(dppe)2(MesSO3)]BF4 (11) in CD2Cl2 at 0 °C (on the left). Used formulas for the determination of the highfield NMR signals in the spectrum of higher order (on the bottom).   Figure 3.18: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 97 K) of the [Ru(dppp)2(tos)]+ ion in 8.[45] Selected distances (Å) and angles (°): Ru1−O1 2.3112(19), Ru1−O2 2.2554(19), Ru1−P1 2.4770(8), Ru1−P2 2.3124(7), Ru1−P3 2.3210(8), Ru1−P4 2.4331(7), S1−O1 1.480(2), S1−O2 1.488(2), S1−O3 1.442(2); O1−Ru1−O2 62.10(7), O3−S1−O1 114.50(13), O3−S1−O2 113.85(12), O1−S1−O2 105.06(11), S1−O1−Ru1 94.32(9), S1−O2−Ru1 96.37(10). Crystal solvent (dichloromethane) and tetrafluoridoborate counterion are omitted.[39]  Figure 3.19: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dppbza)2(tos)]+ ion in 9.[45] Selected distances (Å) and angles (°): Ru1−O1 2.208(3), Ru1−O2 2.251(3), Ru1−P1 2.3468(11), Ru1−P2 2.2693(10), Ru1−P3 2.2664(10), Ru1−P4 2.3814(11), S1−O1 1.496(3), S1−O2 1.487(3), S1−O3 1.434(3); O1−Ru1−O2 63.97(10), P1−Ru1−P2 69.95(4), O3−S1−O1 113.05(18), O3−S1−O2 115.49(19), O1−S1−O2 104.72(16), S1−O1−Ru1 96.27(14), S1−O2−Ru1 94.74(13). Crystal solvent (dichloromethane) and tetrafluoridoborate counterion are omitted. Δ = √; JAB = 	    A= z + 	Δ B= z − 	Δ 
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Figure 3.20: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dppe)2(MesSO3)] ion in 11 (on the left).[45] Distances (Å) and angles (°): Ru1−O1 2.2373(19), Ru1−O2 2.340(2), Ru1−P1 2.4072(8), Ru1−P2 2.2963(8), Ru1−P3 2.4279(8), Ru1−P4 2.3133(8), S1−O1 1.483(2), S1−O2 1.483(2), S1−O3 1.441(2); O1−Ru1−O2 61.64(7). Crystal solvent (dichloromethane) and tetrafluoridoborate counterion are omitted.    
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Crystal structure of [Ru(PiPrPh2)2(tos)2] (10), [Ru(PiPrPh2)2(MesSO3)2] (12) The structure solutions of [Ru(PiPrPh2)2(tos)2] (10) and [Ru(PiPrPh2)2(MesSO3)2] (12) succeeded in the monoclinic space group P21/c. The unit cell of 10 contains four formula units and of 12 eight (CShMOC-6 value: 3.106 (10), 3.328 (12) asymmetric unit: one molecule in 10, two molecules in 12). The structures of 10 and 12 are shown in Figures 3.21 and 3.22. The coordination polyhedron of the cationic complexes is best described as distorted-octahedra. Two diphenyl-i-propylphosphanes and two tosylate ligands coordinate the ruthenium centre in 10, in 12 two phosphanes and two mesitylsulfonate. Both sulfonato ligands form two four-ring chelates. The angles are quite similar to 7, though the distances differ. Instead of two equidistant Ru–O bonds a long bond (≈ 2.3 Å) and a short bond (≈ 2.1 Å) are formed in both tosylate and mesitylsulfonate chelates (Table 3.9). In contrast to 7–9, 11 the di-tosylato complex 10 has three detectable signals/vibrations for the tosylato complex visualised in Figure 3.23. The UV/VIS spectrum of the deep violet compound shows two signals at 383 and 530 nm. The NMR signals of the 13C{1H} spectrum (C–CH3 group of the tosylato ligand, 143.3 ppm) and the 31P{1H} spectrum (a singulett at 69.2 ppm) are as expected. Compound 12 has almost identical analytical values compared to 10 which are listed in Table 3.8. Elemental analysis and HRMS (m /z =811.18 for 10, 839.21 for 12) were performed.   Figure 3.21: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(PiPrPh2)2(tos)2] (10).[45] Distances (Å) and angles (°): Ru1−O1 2.3010(12), Ru1−O3 2.1437(12), Ru1−O4 2.2837(12), Ru1−O6 2.1650(12), Ru1−P1 2.2560(5), Ru1−P2 2.2531(5), S1−O1 1.4760(13), S1−O2 1.4351(13), S1−O3 1.4976(12); O1−Ru1−O3 64.53(4), O4−Ru1−O6 64.16(4).   Figure 3.22: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(PiPrPh2)2(MesSO3)2] (12).[45] Distances (Å) and angles (°): Ru1−O1 2.1280(17), Ru1−O3 2.2955(17), Ru1−O4 2.3034(16), Ru1−O5 2.1343(17), Ru1−P1 2.2492(6), Ru1−P2 2.2436(6), S1−O1 1.5012(17), S1−O2 1.4391(18), S1−O3 1.4747(18); O1−Ru1−O2 64.35(6), O4−Ru1−O5 64.10(6). Crystal solvent (dichloromethane) is omitted.
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  Figure 3.23: The three stretching vibrations of ditosylato-κ2O,O′ ruthenium complex 10. On the left: stretching vibration of the uncoordinated oxygen (S–O, in phase with second tosylate), in the centre: asymmetrically coupled stretching vibration of the coordinated oxygens (S–O, in phase with second tosylate), on the right: symmetrically coupled stretching vibration of the coordinated oxygens (S–O, in phase with second tosylate). 3.3 Diaquaruthenium complexes with phosphane co-ligands The synthesis of the diaquaruthenium complexes was performed according to a procedure by Bailey et al.for [Ru(dppe)2(tos)](tos) as previously shown.[23] The following phosphanes were used for the synthesis of diaqua-ruthenium complexes: dpppha (22), dppen, dppbz and dppv (Scheme 3.6).  N PP PPP P PPdpppha (22),N,N-bis(diphenylphosphanyl)phenylamine dppen,1,1-bis(diphenylphosphanyl)ethenedppbz,1,2-bis(diphenylphosphanyl)benzene dppv,1,2-bis(diphenylphosphanyl)ethene  Scheme 3.6: Overview of phosphanes used for diaquaruthenium complexes 13–16. The synthetic route was identical to chapter 3.2. A mixture of [Ru(H2O)6](tos)2 1 and the appropriate phosphane was suspended in THF and stirred. The crude was solved in DCM or toluene and layered with diethyl ether. The compounds [Ru(dpppha)2(H2O)2](BF4)2 (13), [Ru(dppen)2(H2O)2](tos)2 (14), [Ru(dppbz)2(H2O)2](BF4)2 (15), [Ru(dppv)2(H2O)2](BF4)2 (16) were obatined. For crystallisation the addition of HBF4 in water was necessary for compounds 13, 14 and 15 (Scheme 3.7). 
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 Scheme 3.7: General synthetic procedure for diaquaruthenium complexes 13, 15, 16. Compound 14 could only be obtained with tosylate counterions by layering a toluene solution of 14 with diethyl ether. The crystalline batches of compounds 13, 14, 16 had heterogenous crystal habits. More than one crystalline phase can be identified by colour and shape. Compound 15 has a homogenous appearance in colour and shape. The compounds appear as microcrystalline powder most of the time, whereby a single-crystal-diffraction analysis was possible only for one phase. Nonetheless, these compounds can be used as precursors like compound 16. The compounds were analysed by infrared, UV/VIS and NMR spectroscopy, whereby a “full” characterisation is doubtful as 13, 14, 16 are not pure compounds. This fact is emphasised by elemental analyses and a comparison of a calculated powder pattern of a cryogenic single crystal measurement (100 K) and a powder diffractogram at room temperature (16). HRMS and UV/VIS spectroscopy was used as proof of reproducibility. Please note: The following yields are in the best case an educated guess due to the problem mentioned. Nonetheless, it offers the opportunity to evaluate the approximate requirement for successor reactions. Yields were as follows: ≈ 48% (13), ≈ 54% (14), 62%, (15), ≈23% (16). Crystal structures of [Ru(dpppha)2(H2O)2](BF4)2 (13), [Ru(dppen)2(H2O)2](tos)2 (14), [Ru(dppbz)2(H2O)2](BF4)2 (15), [Ru(dppv)2(H2O)2](BF4)2 (16) The structure solutions succeeded in the triclinic space group P1  for 13 and 16 and in the monoclinic space groups P21/n for 14 and C2/c for 15. The unit cell contains one formula unit in 13 and 16, two in 14 and four in 15 (CShMOC-6 value: 2.486 (13), 1.889 (14), 0.894 (15), 0.820 (16), asymmetric unit: half molecule in 13–16). The structures of 13–16 are shown in Figures 3.24–3.27. The complexes are best described as distorted octahedra, formed by two bisphosphane chelates in equatorial position and two aqua ligands in the axial positions. The Ru–O distance of 16 2.1252 Å is slightly elongated compared to compound 1 with 2.102 Å. The values of 13–15 resemble well with 16. The chelate angle of the bisphosphanes ranges from 69° in 13, over 72° in 14, to 80 and 82° in 15 and 16. The hydrogen bonds are listed in Table 3.11.
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36   Figure 3.24: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dpppha)2(H2O)2]2+ ion in 13 cation.[45] Selected distances (Å) and angles (°): Ru1−O1 2.1254(13), Ru1−P1 2.3351(4), Ru1−P2 2.3396(4); O1−Ru1−O1i 180.0, O1−Ru1−P1 88.79(4), O1−Ru1−P2 90.49(4), P1−Ru1−P2 69.023(16). Crystal solvent (dichloromethane) and tetrafluoridoborate counterions are omitted. Symmetry code: i−x+1, −y+1, −z+1. Ci site symmetry of the cation.  Figure 3.25: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dppen)2(H2O)2]2+ ion in 14.[45] Selected distances (Å) and angles (°): Ru1−O1 2.122(3), Ru1−P1 2.3598(10), Ru1−P2 2.3560(10); O1−Ru1−O1i 180.0, O1−Ru1−P1 88.37(9), O1−Ru1−P2 87.99(9), P1−Ru1−P2 72.34(4). Crystal solvent (dichloromethane) and tetrafluoridoborate counterions are omitted. Symmetry code: i−x, −y+1, −z+1. Ci site symmetry of the cation.  Figure 3.26: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(dppbz)2(H2O)2](BF4)2 (15).[45] Selected distances (Å) and angles (°): Ru1−O1 2.119(2), Ru1−P1 2.3830(8), Ru1−P2 2.119(2); O1−Ru1−O1i 180.0, O1−Ru1−P1 90.20(7), O1−Ru1−P2 84.87(7), P1−Ru1−P2 80.44(3). Symmetry code: i−x+1/2, −y+3/2, −z+1. Ci site symmetry of the cation.  Figure 3.27: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dppv)2(H2O)2]2+ ion in 16.[45] Selected distances (Å) and angles (°): Ru1−O1 2.1252(12), Ru1−P1 2.3641(4), Ru1−P2 2.3849(4); O1−Ru1−O1i 180.0, O1−Ru1−P1 87.97(3), O1−Ru1−P2 96.54(4), P1−Ru1−P2 82.342(14). Tetrafluoridoborate counterions are omitted. Symmetry code: i−x+1, −y+1, −z+1.[39] Ci site symmetry of the cation. 
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Table 3.10: Overview of selected IR, UV/VIS and NMR data of compounds 13–16. IR spectrum measured on ATR (attenuated total reflection) unit as solid. NMR spectra measured in CD2Cl2 at RT. UV/VIS measured in DCM. * Shown: Main signals, subsidiary signals mentioned in the experimental section. ** Additional signals in the solvent-cut off region. The (HOH) values were taken from experimental spectra and quantum chemical calculations, based on DFT.  IR: O–H/cm−1 IR: O–H/cm−1 calcd. UV/VIS: λmax/nm 31P{1H} NMR: δ/ppm 13 ≈3650–3200, 1636 (br) 3508, 3499, 3451, 1630 349, 423 78.7* 14 ≈3000–3250 (br), 1586 3452, 3411, 3387, 1584 364, 428 23.1, 3.14* 15 ≈3650–3200 (br), 1599 3588, 3587, 3358, 1552 434** 50.7 16 ≈3650–3200 (br), 1599 3626, 3382, 1583 360** 69.2, 54.2  Each compound has one crystallographically independent hydrogen bond. The unary graph set is R(6) for 13–16. This means, that the BF4− or tos− counterions saturate both hydrogens of the aqua ligands. The IR signals around 3600–3200 cm−1 and 1580 cm−1 which are vibrations of the aqua ligand indicate the formation of the complexes 13–16. The dried crystalline compound was measured, therefore, the signals have to be ligand signals. The UV/VIS spectra show similar signal sets to previous phosphane complexes (7–9, 11). The 31P{1H} NMR spectrum shows one and two main signals for 13 and 14 and several subsidiary signals, which indicate at least more than one product. A separation by chromatography was not possible. The powder pattern of crystalline product 16 is clearly not identical to the calculated powder pattern derived from the single-crystal diffractogram. Therefore 16 is a mixture of more than one product in the crystalline form, but, in contrast, the 31P{1H} NMR spectrum shows two defined signals, which indicate one solvent species. Compound 15 is a pure compound with one signal at 50.7 ppm (Table 3.10). HRMS signals could not be assigned correctly (except 16), but could be reproduced. Elemental analysis which was tried for 15 is probably affected by a phosphorus error, which adds a proportion of the phosphorus onto the carbon value.[161] Additionally, compound 14 is the trans-analogue of the cis-[Ru(dppen)2(H2O)2]2+ cation synthesised by Bickley et al.[47]   
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Table 3.11: Distances (d) and angles (α) of hydrogen bonds in 13–16. Standard deviations of the last digit are given in parentheses; values without standard deviation are related to hydrogen atoms at calculated positions. D: donor, A: acceptor. Target values of the H∙∙∙H distance and the O–H distance of the water molecules are restrained to 1.31 Å and 0.82 Å. compound D-H···A d(D–H)/Å d(H···A)/Å d(D–A)/Å α(D–H···A)/° 13 O1-H11∙∙∙F1I 0.823 2.00 2.701(2) 142  O1-H12∙∙∙F4I 0.82 2.28 2.871(2) 130 14 O1-H11∙∙∙O2 0.82 2.19 2.793(5) 130  O1-H12∙∙∙O3 0.82 1.97 2.691(4) 145 15 O1-H11∙∙∙F2II 0.82 1.84 2.643(3) 160  O1-H12∙∙∙F1II 0.82 2.25 2.784(3) 122 16 O1-H11∙∙∙F4 0.831 2.30 2.799(2) 118  O1-H12∙∙∙F3 0.828 1.86 2.639(2) 154 I[−x+1, −y+1, −z+1 ], II[ −x+1/2, −y+3/2, −z+1 ]  3.4 Aqua-tosylatoruthenium complexes with phosphane co-ligands The synthesis of the aqua-tosylatoruthenium complexes were made according to a procedure by Bailey et al. for [Ru(H2O)2(PPh3)2(tos)2].[23] The following phosphanes were used for the synthesis of diaquaruthenium complexes: dpppra (23), PPh3, PHtBu2 and PPh2Bn (Scheme 3.8). For [Ru(H2O)2(PPh3)2(tos)2] an elucidation of the crystal structure was desired. The synthetic route was identical to chapter 3.2. A mixture of [Ru(H2O)6](tos)2 1 and the appropriate phosphane was suspended in THF and stirred. The crude was solved in DCM and layered with diethyl ether. The compounds [Ru(H2O)(dpppra)2(tos)](tos) (17), [Ru(H2O)2(PPh3)2(tos)2] (18), [Ru(H2O)2(PHtBu2)2(tos)2] (19), [Ru(H2O)2(PBnPh2)2(tos)2] (20) were obtained (Scheme 3.8). The compounds 17–20 had homogenous crystal habits and colours and were analysed by infrared, UV/VIS and NMR spectroscopy (Table 3.12). Mass spectroscopy and elemental analysis were performed as bulk analyses. The yields of the compounds 17–20 were as follows: 44% (17), 56% (18), 54% (19), 35% (20).  
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[Ru(H2O)6](tos)2[Ru(H2O)2(PHtBu2)2(tos)2] (19) [Ru(H2O)2(PPh3)2(tos)2] (18)[Ru(H2O)2(PBnPh2)2(tos)2] (20)[Ru(H2O)(dpppra)2(tos)](tos) (17) PHPHtBu2PPPh3PPBnPh2PNPdpppra (23) THFRT  Scheme 3.8: General synthetic procedure for aqua-tosylatoruthenium complexes 17–19 and overview of the phosphane ligands used.   Crystal structure of [Ru(H2O)(dpppra)2(tos)](tos) (17)  Figure 3.28: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dpppra)2(H2O)(tos)] ion in 17.[45] Distances (Å) and angles (°): Ru1−O1 2.1912(16), Ru1−P1 2.3416(6), Ru1−O3 2.1952(16), O3−S1 1.4939(17), S1−O2 1.4526(19); P1−Ru1−P2 69.60(2), P1−Ru1−O1 88.65(5), P1−Ru1−O3 99.55(5), O1−Ru1−O3 79.00(6), O3−S1−O2 111.04(10). Crystal solvent (toluene) and tosylate counterion are omitted. The structure solution succeeded in the monoclinic space group P21/n. The unit cell contains four formula units (CShMOC-6 value: 2.831, asymmetric unit: one molecule). The structure is shown in Figure 3.28. The ruthenium(II) centre is coordinated distorted octahedrally by two cis-standing 
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bisphosphane ligands (dpppra (23)) and a tosylato ligand tending towards an aqua ligand (hydrogen bridge). The distance Ru–O (tos) with 2.1952 Å and Ru–O (aqua) with 2.1912 Å resemble well with both tosylato and diaqua complexes (Table 3.9 and Figures 3.24–3.27). The chelate angle of the bisphosphane ligand of 70° is in the same range as for the other complexes (9 and 13) with diphenylphosphanylamine ligands. The orientation of the tosylato ligand is caused by a hydrogen bond between a sulfonate oxygen and the coordinated aqua ligand (∙∙∙H–OH). The tosylato counterion saturates the second hydrogen. The hydrogen bond of compound 17 and the bonds of the following compounds 18–20 are listed in Table 3.13 in the next section. The unary graph set consists of an intramolecular hydrogen bond S		(6) and a finite pattern D (O1–H11a∙∙∙O5I). Table 3.12: Overview of selected IR, UV/VIS and NMR data of compounds 17-20. IR spectrum measured on ATR (attenuated total reflection) unit as solid. NMR spectra measured in CD2Cl2 at RT. UV/VIS measured in DCM. The (SO) and (HOH) values were taken from experimental spectra and quantum chemical calculations, based on DFT.  IR: O–H/cm−1, SO/cm−1 IR: O–H/cm−1, SO/cm−1 calcd. UV/VIS: λmax/nm 31P{1H} NMR: δ/ppm 17 3350–3057, 1623, 1200(sh), 1011, ≈ 950 (sh) 3688, 2965, 1612, 1220, 1016, 952 306, 362 83.6, 62.2 18 3349 (br), 1111, 1024, 858 3539, 3505, 3356, 3291, 1109, 1057, 859 372, 474 52.6 19 3328 (br), 1126, 1087, 1025, 920 3395, 3381, 3334, 1147, 1113, 1058, 940 377, 516 75.0 20 ≈3400 (br), 3376 (br), 1180, 1151, 1025, 917 3442, 3324, 3274, 1180, 1143, 1058, 939 360, 463*** 59.8  There are both aqua and tosylato ligand signals detectable in the IR spectrum Table 3.12. An illustration of the vibrations is given in Figure 3.29. The UV/VIS signals are in the same range as for previous complexes (7–9, 11, 13–16). Two triplets are detectable for 17 in the 31P{1H} NMR spectrum as 
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expected for two cis-standing bisphosphane ligands (dpppra) in this complex. Elemental analysis succeeded and HRMS with m/z= 1127.24 and 1209.29 are repeatable mass peaks for this complex.  Figure 3.29: Symmetrically and asymmetrically coupled vibrations of aquatosylato complex 17. a) Stretching vibration of the hydrogen of the aqua ligand pointing away from the tosylato ligand, b) stretching vibration of the hydrogen pointing toward the tosylato ligand, c) scissoring of the aqua ligand, d) S–O stretching vibration of the uncoordinated oxygen of the tosylato ligand pointing away from the aqua ligand, e) wagging of the hydrogen of the aqua ligand pointing towards the tosylato ligand, f) S–O stretching vibration of the oxygen of the tosylato ligand coordinated to the ruthenium centre. The values of the different vibrations were taken from quantum-chemical calculations based on DFT.   Crystal structure of [Ru(H2O)2(PPh3)2(tos)2] (18), [Ru(H2O)2(PHtBu2)2(tos)2] (19), [Ru(H2O)2(PBnPh2)2(tos)2] (20) The structure solutions succeeded in the triclinic space group P1  for 18, and in the monoclinic space groups C2/c and P21/n for 19 and 20. The unit cells contain two formula units in 18 and four formula units each in 19 and 20 (CShMOC-6 value: 0.563 (18), 0.677 (19), 0.534 (20) asymmetric unit: one molecule in 18 and 20, half molecule in 19). The crystal structures are shown in Figures 3.30–3.32. The ruthenium centre in 18–20 is coordinated octahedrally by two, cis-standing phosphane ligands (equatorial), two trans-standing tosylato ligands (axial) oriented towards two cis-standing aqua ligands (equatorial). The distances between the tosylato ligands and the ruthenium centre are shorter (≈ 2.12 Å) compared to tosylato-κ2O,O′ complexes (7–9) (≈ 2.26 Å), while the aqua ruthenium distance is 
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slightly longer (≈ 2.21 Å (18–20)↔ 2.11 Å (13–16)). The formed hydrogen bonds are listed in Table 3.13. In compound 18 and 19 the hydrogen bond network is exclusively intramolecular (between tosylato and aqua ligand), while in compound 20 an intermolecular hydrogen bond between two complexes is formed additionally. Since all four hydrogen bonds are crystallographically dependent, a ring pattern is formed (N1 = R(12) in 18. In 19, the unary is N1 = DD and the binary graph set N2 = R(10). In 20, the unary graph set consists of a ring pattern and a finite pattern N1 = R(12)D. The binary graph set regarding the intermolecular bond between two complex molecules consists of a ring pattern R(4).    Figure 3.30: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(PPh3)2(H2O)2(tos)2] (18).[45] Distances (Å) and angles (°): Ru1−O1 2.1261(17), Ru1−P1 2.2753(7), Ru1−O7 2.2158(18), O1−S1 1.4927(18), S1−O2 1.453(2); P1−Ru−O7 93.98(5), P1−Ru1−O1 94.28(5), O1−Ru1−O7 90.87(7), O1−S1−O3 111.26(11). Crystal solvent (diethyl ether) is omitted.  Figure 3.31: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(PHtBu)2(H2O)2(tos)2] (19).[45] Distances (Å) and angles (°): Ru1−O1 2.2245(12), Ru1−P1 2.2933(4), Ru1−O3 2.1416(11), O3−S1 1.4904(12), S1−O2 1.4570(13); P1−Ru−O1 89.60(3), P1−Ru1−O3 97.82(3), O1−Ru1−O3 85.98, O3−S1−O2 112.51(7). Symmetry code: i −x+1, y, −z+1/2. Ci site symmetry.   Figure 3.32: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 293 K) of [Ru(PPh2Bn)2(H2O)2(tos)2] (20) (On the left side).[45] Distances (Å) and angles (°): Ru1−O1 2.1993(16), Ru1−P1 2.2586(6), Ru1−O3 2.1248(15), O3−S1 1.4887(16), S1−O5 1.4506(17); P1−Ru1−O1 91.59(5), P1−Ru1−O3 93.84(5), O1−Ru1−O3 91.36(6), O3−S1−O5 111.83(10). Crystal solvent (diethyl ether) is omitted. 
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The IR spectrum shows a broad signal at around 3350 cm−1 for the aqua ligands and distinctive signals in the area around 1180–858 cm−1 for the tosylato ligands (Table 3.12). A visualisation and description of the different vibrations for 19 are shown in Figure 3.33. The UV/VIS signals of 18–20 are in the same range as for previous complexes (7–9, 11, 13–16) and one singulett is detectable in a 31P{1H} NMR spectrum confirming the cis-standing, chemically equivalent phosphane ligands. Elemental analysis confirmed the formation of complexes 18–20. HRMS was performed and shows reproducible peaks at m/z = 838.12 for 18, 606.19 for 19 and 866.16 for 20. Table 3.13: Distances (d) and angles (α) of hydrogen bonds in 17–20. Standard deviations of the last digit are given in parentheses; values without standard deviation are related to hydrogen atoms at calculated positions. D: donor, A: acceptor. Target values of the H∙∙∙H distance and the O–H distance of the water molecules are restrained to 1.31 Å and 0.82 Å. compound D-H···A d(D–H)/Å d(H···A)/Å d(D–A)/Å α(D–H···A)/° 17 O1–H11a∙∙∙O5I 0.83 1.79 2.621(3) 174  O1–H12a∙∙∙O2 0.83 1.90 2.720(2) 169 18 O7–H71∙∙∙O6 0.82 2.11 2.803(3) 140  O7–H72∙∙∙O3 0.83 2.112 2.760(3) 135  O8–H81∙∙∙O4 0.83 1.940 2.711(3) 154  O8–H82∙∙∙O2 0.83 2.00 2.781(3) 155 19 O1–H11∙∙∙O2 0.822 1.89 2.658(2) 154  O1–H12∙∙∙O4II 0.821 2.05 2.793(2) 150 20 O2–H21∙∙∙O8 0.823 1.99 2.754(3) 154  O2–H22∙∙∙O4 0.827 2.02 2.795(3) 155  O1–H11∙∙∙O7 0.822 2.02 2.769(3) 150  O1–H12∙∙∙O5 0.818 2.26 2.808(2) 125  O1–H12∙∙∙O5III 0.818 2.08 2.832(2) 151 I[ −x+1, −y+1, −z+1 ], II[ −x+1, y, −z+1/2 ], III[ −x, −y+2, −z+1 ] 
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44   Figure 3.33: Symmetrically and asymmetrically coupled vibrations of aqua and tosylato ligands of compound 19. a) asymmetrically coupled stretching vibration of the aqua ligands (in phase), b) asymmetrically coupled stretching vibration (aphasic) of the aqua ligands, c) symmetrically coupled stretching vibration (in phase) of the aqua ligands, d) asymmetrically coupled stretching vibration of the uncoordinated S–O oxygens, asymmetrically coupled scissoring of the hydrogens of the aqua ligands, e) S–O stretching vibration (in phase), f) S–O stretching vibration (aphasic), g) S–O stretching vibration (aphasic), asymmetrically coupled twisting of the hydrogens of the aqua ligands. The values of the different vibrations were taken from quantum-chemical calculations based on DFT. Vibrations of 18 and 20 are similar. 3.5 Short excursion: bisphosphanes dppbza (21), dpppha (22), dpppra (23) The bisphosphanes dppbza (21), dpppha (22), dpppra (23) were reproduced from literature.[162-164] Chlorodiphenylphosphane was solved in DCM and treated with one equivalent of benzylamine, aniline or propylamine in presence of triethylamine. After addition of a second equivalent, stirring overnight and evaporation of the solvent, the residue was resolved in DCM and crystallised by layering with acetonitrile (Scheme 3.9). The yields were as follows: 36% (21), 71% (22), 61% (23). Elemental analysis and HRMS (for 23: m/z = 428.16 ([M–H]+, C27H28NP2)) were performed as bulk analyses. Decoupled 13C{1H}- and 31P{1H} NMR spectra (THF-d8) confirm the published ppm values.[165] 
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45   Scheme 3.9: General synthetic procedure for amine bisphosphane ligands dppbza 21, dpppha 22, dpppra 23.  3.6 Reaction of complexes [Ru(dppe)2(tos)]BF4 (7) and [Ru(H2O)6] (tos)2 (1) with NO The previously shown phosphaneruthenium complexes were treated with NO gas to investigate their reaction behaviour in terms of hyponitrite formation. Please note: Despite only four complexes obtained, most of the phosphane complexes (7–20) were tested, whereby either a nitrosyl complex or even a hyponitrite complex was aim of this reaction. Complexes that did not crystallise or reactions in which the phosphorus of the phosphane was oxidised are not discussed in this work.  The general procedure was as follows: The starting complex was solved in a suitable solvent (DCM or EtOH) and treated in absence of oxygen with nitrogen monoxide. For 24 a reducing agent (tden) was added previously to investigate, whether a reductive coupling of NO was possible. Using different counterions (tos− and BF4−) and a different reaction time resulted in complexes 25 and 26. And by adding PPh3 to the process in excess to 1 compound 27 was formed. A detailed discussion of the reaction pathways is given in chapter 4.3. After removal of the solvent, the crude was solved in DCM and layered with diethyl ether. The compounds [Ru(dppe)2(H)(NO2)] (24), [Ru(dppe)2(NO)](tos) (25), [Ru(dppe)2(NO)F]SbF6 (26), [Ru(PPh3)2(NO)2] (27) were obtained (Scheme 3.10). Compound 25 was originally synthesized by Townsend et al. and the crystal structure described by Pierpont et al.[166] Compound 27 was synthesised by Gaughan et al. using a different synthetic method.[167] In contrast to standard synthetic procedures, complex 27 was formed by reaction of a ruthenium complex with 
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gaseous NO. The crystals of compounds 24–27 had homogenous habits and colours in presence of powdery side products. As far as possible the complexes were analysed by infrared and NMR spectroscopy. Mass spectroscopy and elemental analysis were performed as bulk analyses. The yields of the compounds 24–27 were as follows: few crystals (24), few crystal agglomerates (25), 45% (26), 30% (27). In general, the nitrosyl complexes are described using the Enemark-Feltham notation.[168] [Ru(dppe)2(tos)]BF4 (7)[Ru(dppe)2(tos)](tos) (7)[Ru(H2O)6](tos)2 (1) toluene, 72 °CNNNNtden, NO [Ru(dppe)2(H)(NO2)] (24)NODCM, RT [Ru(dppe)2(NO)](tos) (25)[Ru(dppe)2(tos)]BF4 (7) NO, SbF6xH2ODCM, RT, 24 h [Ru(dppe)2(NO)F](SbF6)2 (26)NO, PPh3EtOH, RT [Ru(PPh3)2(NO)2] (27)  Scheme 3.10: General synthetic procedure for complexes 24–27. Crystal structure of [Ru(dppe)2(H)(NO2)] (24)  Figure 3.34: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(dppe)2(H)(NO2)] (24).[45] Distances (Å) and angles (°): Ru1−N1 2.193(3), Ru1−H1 1.49(4), Ru1−P1 2.3329(11), Ru1−P2 2.3363(11), N1−O1 1.251(4), N1−O2 1.214(4); H1−Ru1−N1 179.4(17), P1−Ru1−P2 82.31(4), O1−N1−O2 119.0(3), Ru1−N1−O1 118.9(2).  Figure 3.35: Difference-Fourier map of 24. Shown: ΔF analysis, prior to the H atom’s assignment (H1), in terms of the residual density’s height and position along the tentative H–Ru bond: difference Fourier peak (0.82 e Å −3), distance from Ru1 (1.237 Å), refined distance (1.49(4) Å), Uiso (0.025(11) Å2). 
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The structure solution succeeded in the monoclinic space group P21/n. The unit cell contains four formula units (CShMOC-6 value: 2.634, asymmetric unit: one molecule). The structure is shown in Figure 3.34. The complex is a distorted octahedron. The ruthenium centre is coordinated equatorially by two dppe ligands, while the two axial positions are occupied by a nitrito-κN and a hydrido ligand. Due to almost immediate dissolution of the crystals when taken out of the mother liquor, further analytics were not possible. Nonetheless, the X-ray method allows a particularly reliable assignment of the tentative hydrogen (H1) on basis of a data set of very good quality. The Difference-Fourier map including the relevant data of the tentative hydrogen bond is shown in Figure 3.35, whereby a Ru–H bond is evident. The occurrence of this complex correlates always with the occurrence of compound 25. If an apparatus is used with nearly complete water exclusion (i.e. without wash bottles, using dried solvent etc.) compound 24 could not be obtained.  Crystal structure of [Ru(dppe)2(NO)](tos) (25) [Ru(dppe)2(NO)F]SbF6 (26)  Figure 3.36: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 98 K) of the [Ru(dppe)2(NO)] ion in 25.[45] Distances (Å) and angles (°): Ru1−N1 1.7926(16), N1−O1 1.190(2), Ru1−P1 2.3366(5), Ru1−P2 2.3619(5), Ru1−P3 2.3583(5); Ru1−N1−O1 177.59(16), P1−Ru1−P2 78.097(17), P1−Ru1−P3 103.880(18). Crystal solvent (dichloromethane) and tosylate counterion are omitted.   Figure 3.37: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(dppe)2(NO)F] (26).[45] Distances (Å) and angles (°): Ru1−N1 2.02(2)*, N1−O1 1.02(2), Ru1−F7 1.774(10), Ru1−P1 2.4361(12), Ru1−P2 2.4452(12); Ru1−N1−O1 178.9(14), F1–Ru1−N1 178.6(7), P1−Ru1−P2 81.33(4). Symmetry code: I −x+2, −y+1, −z (substitutional disorder of F7 and N1–O1 omitted for reasons of clearity). The structure solutions succeeded in the triclinic space group P1  for 25 and 26. The unit cells contain two and one formula units for 25 and 26 (CShMTBPY-5 value: 1.180, CShMOC-6 value: 1.964, asymmetric unit: one molecule in 25, half molecule in 26). The structures are shown in Figures 3.36 and 3.37. The complex cation in 25 is coordinated in a distorted trigonal-bipyramidal fashion in accordance with 
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literature.[166] The bisphosphane ligands occupy both axial positions and one equatorial position. The NO ligand is in the remaining position. The Ru–N–O moiety is almost linear with 177.59° and is described best as {RuNO}8, most likely a d8 Ru(0) NO+ complex. This is emphasised by a N–O bond length of 1.190 Å and a Ru–N bond length of 1.7926 Å. The crystallographic data is similar to the previously given literature (Table 3.14).[166] A shortened Ru–N bond indicates for 25 a back donation from the ruthenium centre into π* orbitals of the nitrosyl ligand. The values for compound 26 are not reliable in terms of distances and angles regarding the F–Ru–N–O axis due to a disorder of the F and NO position on an inversion centre. Nonetheless, a {RuNO}6 complex is a reasonable choice to describe this distorted octahedrally coordinated complex. Two dppe ligands coordinate equatorially, while a NO and a fluorido ligand occupy the axial positions (occupation: N–O 50% - F 50%). In comparison to K[Ru(NO)Cl3(mal)] (mal: maltol) the NO distance is shortened, the Ru–N distance is elongated and the R–N–O angle is quite similar.[169] Therefore, to confirm the oxidation state of complex 26 spectroscopic analysis has to be performed. Table 3.14: Overview of the bond distances (d) and angles (α) of compound 25 and 26 together with [Ru(dppe)2(NO)]BPh4 {RuNO}8 and K[Ru(NO)Cl3(mal)] {RuNO}6.[169] IR spectrum measured on ATR (attenuated total reflection) unit as solid. NMR spectra measured in CD2Cl2 at RT.  d(NO)/Å d(RuN)/Å α(RuNO)/° (NO)/cm−1 31P{1H} NMR δ/ppm [Ru(dppe)2(NO)]BPh4[166] 1.20 (1) 1.74(1) 174 (1) 1673 – [Ru(dppe)2(NO)](tos) (25) 1.190(2) 1.792(2) 177.5(2) 1665 61.4, 31.8 K[Ru(NO)Cl3(mal)] (mal: maltol)[169] 1.149(4) 1.735(3) 174.4(2) 1857 – [Ru(dppe)2(NO)F]SbF6 (26)* 1.02(2) 2.02(2) 178.6(7) 1846 41.5 (d, J = 34.6 Hz) * disorder of F and N–O on an inversion centre. Reduced reliability of the given values. A comparison of the NO stretching vibrations shown in Table 3.14 between compound 25, 26 with literature values confirms the proposed oxidation states. A comparison of the compounds among themselves makes the differentiation between a {RuNO}8 and {RuNO}6 even clearer. The 31P{1H} NMR spectra show two signals for the chemically independent phosphorus atoms for compound 25 and one duplet for the four chemical dependent phosphorus atoms coupled with the 19F ligand for compound 26 which emphasises the coordination of only one fluorido and a nitrosyl ligand. Compound 25 is exclusively formed in the absence of a reductive agent or a BF4 counterion. Compound 26 is formed from 25 after a period of time by consumption of parts of the BF4 or SbF6 counterions, visible through 
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colour change from red-brown 25 to citron yellow 26. High resolution mass spectroscopy confirmed the formation of the complexes (m/z = 928.17 (25), 1052.15. (26)). Crystal structure of [Ru(PPh3)2(NO)2] (27)  Figure 3.38: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(PPh3)2(NO)2] (27).[45] Distances (Å) and angles (°): Ru1−N1 1.797(5), N1−O1 1.183(7), Ru1−N2 1.802(5), N2−O2 1.177(6), Ru1−P1 2.3367(15), Ru1−P2 2.3415(15); N1–Ru1–N2 141.9(2), Ru1−N1−O1 169.9(5), Ru1−N2−O2 172.8(5), P1−Ru1−P2 104.87(5). The structure solution succeeded in the monoclinic space group P21/n. The unit cell contains four formula units (CShMT-4 value: 2.131, asymmetric unit: one molecule). The structure is shown in Figure 3.38. Compound 27 is coordinated distorted tetrahedrally by two triphenylphosphane and two nitrosyl ligands. A comparison of the bond lengths and angles of compound 27 are almost identical to published values.[158, 167] The Ru–N–O angle is 170° and 173° therefore, the nitrosyl ligands bind nearly linear. The NO ligands point away from each other. A shortened NO distance indicates a back donation of the ruthenium centre in the π* orbitals of the nitrosyl ligand. The infrared bands at 1651 ((NO)sym) and 1605 ((NO)asym) and the 31P{1H} NMR signal of the chemically equivalent phosphorus atoms at 54.8 ppm resemble well with already published values of the {Ru(NO)2}10 complex.[158] An elemental analysis validates the formation. Bhaduri et al. obtained originally the crystal structure of 27.[170]    
Results 
50  
3.7 Hydrogenhyponitrito and hyponitritoruthenium complexes with bisphosphane co-ligands After a reductive coupling of two nitrogen monoxide molecules was not possible a different approach for hyponitrito complexes was performed. To obtain hydrogenhyponitrito compounds the crude of the respective phosphane complexes (7, 8, 16) were solved in DCM and under cryogenic conditions (−72 °C) triphenylstannylhyponitrite (34) solved in DCM was added. After addition of tetrafluoroboric acid (in water) and intensive stirring tentative stannyl derivatives precipitated, while the hydrogenhyponitrito complex remained in solution. Evaporation of the main volume of the solvent, filtration and layering with diethyl ether leads to crystal growth beside another precipitation of tentative stannyl derivatives. The grown crystals were then big enough to pick them manually (Scheme 3.11). The procedure was tested with more compounds than 7, 8, 16 but these syntheses did not succeed. The compounds [Ru(dppe)2(N2O2H)]BF4∙Et2O (28a), [Ru(dppe)2(N2O2H)]BF4 (28b), [Ru(dppp)2(N2O2H)]BF4∙Et2O (29), [Ru(dppv)2(N2O2H)]BF4∙TBME (30) were obtained. Preparation of hyponitrito complexes from this reaction set-up (for example by leaving out tetrafluoroboric acid) was not possible. A reaction with sodium hyponitrite or silver hyponitrite was not possible as well and leads to decomposition of the hyponitrite precursors. The yields were as follows: 80% (28a), 78% (29), 24% (30). The hydrogenhyponitrito complexes (28–30) were analysed by IR, UV/VIS (solution and solid-state), NMR (solution and solid-state) spectroscopy. HRMS was performed as bulk analysis.  To obtain the corresponding hyponitrito complexes compounds 28–30 were solved in DCM and treated with imidazole (Imi) as amine base. The deprotonation was indicated by a colour change (Table 3.15). The solution was then layered with diethyl ether and crystallised (Scheme 3.11). Compounds [Ru(dppe)2(N2O2)]∙HImi(BF4) (31), [Ru(dppp)2(N2O2H)]BF4∙Imi (32) and [Ru(dppv)2(N2O2)]∙HImi(BF4)∙Imi (33) were obtained, whereby 32 was not deprotonated by imidazole. A reaction with diisopropylethylamine (DPEA, Hünig's base) and diazabicycloundecene (DBU) is possible, but only crystal structures with disorder in the amine cation were obtained. The yields of the compounds were as follows: 83% (31), 72% (32), 91% (33). These compounds were analysed by IR and UV/VIS spectroscopy and HRMS was performed as bulk analysis. Complexes 28–33 are the first mononuclear trans-hyponitrito/hydrogenhyponitrito complexes synthesised. Table 3.15: Overview of the colour changes before and after the addition of imidazole.[39] 28 → 31 red-orange → yellow 29 → 32 brown-red → brown-red 30 → 33 yellow → pale yellow 
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51   Scheme 3.11: Formation of the compounds 7–16 and their usage as precursor for the hydrogenhyponitrito compounds 28–30, followed by the formation of the hyponitrito compounds 31–33. On the bottom: formation of 28 and 31 starting with precursor 7. The reaction using 8 and 16 are identical.[39] Crystal structure of [Ru(dppe)2(N2O2H)]BF4∙Et2O (28a), [Ru(dppe)2(N2O2H)]BF4 (28b), [Ru(dppp)2(N2O2H)]BF4∙Et2O (29), [Ru(dppv)2(N2O2H)]BF4∙TBME (30) The structure solution succeeded in the orthorhombic space group Pbca for 28a, the monoclinic space group P21/n for 28b and 29 and the monoclinic space group P21/c for 30. The unit cells contain eight formula units for 28a and four formula units each for 28b, 29 and 30 (CShMOC-6 value: 3.622 (28a), 3.442 (28b), 2.711 (29), 2.775 (30), asymmetric unit: one molecule in 28a–30). The structures are shown in Figures 3.39–3.42. The complexes are best described as distorted octahedra. The ruthenium centres are coordinated by two cis-standing bisphosphane ligands and a hydrogenhyponitrite which coordinates κ2N,O forming a chelate four-ring. The bond distances and angles are listed in Table 3.16. The hydrogenhyponitrito ligand resembles trans-H2N2O2 and the trans-N2O22− anion in the sodium salt in terms of bond distances, whereas the angles about the nitrogen atoms are enlarged for the hydroxy-bonding N, and diminished for the chelate-N. The dominant motif of the crystal structures shown is the hydrogen bond between a hydrogenhyponitrite unit and an ether acceptor (diethyl ether or TBME). If 28 is crystallised from DCM/toluene (a solvent free from acceptor positions) the tetrafluoridoborate counterion forms a hydrogen bond with the hydrogenhyponitrite donor (see 28b). The hydrogen bonds of compounds 28–33 are listed in Table 3.17. An example of a hydrogen bond between a tetrafluoridoborate counterion or a carbonyl co-ligand and a ligand is known for the dinuclear hydrogenhyponitrito complexes of Böttcher et al.[99, 106] 
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52   Figure 3.39: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(dppe)2(N2O2H)]BF4∙Et2O (28a).[45] Distances (Å) and angles (°): Ru1−N2 2.151(2), Ru1−O1 2.1728(17), Ru1−P1 2.3875(6), Ru1−P2 2.3357(6), Ru1−P3 2.3229(6), Ru1−P4 2.3725(6), N1−N2 1.258(3), N1−O1 1.309(3), N2−O2 1.384(3); N2−Ru1−O1 56.92(7), N2−N1−O1 106.77(19), N1−O1−Ru1 96.77(13), N1−N2−O2 115.72(19), N1−N2−Ru1 99.53(15), O2−N2−Ru1 144.55(15).[39]   Figure 3.40: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(dppe)2(N2O2H)]BF4 (28b).[45] Distances (Å) and angles (°): Ru1−N2 2.150(2), Ru1−O1 2.1624(18), Ru1−P1 2.3710(7), Ru1−P2 2.3259(7), Ru1−P3 2.3513(7), Ru1−P4 2.3709(7), N1−N2 1.269(3), N1−O1 1.329(3), N2−O2 1.392(3); N2−Ru1−O1 57.38(8), N2−N1−O1 105.7(2), N1−O1−Ru1 97.05(14), N1−N2−O2 112.0(2), N1−N2−Ru1 99.68(16), O2−N2−Ru1 145.69(18).[39]    Figure 3.41: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(dppp)2(N2O2H)]BF4∙Et2O (29).[45] Distances (Å) and angles (°): Ru1−N2 2.201(3), Ru1−O1 2.137(2), Ru1−P1 2.4144(9), Ru1−P2 2.3404(8), Ru1−P3 2.3183(9), Ru1−P4 2.4112(9), N1−N2 1.236(4), N1−O1 1.307(4), N2−O2 1.380(4); N2−Ru1−O1 56.99(11), N2−N1−O1 109.0(3), N1−O1−Ru1 97.4(2), N1−N2−O2 113.3(3), N1−N2−Ru1 96.6(2), O2−N2−Ru1 150.1(2). Crystal solvent (dichloromethane) and tetrafluoridoborate counterion are omitted.[39]  Figure 3.42: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(dppv)2(N2O2H)]BF4∙0.81TBME (30).[45] Distances (Å) and angles (°): Ru1−N2 2.120(3), Ru1−O1 2.163(3), Ru1−P1 2.3465(11), Ru1−P2 2.3025(11), Ru1−P3 2.2885(10), Ru1−P4 2.3510(11), N1−N2 1.287(5), N1−O1 1.346(5), N2−O2 1.343(5); N2−Ru1−O1 58.68(13), N2−N1−O1 105.7(3), N1−O1−Ru1 95.8(2), N1−N2−O2 113.6(3), N1−N2−Ru1 99.8(3), O2−N2−Ru1 146.5(3). Crystal solvent (dichloromethane) is omitted.[39] 
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Table 3.16: Overview of bond distances (d) and angles (α) of free hyponitrite fragments from Reference 171 and the products of this work.[39, 171]  compound fragment/ ligand d(NN)/Å d(N–O)/Å α(N–N–O)/° [HEt2NCH2CH2NEt2H] [N2O2H]∙H2N2O2[171] H2N2O2 1.226(4) 1.363(3) 109.9(3) HN2O2− 1.232(3) 1.371(3) (–O−) 110.1(2) (–O−)    1.402(3) (–OH) 108.2(2) (–OH) Na2N2O2∙5H2O[171] N2O22− 1.256(2) 1.3622(11) 112.14(9) protonated compounds 28a HN2O2− 1.258(3) 1.309(3) (–O–Ru) 106.77(19) (–O–Ru)    1.384(3) (–OH) 115.72(19) (–OH) 29 HN2O2− 1.236(4) 1.307(4) (–O–Ru) 109.0(3) (–O–Ru)    1.380(4) (–OH) 113.3(3) (–OH) 30 HN2O2− 1.287(5) 1.346(5) (–O–Ru) 105.7(3) (–O–Ru)    1.343(5) (–OH) 113.6(3) (–OH) 32 HN2O2− 1.263(3) 1.348(3) (–O–Ru) 105.74(18) (–O–Ru)    1.370(3) (–OH) 113.72(18) (–OH) deprotonated compounds 31 N2O22− 1.260(3) 1.369(3) (–O–Ru) 104.7(2) (–O–Ru)    1.345(3) (–O−) 116.0(2) (–O−) 33 N2O22− 1.268(3) 1.383(2) (–O–Ru) 105.71(17) (–O–Ru)    1.323(2) (–O−) 117.06(18) (–O−)  Crystal structure of [Ru(dppe)2(N2O2)]∙HImi(BF4) (31), [Ru(dppp)2(N2O2H)]BF4∙Imi (32) and [Ru(dppv)2(N2O2)]∙HImi(BF4)∙Imi (33) The structure solutions succeeded in the orthorhombic space group P212121 for 31 and the monoclinic space group P21/n for 32 and 33. The unit cells contain four formula units for 31–33 each. (CShMOC-6 value: 3.309 (31), 2.671 (32), 2.849 (33), asymmetric unit: one molecule in 31–33). The crystal structures are shown in Figures 3.44–3.46. The coordination form is identical to compounds 28–30. A ruthenium centre is coordinated by two bisphosphane ligands (dppe, dppp, dppv) and a hyponitrito (hydrogenhyponitrito for 32) ligand which forms a four-ring chelate. Protonated imidazole (HImi) replaces the ether-hydrogen-bond acceptor (or BF4−-acceptor) in compound 31 and 33. In compound 32 the hydrogenhyponitrite moiety is not deprotonated by imidazole. Nonetheless, imidazole replaces also the ether acceptor. In 33, a complex H-bond system was formed by imidazolium and imidazole 
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(Figure 3.43). In contrast, 31 was a fragment of 32 forming only one H-bond (N4H7∙∙∙O1). The hydrogen bonds of the compounds 31–33 are listed in Table 3.17. The bond distances and angles are almost unaltered after deprotonation and resemble exceptional well with the previous protonated compounds 28–30, the free hyponitrous acid and its hyponitrito fragments (Table 3.16).    Figure 3.43: The hydrogen-bond network of 33. Reduced illustration of the complex cation. Grey: carbon, blue: nitrogen, white: hydrogen, cyan: ruthenium, orange: phosphorus.[39]    Figure 3.44: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(dppe)2(N2O2)]∙HImiBF4 (31).[45] Distances (Å) and angles (°): Ru1−N1 2.125(2), Ru1−O2 2.1440(18), Ru1−P1 2.3402(7), Ru1−P2 2.3712(7), Ru1−P3 2.3708(7), Ru1−P4 2.3351(7), N1−N2 1.260(3), N1−O1 1.345(3), N2−O2 1.369(3); N1−Ru1−O2 58.40(8), N2−N1−O1 105.7(3), O1−N1−Ru1 95.8(2), N2−N1−O1 116.0(2), N2−N1−Ru1 100.71(17), O1−N1−Ru1 142.90(17), N1−N2−O2 104.7(2).[39]  Figure 3.45: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(dppp)2(N2O2H)]BF4∙Imi (32).[45] Distances (Å) and angles (°): Ru1−N1 2.1940(19), Ru1−O1 2.1353(16), Ru1−P1 2.4147(6), Ru1−P2 2.3100(6), Ru1−P3 2.3513(6), Ru1−P4 2.4062(6), N1−N2 1.263(3), N1−O2 1.370(3), N2−O1 1.348(3); N1−Ru1−O1 57.48(7), N2−N1−O2 113.72(18), N2−O1−Ru1 98.40(12), N1−N2−O1 105.74(18), N2−N1−Ru1 98.38(14), O2−N1−Ru1 147.86(15). Crystal solvent (dichloromethane) is omitted.[39]  
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Figure 3.46: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 97 K) of [Ru(dppv)2(N2O2)]∙ HImi+∙Imi in 33.[45] Distances (Å) and angles (°): Ru1−N2 2.1240(18), Ru1−O1 2.1487(15), Ru1−P1 2.3402(6), Ru1−P2 2.3036(6), Ru1−P3 2.2846(6), Ru1−P4 2.3469(6), N1−N2 1.268(3), N1−O1 1.383(2), N2−O2 1.323(2); N2−Ru1−O1 59.31(7), N2−N1−O1 105.71(17), N1−O1−Ru1 95.01(11), N1−N2−O2 117.06(18), N1−N2−Ru1 99.94(13), O2−N2−Ru1 142.54(15). Crystal solvent (dichloromethane) and tetrafluoridoborate counterion are omitted.[39]Table 3.17: Overview of selected distances (d) and angles (α) the hydrogen bonds formed in the products 510 by the hydrogen hyponitrite moiety and an ether, a tetrafluoridoborate anion or imidazole.[39]  compound D-H···A d(D-H)/Å d(H···A)/Å d(D–A)/Å  α(D-H···A)/° protonated compounds: 28a O2–H2A∙∙∙O3 1.05(3) 1.63(3) 2.639(3) 159(3) 29 O2–H2A∙∙∙O3 1.12(5) 1.62(5) 2.663(4) 151(4) 30 O2–H2A∙∙∙O3 0.93(2) 1.80(4) 2.629(6) 148(6) 32 O2–H1∙∙∙N3 0.99(4) 1.66(4) 2.6929(3) 165(4)  N4–H2∙∙∙F2 0.88(5) 1.90(5) 2.768(3) 172(4) 28b O2–H2A∙∙∙F1 0.74(5) 2.01(5) 2.674(3) 150(6) deprotonated compounds: 31 N4–H7∙∙∙O1 0.88a 1.66 2.520(3) 166.2 32 N3–H62∙∙∙O2 0.92(2)b 1.65(2) 2.567(3) 174(4)  N4–H64∙∙∙N6 0.88a 1.95 2.801(3) 161.1  N5–H60∙∙∙O1I 0.91(2)b 1.92(2) 2.800(3) 164(4) I –x + 1, −y + 1, −z + 2. a constraint refinement b restraint refinement   
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Difference-Fourier Analysis Though the determination of a hydrogen position in a standard X-ray analysis is subject to methodological limitations, a Difference-Fourier analysis can be used to visualise residual electron density prior to the H atom’s assignment. The results of the ΔF analysis, in terms of the residual density’s height and position along the tentative hydrogen bond are shown in Fig. 3.47. As shown the assignment of a hydrogen atom at the oxygen (O2) of hydrogenhyponitrite is evident for 28a–30, 32. [Ru(dppe)2(N2O2H)]BF4∙Et2O (28a)  [Ru(dppe)2(N2O2H)]BF4 (28b)  [Ru(dppp)2(N2O2H)]BF4∙Et2O (29) [Ru(dppv)2(N2O2H)]BF4∙TBME (30)  [Ru(dppe)2(N2O2)]∙HImi(BF4) (31)  [Ru(dppp)2(N2O2H)]BF4∙Imi (32)  [Ru(dppv)2(N2O2)]∙HImi(BF4)∙Imi (33)  Figure 3.47: Difference-Fourier map of 28a–33. around the hydrogenhyponitrite/ ether (or tetrafluoridoborate; on the left) or the hyponitrite/ imidazole couple (on the right).[39]
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Nonetheless, for compounds 29 and 30 residual densities are also located at the O1 atom indicating a possible O–H bond (0.80 e Å −3 (29), 1.31 e Å −3 (30)), but both a missing hydrogen bond acceptor and a proposed bond distance of around 1.3 Å which is too large for an O–H bond lead to the conclusion, that these are mere artefacts. A comparison with compounds 32 and 33 emphasises this conclusion since the residual density at the O1 atom is greatly reduced. Table 3.18 shows the result of the subsequent least-squares refinement with the positional parameters and an individual isotropic temperature parameter of the hydrogen atom as the refined parameters as far as possible. Table 3.18: Position and height of the residual density in the absence of the respective hydrogen atom together with the position after the refinement and the temperature factor of the hydrogen atom in 28a–33. If necessary, an afix constraint for O–H or N–H was applied.[39]  difference Fourier peak in e Å −3 distance from O/N d/Å refined distance d/Å Uiso/Å2 28a 0.58 0.962 (O–H) 1.05(3) 0.035b 28b 0.60 0.705 (O–H) 0.74(5) 0.09(2) 29 0.54 0.981 (O–H) 1.12(5) 0.049b 30 0.31 1.035 (O–H) 0.93(2) 0.064b 31 0.36 0.913 (N–H) 0.88a 0.07(2) 32 0.77 0.947 (O–H) 0.994(4) 0.05(1) 33 0.74 0.996 (N–H) 0.92(2) 0.05(1) aconstraint: afix 43 (fixed distance, riding model), b constraint: afix 148 (refinement of OH-distance) Further analytics of compounds 28a–33 Both the hydrogenhyponitrito and the hyponitrito complexes 28a–33 were confirmed by high resolution mass spectroscopy. Using the FAB (fast atom bombardment) method the complex cation can be observed intact. The mass peaks are as follows: m/z= 959.18 (C52H49N2O2P4102Ru, 28), 987.21 (C54H53N2O2P4102Ru, 29), 955.15 (C52H45N2O2P4102Ru, 30), 961.18 (C52H49N2O2P4102Ru, 31), 987.21 (C54H53N2O2P4102Ru, 32), 957.14 (C52H48O2P4Ru, ESI+, 33). A comparison of solid-state and solution UV/VIS (in DCM) was done for 28a, 29, 30. As seen in Figure 3.48 the solution and solid-state spectra of compound 29 are similar to each other which indicates that solid-state species and solution species are probably the same. This is similar for compound 28a and 30. The later described comparison between solution and solid-state NMR spectra emphasise this observation. UV/VIS values are listed in Table 3.19.  
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  Figure 3.48: UV/VIS spectra of [Ru(dppp)2(N2O2H)]BF4∙Et2O (29) (on the left): black: solid-state (386.0, 445.3, 545.3 nm; y-value (k/s) tripled); red: solution in DCM (371.5, 453.2 nm). In the case of the solid-state spectrum, the Y axis refers to the Kubelka-Munk function (k/s = (1−R)2/2R).[156] Table 3.19: UV/VIS values of compounds 28a, 29 and 30 obtained from solution (DCM) and solid-state measurements.  UV/VIS peaks in solution (DCM) λmax/nm UV/VIS peaks in solid-state λmax/nm [Ru(dppe)2(N2O2H)]BF4∙Et2O (28a) 357.6 378.0, 532.9 [Ru(dppp)2(N2O2H)]BF4∙Et2O (29) 371.5, 453.2 386.0, 445.3, 545.3 [Ru(dppv)2(N2O2H)]BF4∙TBME (30) 358 ≈ 388   Figure 3.49: Vibrations of the hydrogenhyponitrito ligand of compound 28a. a) stretching vibration of the N–N bond, bending of the O–H pointing away at the greatest extent of the N–N vibration, b) stretching vibration of the N–N bond, bending of the O–H pointing away at the smallest extent of the N–N vibration, c) stretching vibration of the coordinated O–N bond, bending of the O–H pointing inward at the greatest extent of the O–N vibration, d) stretching vibration of the uncoordinated O–N bond, bending of the O–H pointing inward at the greatest extent of the O–N vibration, e) symmetrically coupled stretching vibration of the uncoordinated O–N bond with scissoring of the O–N–N moiety. The values of the different vibrations were taken from quantum-chemical calculations based on DFT. Vibrations of 29 and 30 are similar. IR vibrational frequencies of 28a–33 are given in Table 3.20. A visualisation of the hydrogenhyponitrite/ hyponitrite vibrations is shown in Figures 3.49 and 3.50. A comparison of calculated and experimental signals confirms the formation of compounds 28a–33.
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Table 3.20: Overview of infrared vibrations (NO)/cm−1 of 28a–33. The IR frequencies were taken from quantum chemical calculations, based on DFT.[39]  (N–O)/cm−1 (N–N)/cm−1 found calculated assignment found calculated protonated compounds: [Ru(dppe)2(N2O2H)]BF4 (28a) 715 1032 1100 709 1035 1109 O↔N–N O↔N–N N↔O–Ru 1311 1450 1310 1455 [Ru(dppp)2(N2O2H)]BF4 (29) 730 1023 1115 715 1022 1122 O↔N–N O↔N–N N↔O–Ru 1313 1453 1314 1453 [Ru(dppv)2(N2O2H)]BF4 (30) 718 1035 1112 707 1035 1112 O↔N–N O↔N–N N↔O–Ru 1313 1307 1453 [Ru(dppp)2(N2O2H)]BF4 (32) 734 1020 1131 714 1027 1131 O↔N–N O↔N–N N↔O–Ru 1313 1453 1313 1451  deprotonated compounds: [Ru(dppe)2(N2O2)]∙(HImi)BF4 (31) 717 943 730 943 O↔N–N N↔O–Ru 1252 1390 1252 1386 [Ru(dppv)2(N2O2)]∙(HImi)BF4 (32) 716 935 716 939 O↔N–N N↔O–Ru 1253 1385 1253 1385   Figure 3.50: Vibrations of the hyponitrito ligand of compound 31. a) stretching vibration of the N–N bond, b) symmetrically coupled stretching vibration of the N–N bond, stretching vibration of uncoordinated N–O, c) stretching vibration of the coordinated O–N bon, d) symmetrically coupled stretching vibration of the uncoordinated O–N bond with scissoring of the O–N–N moiety. The values of the different vibrations were taken from quantum-chemical calculations based on DFT. Vibrations of 32 and 33 are similar.   
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31P{1H} NMR spectroscopy of compound 28aA reliable determination of the phosphorus signals in the 31P{1H} NMR spectrum of compound 28a in solution is difficult in the region around 56, 54 and 52 ppm (Figure 3.51). Though there are computational programs to separate these signals, a different approach was made by using 31P{1H} NMR spectroscopy (Figures 3.52–3.54).  Figure 3.51: 31P{1H} NMR spectrum of [Ru(dppe)2(N2O2H)]BF4 (28a) in CD2Cl2 at RT.  Figure 3.52: 31P{1H}-MAS NMR spectrum of compound 28a, recorded at 10 kHz rotation in a 4 mm rotor (202 MHz). Rotation bands are marked with an asterisk.[39] Additionally, the recording of solid-state NMR spectra of compounds 28a–30 emphasise the formation of the said compounds  (Figures 3.52–3.54). The chemically independent phosphorus atoms show four signals, whereby the signals of the spectrum of compound 29 is shifted to the highfield region 
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compared to 28a and 30 probably indicating a higher electron density at the phosphorus atoms of the dppp ligand. An additional splitting of the signals as in the solution spectrum of compound 28a was not observed.  Figure 3.53: 31P{1H}-MAS NMR spectrum of compound 29, recorded at 10 kHz rotation in a 4 mm rotor (202 MHz). Rotation bands are marked with an asterisk.[39]  Figure 3.54: 31P{1H}-MAS NMR spectrum of compound 30, recorded at 10 kHz rotation in a 4 mm rotor (202 MHz). Rotation bands are marked with an asterisk.[39] Photochemical reactions of protonated and deprotonated compounds 28–33 The measurements described in this subchapter were performed by Prof. Dr. Dominik Schaniel (Université de Lorraine). The compounds were irradiated with a laser of 365 nm wavelengths (70 mW) over a period of 2–180 min. Due to great resemblance of the hydrogenhyponitrite complexes to each other [Ru(dppe)2(N2O2H)]BF4 28b is shown as best example. During the irradiation process the colour of compound 28b changed from yellow orange to a darker red-brownish colour. A darkening of the colour of compounds 28a–30 is also observed. An observable, continous increase of absorption in the UV/VIS spectrum over time is evident in Figure 3.55. A difference plot visualises the growth of signals at 525, 420 and 312 nm (Figure 3.56). In the region of 400–600 cm−1 a remarkable decrease at 526 cm−1 (calculated (N2O2H) ≈ 506 cm−1) is detectable and an increase 546 cm−1 indicating the tentative formation of a nitrosyl complex (probably [Ru(dppe)2NO]BF4) stretching vibration of Ru–N or a scissoring of Ru–N–O (Figures 5.57 and 5.58), whereby the calculated value for a rather small Ru–N–O scissoring vibration lays at 539 cm−1 and for a significant Ru–N stretch at 559 cm−1. A summary of the experimental and calculated values is given in Table 3.21. In the region of 600–900 cm−1 a signal at 730 increases significantly, while several signals, for example 650, 674, 815 and 875 cm−1 decrease. A concrete assignment for the signals is not possible, but a rearrangement of the co-ligands (dppe) is 
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plausible, more precisely several phenyl group vibrations are likely (Figure 3.59–3.60). In the region of 900–1500 cm−1 a signal increase is detectable at 1157, 1463 and probably 1049 cm-1 and a signal decrease at 992, 1074 cm-1. The signal increase in this region is a result of the scissoring and twisting vibrations of the CH2-groups (calcd.: 1049, 1157 cm-1) and rocking of a phenyl-group (calcd.: 1441 cm1). Nonetheless, as the signal at 992 cm-1 is probably also a vibration of CH2 or phenyl groups (calcd.: 993–999 cm-1) the decrease of the signal at 1074 cm-1 is an indicator for the tentative transformation of the hydrogenhyponitrito ligand (calcd.: 1027 cm-1) (Figures 3.61–3.62). In contrast to the fingerprint area, the area around 1500–2300 cm−1 is much more significant for the characterization of NO and N2O gas and derivatives. The increase at 1676 cm−1 and on a smaller scale at 1589 and 1610 cm−1 show the formation of a NO complex. A comparison with experimental values of [Ru(dppe)2(NO)]BF4 from this work (1665 cm−1) and the value of the original literature (1675 cm−1) confirm the formation of a [Ru(dppe)(NO)]+ complex similar/identical to 25.[166] Also, there is a temporary signal increase 2195 and 2220 cm−1, whereby the latter signal increases at expense of the first (Figures 3.63–3.64). The signals of gaseous N2O are in this region and would be in accordance with an aqua complex (3385 cm−1) formed by N2O release and protonation of the resulting hydroxide ligand of the hydrogenhyponitrito ligand (HN2O2− + H+→ H2O + N2O) (Figures 3.65–3.66).[172-173] In combination with the formation of a NO complex and therefore NO gas which could not be detected undoubtedly (HN2O2− → NO + NO + H+) a reaction of the formed aqua complex and a gaseous NO molecule seems reasonable (Ru–H2O + NO → H2O + Ru–NO). Such a reaction would explain the diminishing, tentative water signal. Analyses for 29 and 30 and 32 were similar (Table 3.21). The corresponding hyponitrito compound 31 shows no difference to 28a. Compound 33 was not synthesised at this time and was therefore not analysed with this method.  Table 3.21: Selected IR signals of compounds 28b–32 obtained by irradiation with a 365 nm laser after a certain amount of time.[166]  (Ru–N–O)/ cm−1 scissoring, (Ru–N)/cm−1 (calcd.) (N–O)/cm−1 (calcd.) (N2O)/cm−1 (H2O)/cm−1 28b 546 (539, 559) 1676 (1665*, 1675[166], calcd. 1648) 2195, 2220 3385 29 548 (522, 557) 1660 (1656*, calcd. 1657) 2221 3421 30 526, 538 (**) 1690 2220 3420 31 – (only decrease) 1676 2220 3410 32 548 1660 2220 3400 * results of this work, compounds 25 and 36, ** not obtained 
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63   Figure 3.55: Series of UV/VIS spectra during irradiation with a 365 nm laser of compound 28b.  Figure 3.56: UV/VIS-Difference plot of signal changes during irradiation of compound 28a.   Figure 3.57: Series of IR spectra during irradiation with a 365 nm laser in the region of 400–600 cm−1 of compound 28a.  Figure 3.58: IR-Difference plot of signal changes during irradiation in the region of 400–600 cm−1 of compound 28a.  Figure 3.59: Series of IR spectra during irradiation with a 365 nm laser in the region of 600–900 cm−1 of compound 28a.  Figure 3.60: IR-Difference plot of signal changes during irradiation in the region of 600–900 cm−1 of compound 28a. 
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64   Figure 3.61: Series of IR spectra during irradiation with a 365 nm laser in the region of 900–1500 cm−1 of compound 28a.  Figure 3.62: IR-Difference plot of signal changes during irradiation in the region of 900–1500 cm−1 of compound 28a.  Figure 3.63: Series of IR spectra during irradiation with a 365 nm laser in the region of 1600–2300 cm−1 of compound 28a.  Figure 3.64: IR-Difference plot of signal changes during irradiation in the region of 1600–2300 cm−1 of compound 28a.  Figure 3.65: Series of IR spectra during irradiation with a 365 nm laser in the region of 2300–4000 cm−1 of compound 28a.  Figure 3.66: IR-Difference plot of signal changes during irradiation in the region of 2300–4000 cm−1 of compound 28a. 
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3.8 Short excursion: Synthesis of triphenylstannyl hyponitrite (34)  Scheme 3.12: General synthetic procedure for compound 34. Triphenylstannyl hyponitrite (34) was synthesised from literature.[174-175] Commercially obtainable trans-sodium hyponitrite was treated with silver nitrate cooled by an ice bath under exclusion of light. The solid was washed with ethanol, dried and used without further analytics. The green-yellow trans-silver hyponitrite was suspended with two equivalents triphenylstannyl chloride in toluene and stirred for 18-20 hours. The reaction finished, when no coloured silver compound was left. After evaporation of the solvent, the crystalline slurry was recrystallised from toluene/i-hexane. (Scheme 3.12) The obtained colourless compound trans-((Ph3Sn)2N2O2) 34 was dried and used for compounds 28a–33. The yield of ca. 350 mg was directly solved in DCM and used for the subsequent reactions. Compound 34 was analysed by IR and 119Sn{1H} NMR spectroscopy (singulett: −87.9 ppm). As bulk analyses HRMS (m/z = 715.9 [M+−N2O]+) and elemental analysis were performed. The obtained values resemble very well with the values given in literature.[165]  3.9 Pyrrolidinediazoniumdiolato and benzyldiazoniumdiolatoruthenium complexes with bisphosphane co-ligands The acquisition of cis-hyponitrito complexes was not possible and was avoided due to its explosive behaviour and its sensitivity to substitution. A form of cis-Ag2N2O2 and cis-((Ph3Sn)2N2O2) was not obtainable due to decomposition. As suitable replacement of cis-hyponitrite N-diazoniumdiolate and C-diazoniumdiolate compounds were tested, especially to investigate whether a cis-hyponitrite ligand would fit in the two coordination sites of the chelate-tosylato ligand of compounds 7 and 8 in terms of distances and angles. For compound 33 a similar reaction behaviour was expected. Reactions of the N-sulfonatodiazoniumdiolate did not succeed due to poor solubility in organic solvents.  Scheme 3.13: General synthetic procedure for compound 41 and 37
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The N-diazoniumdiolato complexes were synthesised similarly to the procedure for 28a–33 (Scheme 3.13). The starting compounds 7, 8, 16 were solved in DCM and cooled using an i-propanol/dry-ice bath. The sodium N-pyrrolidindiazoniumdiolate 38 was solved in MeOH and added dropwise. After stirring for 1 h, evaporation of the solvent and recrystallisation from DCM/diethyl ether, two N-diazoniumdiolato complexes ([Ru(dppe)2(pdd)]BF4 (35), [Ru(dppv)2(pdd)]BF4 (37)) and one nitrosyl complex ([Ru(dppp)2(NO)]BF4 (36)) could be obtained. The yields were as follows: 46% (35), 23% (36), 32% (37). The N-diazoniumdiolate (38) is subject to steady decomposition (brown gas, yellowish solid), therefore the given yield can vary. The complexes were analysed by IR, UV/VIS and 31P{1H} spectroscopy. HRMS was performed as bulk analysis. The procedure for C-diazoniumdiolato complexes is almost identical compared to N-diazoniumdiolato complexes (Scheme 3.13). Compounds 7, 8, 16 were solved in DCM and cooled using an i-propanol/dry-ice bath. The sodium hydrogenbenzyldiazoniumdiolate (42, Hbdd) was solved in DCM and added dropwise. After stirring for 1 h and evaporation of the solvent, recrystallisation of the crude from DCM/diethyl lead to the compounds [Ru(dppe)2(bdd)]BF4 (39), [Ru(dppp)2(bdd)]BF4 (40) and [Ru(dppv)2(bdd)]BF4 (41). The yields were as follows: 74% (39), 80% (40), 56% (41). The complexes 35–37 and 39–41 were analysed by IR, UV/VIS and 31P{1H} spectroscopy. HRMS was performed as bulk analysis.  Crystal structure of [Ru(dppv)2(pdd)]BF4 (37) (and analytics of [Ru(dppe)2(pdd)]BF4 (35))  The structure solution of 37 succeeded in the monoclinic space group P21/c. The unit cell contains 2 formula units (CShMOC-6 value: 1.368, asymmetric unit: one molecule). The structure is shown in Figure 3.67. The complex is best described as distorted octahedron. The ruthenium centre is coordinated by two cis-standing dppv units and a pyrrolidindiazioniumdiolato-κ2O,O ligand (pdd, 38) filling up the remaining coordination sites and are forming a chelate five-ring. Please note, that the crystal structure was obtained with a R(Fobs) of 0.0567 and Rw(F2) of 0.1469, but it is clearly visible that the pyrrolidine moiety is unsatisfactorily solved in terms of crystallography. Different crystallisation methods (including a variation of the used solvents) did not succeed in a better crystal quality and therefore in a better data set. Crystals of 35 were obtained, but the quality of the data set was not suitable to solve this structure. 
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 Figure 3.67: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dppv)2(pdd)] ion in 37 (on the left).[45] Distances (Å) and angles (°): Ru1−O1 2.119(3), Ru1−O2 2.119(4), O1−N1 1.317(6), O2−N2 1.262(7), N1–N2 1.205(7), N2–N3 1.446(8), Ru1−P1 2.2816(10), Ru1−P2 2.3637(11); O1−Ru1−O2 73.3(2), O1–N1–N2 116.8(5), N1–N2–O2 125.2(5), N1–N2–N3 122.9(6), N1–O1–Ru1 113.3(3), N2–O2–Ru1 111.3(4), P1−Ru1−P2 84.49(4), P1−Ru1−P3 93.12(4). Crystal solvent (diethyl ether) and tetrafluoridoborate counterion are omitted.  The Ru–O distance of 37 of 2.119 Å is in accordance with the trans-hydrogenhyponitrito complexes 28a–30 (averaged: 2.159 Å). A comparison with a crystal structure of cis-sodium hyponitrite and the compounds 39–41 is given in Table 3.22.[171] The resemblance of the distances of the cis-hyponitrite salt compared to product 37 is in an acceptable range. Both N–O distances are shorter than the uncoordinated salt and the N–O distance of the substituted nitrogen is remarkably shorter than of the unsubstituted nitrogen which is a tentative result of the pyrrolidine substituent. In contrast, the accordance of the angles between the NN–O moieties is evident. Table 3.22: Overview of bond distances (d) and angles (α) of free hyponitrite fragments from Reference 171 and the products of this work.   d(NN)/Å d(N–O′)/Å d(N–O′′)/Å α(O′–NN)/° α(O′′–NN)/° Na2N2O2[171] 1.20(3) 1.40(3) 1.41(3) 117.6(4) 120.8(4) [Ru(dppv)2(pdd)]BF4 (37) 1.205(7) 1.317(6) 1.262(7) 116.8(5) 125.2(5) [Ru(dppe)2(bdd)]BF4 (39) 1.270(4) 1.330(4) 1.312(4) 114.9(3) 124.7(3) [Ru(dppp)2(bdd)]BF4 (40) 1.270(3) 1.328(3) 1.311(3) 114.4(2) 124.3(2) [Ru(dppv)2(bdd)]BF4 (41) 1.262(5) 1.343(4) 1.306(4) 115.0(3) 125.5(3)  
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 Figure 3.68: Vibrations of the pdd (38) ligand in compound 37. a) stretching vibration of the NN double bond b) stretching vibration of the N–N bond, c) stretching vibration of the unsubstituted O–N d) asymmetrically coupled stretching vibrations of the O–N bonds, whereby the vibration of the O–N bond of the substituted nitrogen is dominant. The values of the different vibrations and the xyz-file were taken from quantum-chemical calculations based on DFT.  A comparison of experimental and calculated IR signals of 37 and 35 is listed in Table 3.23. An illustration of the IR vibrations of compound 37 obtained from DFT calculations is given in Figure 3.68. The UV/VIS spectra of both complexes have a signal in the ultraviolet region with 371 (35) and 364 nm (37) in good accordance with the hydrogenhyponitrite complexes 28a–30. 31P{1H} NMR spectra of 35 and 37 were recorded which are spectra of higher order, but an assignment of the signals without an NMR-solving program due to their complexity was not possible at the time. Nonetheless, HRMS spectra of the complexes show the formation of the desired compounds with m/z = 944.17 (C52H48O2NP4Ru), 1024.21 (C56H52O2N3P4Ru).  Table 3.23: Overview of infrared vibrations in cm−1 of 37, 39–41. The IR frequencies were taken from quantum chemical calculations, based on DFT.  (N–O)/cm−1 (N–C/N–Npyr)/cm−1 (NN)/cm−1  experimental calculated experimental calculated experimental calculated  N-diazoniumdiolato compounds 35 874, 1167, 1190 – 1257 – 1378 – 37 885, ≈ 1140, 1187 875, 1134, – ≈ 1240 1248 ≈ 1400 1387  C-diazoniumdiolato compounds 39 923, 1146, 1192 919, 1134, 1181 1217 1203 1408(sh) 1406 
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40 933, 1142, 1197 930, 1144, 1192 – 1204 1410(sh) 1403 41 910, 1146, 1191 909, 1132, 1181 1209 1201 1400(sh) 1398 [Fe(bdd)3][176] 958 – – – 1373 – bdd[176] 953 – – – 1376 – Et2N–N2O2Na[109] 952 925* – – 1384 1353* * values derived from literature.[109]  Crystal structure of [Ru(dppp)2(NO)]BF4 (36) The structure solution succeeded in the monoclinic space group P21. The unit cell contains two formula units (CShMTBPY-5 value: 2.041, asymmetric unit: one molecule). The structure is shown in Figure 3.69. The trigonal-bipyramidal complex is coordinated by two bisphosphane ligands (dppp) occupying each an axial and an equatorial position. The nitrosyl ligand resides on the remaining position. The Ru–N–O moiety is almost linear with 170.8° and is best described as {RuNO}8, most likely a d8 Ru(0)–NO+ complex. This is emphasised by a N–O bond length of 1.169 Å and a Ru–N bond length of 1.795 Å. The crystallographic data is resembles well to the given literature (Table 3.24).[177-178] A synthesis for the tetraphenylborate complex was not given in 177, nevertheless several preparations of the complex cation are known.[178-179] A shortened Ru–N bond indicates for 36 a back donation from the ruthenium centre into π* orbitals of the nitrosyl ligand.    Figure 3.69: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of [Ru(dppp)2(NO)]BF4 (36) (on the left).[45] Distances (Å) and angles (°): Ru1−N1 1.795(3), N1−O1 1.169(4), Ru1−P1 2.4006(9), Ru1−P2 2.3441(10), Ru1−P3 2.4046(10); Ru1−N1−O1 170.7(3), P1−Ru1−P2 89.58(4), P1−Ru1−P3 176.01(4). Crystal solvent (diethyl ether) is omitted. 
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Table 3.24: Selected bond distances (d), angles (α) and the N–O stretching vibration of compound [Ru(dppp)2(NO)]BPh4 and [Ru(dppp)2(NO)]BF4 (36).[177-178]   d(N–O)/Å d(Ru–N)/Å α(Ru–N–O)/° (NO)/cm−1 [Ru(dppp)2(NO)]BPh4[177] 1.23(3) 1.72(2) 169.5(2.5) 1670 (KBr)[178] [Ru(dppp)2(NO)]BF4 (36) 1.169(4) 1.795(3) 170.7(3) 1656 (ATR)  The (NO) stretching vibration of compound 36 is also in good accordance with the given literature and is in the region of {RuNO}8 complexes as shown for compound 25.[178] The UV/VIS spectrum of the brown crystals shows three signals at 373, 432, 573 nm. The 31P{1H} NMR spectrum shows three different isomers, a tentative result of the flexibility of the dppp ligand in solution (Figure 3.70). Six triplets are identified and can be divided in three signal sets (a: J = 39.1 Hz, b: J = 31.0 Hz, c: J = 32.4 Hz) of the three isomers. According to the integrals isomer a has a percentage share of 80.65%, b of 16.13% and c of 3.22%.   Figure 3.70: 31P{1H} NMR spectrum of solved crystals of 36 in CD2Cl2 at RT.    
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Crystal structures of [Ru(dppe)2(bdd)]BF4 (39), [Ru(dppp)2(bdd)]BF4 (40) and [Ru(dppv)2(bdd)]BF4 (41) The structure solutions succeeded in the monoclinic space groups P21 for 39 and P21/n for 40 and 41. The unit cell contains two formula units in 39 and four each in 40 and 41. (CShMOC-6 value: 1.436 (39), 0.971 (40), 1.076 (41), asymmetric unit: one molecule in 39–41). The structures are shown in Figures 3.71–3.73.  Figure 3.71: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dppe)2(bdd)] ion in 39.[45] Distances (Å) and angles (°): Ru1−O1 2.097(3), Ru1−O2 2.122(2), O1−N1 1.330(4), O2−N2 1.312(4), N1–N2 1.270(4), N1–C1 1.463(5), Ru1−P1 2.3902(9), Ru1−P2 2.3239(9); O1−Ru1−O2 75.47(10), O1–N1–N2 124.7(3), N1–N2–O2 114.9(3), N2–N1–C1 118.7(3), N1–O1–Ru1 110.1(2), N2–O2–Ru1 114.7(2), P1−Ru1−P2 83.62(3), P1−Ru1−P3 100.03(3). Tetrafluoridoborate counterion is omitted.  Figure 3.72: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dppp)2(bdd)] ion in 40.[45] Distances (Å) and angles (°): Ru1−O1 2.1447(17), Ru1−O2 2.1239(18), O1−N1 1.328(3), O2−N2 1.311(3), N1–N2 1.270(3), N1–C1 1.479(3), Ru1−P1 2.4216(7), Ru1−P2 2.3420(7); O1−Ru1−O2 73.81(7), O1–N1–N2 124.3(2), N1–N2–O2 114.4(2), N2–N1–C1 117.5(2), N1–O1–Ru1 110.20(14), N2–O2–Ru1 116.53(15), P1−Ru1−P2 91.05(2), P1−Ru1−P3 94.34(2). Tetrafluoridoborate counterion is omitted.   Figure 3.73: ORTEP-3 plot (ellipsoids drawn at the 50% probability level at 100 K) of the [Ru(dppv)2(bdd)] ion in 41 (on the left side).[45] Ru1−O1 2.121(2), Ru1−O2 2.134(2), O1−N1 1.343(4), O2−N2 1.306(4), N1–N2 1.262(5), N1–C1 1.484(5), Ru1−P1 2.3565(9), Ru1−P2 2.3017(9); O1−Ru1−O2 75.12(10), O1–N1–N2 125.5(3), N1–N2–O2 115.0(3), N2–N1–C1 118.6(3), N1–O1–Ru1 109.1(2), N2–O2–Ru1 115.2(2), P1−Ru1−P2 83.69(3), P1−Ru1−P3 96.15(3). Crystal solvent (dichloromethane) and tetrafluoridoborate counterion are omitted. 
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The ruthenium centre of compounds 39–41 is coordinated octahedrally by two bisphosphane co-ligands and a benzyldiazoniumdiolate (bdd). A comparison of bond angles and distances of sodium cis-hyponitrite and these compounds is given in Table 3.22. The NN distance is clearly longer than the 1.2 Å of the cis-hyponitrite, while the N–O distances diminish. The NN–O′ and NN–O′’ angle resemble in an acceptable range with the cis-hyponitrite salt and pdd-compound 37 as well.    Figure 3.74: Vibrations of the bdd (42) ligand in compound 41. a) asymmetrically coupled stretching vibration of the N–N double bond with scissoring of the CH2 group b) stretching vibration of the C–N bond, c) symmetrically coupled stretching vibration of the unsubstituted O–N bond with twisting of the CH2 group d) asymmetrically coupled stretching vibration of the unsubstituted O–N bond with twisting of the CH2 group e) asymmetrically coupled stretching vibrations of the O–N bonds, whereby the vibration of the O–N bond of the substituted nitrogen is dominant. The values of the different vibrations were taken from quantum-chemical calculations based on DFT. Vibrations of 39 and 40 are similar. The calculated and experimental IR signals of the bdd ligand of compounds 39–41 are very similar and are given in Table 3.23. The illustration of these vibrations is given in Figure 3.74. The UV/VIS spectra show one signal at 370 nm for 39, 379 nm for 40 and 365 nm for 41. These signals are accordance with the pdd compounds 35 and 37 and the hydrogenhyponitrito compounds 28a–30 which are also in the ultraviolet region. The 31P{1H} NMR spectra of 39 and 41 are similar to compound 11 and to the solution spectrum of 28a (Figures 3.75 and 3.77). The spectra of higher order are analysed as shown for compound 11, summarised in Table 3.25. The spectrum of compound 40 is shown in Figure 3.76 whose overlapping signals prevent a comparable analysis as for 39 and 41, but a resemblance is nevertheless detectable. HRMS confirms the formation of the compounds (m/z = 1049.23 (C59H55O2N2P4Ru, 39), 1077.26 (C61H59O2N2P4Ru, 40), 1045.20 (C59H51O2N2P4Ru, 41).  
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Table 3.25: 31P{1H} NMR signals in DCM at RT and couplings given in parenthesis of compounds 39 and 41.   P′ P′′ P′′′ P′′′′ 39 55.8 (dd, 11.6 Hz, 21.1 Hz) 55.6 (dd, 11,7 Hz, 21.1 Hz) 55.1 (dd, 13.3 Hz, 21.1 Hz) 54.9 (dd, 13.3 Hz, 21.1 Hz) 50.3 (dd, 11.7 Hz, 21.9 Hz) 48.3 (dd, 11.6 Hz, 21.9 Hz) 44.6 (dd, 13.3 Hz, 21.2 Hz) 42.6 (dd, 13.3 Hz, 21.1 Hz)  A = 49.1 ppm, JAB = 332.1 Hz (trans-coupling) B = 43.8 ppm, JAB = 332.1 Hz (trans-coupling) 41 66.1 (dd, 6.7 Hz, 19.9 Hz) 65.9 (dd, 7.0 Hz, 19.6 Hz) 65.5 (dd, 8.3 Hz, 20.1 Hz) 65.3 (dd, 8.1 Hz, 20.3 Hz) 56.3 (dd, 6.9 Hz, 20.2 Hz) 54.1 (dd, 6.8 Hz, 20.3 Hz) 53.3 (dd, 8.1 Hz, 19.8 Hz) 51.2 (dd, 8.2 Hz, 19.6 Hz)  A = 54.8 ppm, JAB = 348.3 Hz (trans-coupling) B = 52.8 ppm, JAB = 348.3 Hz (trans-coupling)    Figure 3.75: 31P{1H} NMR spectrum of [Ru(dppe)2(bdd)]BF4 (39) in CD2Cl2 at RT. 
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3.10 Short excursion: sodium pyrrolidinediazoniumdiolate (38) Sodium pyrrolidindiazoniumdiolate was synthesised using the synthesis of Saavedra et al.[180] Freshly prepared sodium methanolate was mixed with pyrrolidine in a pressure flask which was flushed with argon. The mixture was treated with nitrous oxide under intensive stirring. After precipitation of the diolate, the colourless slurry was filtered and washed with diethyl ether and dried in vacuo (Scheme 3.14). Even strict evasion of air and especially water and storage at −4 °C does not prevent the slow decomposition of the product (brown gas, yellowish solid). Therefore, only an ill-defined product was used directly for the synthesis of compounds 35–37. HRMS and elemental analysis were performed, but did not succeed.  Scheme 3.14: General synthetic procedure for compound 38.   3.11 Short excursion: hydrogen benzyldiazoniumdiolate (42) Hydrogen benzyldiazoniumdiolate (42) was prepared using the synthesis of Maskill et al.[181] Sodium nitrate solved in water was added dropwise to an ice-cold solution of N-benzylhydroxylamine hydrochloride which was solved in methanol and acidified with hydrochloric acid (2M). The resulting fluffy, colourless solid was filtered off, washed with ice-cold water and dried in vacuo (Scheme 3.15).   Scheme 3.15: General synthetic procedure for 42. 
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Elemental analysis and HRMS (m/z = 151.05 (C7H7O2N2)) confirm the formation of this compound. A comparison of the IR spectrum of 42 and the corresponding ruthenium complexes 39–41 emphasise this result (N–O stretching vibration: 947, 1159, 1186 cm−1; N–C stretching vibration: 1211 cm−1; N–N stretching vibration: 1395 cm−1). The comparison of the IR spectrum done in this thesis with the spectrum of Kovalchu et al. shows resemblance.[176]   
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4 Discussion This subchapter will deal with the crystallographical conditions of the hexaaquaruthenium salts, their classification in terms of the HSAB principle and crystal field model. In the second subchapter the frontier orbitals of the phosphane complexes are analysed. Their reaction mechanism with gaseous nitric oxide is then set up with a focus on the missing hyponitrite compound. The main part of this chapter deals with the trans-hydrogenhyponitrito/hyponitrito compounds, especially their preparation, reaction behaviour and their classification in terms of the spectrochemical series. Finally, a similar approach is made for the diazoniumdiolato complexes including their ability to substitute the cis-hyponitrite moiety. Most complexes in this work have OC-6 symmetry (IUPAC polyhedral). To simplify the orbital considerations the orbitals are named as for the Oh case (t2g, eg etc.). 4.1 Hexaaquaruthenium(II) complexes with different counterions Studies on the hexaaquaruthenium cation were performed for a long time only in dilute solutions.[26, 182-184] The crystallisation and the resulting crystal structure enabled reactions on a larger scale and an understanding of which attractive interactions enable crystal formation in general.[10, 28] Essentially, the formation of hydrogen bonds represents the main driving force of the crystallisation of hexaaquaruthenium(II) salts, whereby the tosylato and complex ions are oriented in layers, a motif that is more or less identical for all hexaaqua compounds (1–6) in this work. Since, in the original crystal structure of hexaaquaruthenium tosylate from Bernhard et al., no hydrogen positions were determined, but the crystal structure obtained in this work revealed that the hydrogen-bond network saturates the aqua ligands (twelve hydrogen atoms → twelve hydrogen bonds).[10] This principle is evidently valid for the new synthesised compounds 2–6 (Figure 4.1). In [Ru(H2O)6]SO4 (3) the sulphate anion can support three instead of two hydrogen bonds which leads to the situation of six donors : twelve hydrogens : four acceptors (SO42−)—a known characteristic in literature.[185] Compound 5 which includes a sterically demanding biphenyldisulfonate anion compensates this fact with two  molecules of crystal water. Additionally, the graph-set analysis elucidates the tight hydrogen-bond network over the different layers of cationic complexes and the counterions in compounds 1–6. The Ru–O average distance and the angles between the aqua ligands and the ruthenium centre (O–Ru–O′) are almost unaltered, whereby higher values for distances are obtained, as expected, for room temperature measurements instead of cryogenic ones. 17O NMR measurements confirmed the given value for [Ru(H2O)6]2+ and showed, additionally, the signal for the tosylate counter-ion.[186] UV/VIS studies showed that, both in solid-state and in solution, independent of the pH in the acidic area, the hexaaquaruthenium complex is present as shown in Figure 4.1.[11] 
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78   Figure 4.1: The hydrogen-bond network of [Ru(H2O)6](OTf)2 (2). Grey: carbon, white: hydrogen, cyan: ruthenium, green-yellow: fluorine, blue lines: hydrogen bonds.  Regarding Pearson’s HSAB concept, a combination of hard (high charge density, small atomic radius, less polarisable) and soft (low charge density, big atomic radius, easy polarisable) Lewis acids and bases is disfavoured in terms of reactivity and bond strength than the soft-soft (covalent case) and hard-hard (ionic case) combination.[58] Nonetheless, this empirical concept has limitations as for example the reaction of the hard acid H+ and the soft base H− shows (H+ + H− → H2). Modern explanations emphasise the importance to considerate the acidity/basicity beside the hardness/softness of the components, as well.[187] In coordination chemistry, large ligands with low charge and low electronegativity stabilise metal centres in low oxidation states, whereby high-valent metal centres are stabilised by the contrary.[58] Therefore, it is not surprising that the synthesis of [Ru(H2O)6]2+ with a soft ruthenium(II) centre and has to be done in the strict absence of potential ligands other than sulfonic acid and water. Chloride impurities, for example, react immediately with the hexaaqua ion forming tentative chlorido complexes which are thermodynamically more favoured (brown colour of the otherwise pink solution). Nonetheless, it should be mentioned that [Ru(H2O)6]2+ can be prepared—as previously described—in diluted form using chlorido products, but only by the strict separation of the chlorido-product derivatives via ion exchange.[26, 182] Also, the elucidation of the reaction pathway with small molecules and the kinetics delivers a valid explanation for the reaction behaviour of the complex.[14] Aebischer et al. discovered that complex formation starts with a Ru–O bond rupture (dissociative interchange mechanism) which is, therefore, the rate-determining step.[14, 155] Strong π-acceptor ligands clearly decrease the activity of the cis-standing aqua ligand, but increase it for the trans-standing one. Each step of water substitution slows down the reaction.[14, 188] With a rate constant of 1.8 ∙ 10−2 s−1 for water exchange of the first coordination sphere (inner-sphere interchange rate constant) for [Ru(H2O)6]2+, 
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the fast reaction with amines and halogens can be explained. If the RuO bond breaks as the first step, the vacant coordination site can easily be occupied by a π-base halogen or a σ-donor amine.[189] An octahedral complex with an unoccupied coordination site due to ligand dissociation has fewer negative point charges which repulse the d-electrons of ruthenium. The now diminished crystal-field splitting (↓ΔO) results in a reduced ligand field stabilisation energy. The energy loss can be assigned as the activation energy of the ligand substitution and its magnitude is directly correlated to the ligand exchange rate, independent of the thermodynamics of the newly formed bond. In the case of [Ru(H2O)6]2+ the t2g orbitals which are non-bonding for pure σ-donors are filled with six electrons resulting in a ligand-field stabilisation energy of –2.4 ΔO. In the case of an aqua-ligand-bond dissociation the relative ΔO is reduced (Scheme 4.1).[190] This leads to the second subchapter, the reaction of hexaaquaruthenium(II) phosphanes with diverse phosphanes.  Scheme 4.1: Qualitative energy-level scheme. Electron distribution of [Ru(H2O)6]2+: a	 t	 et . The crystal structure of 1  resulted in a different crystal system and, therefore, in another space group compared to the former crystal structure of [Ru(H2O)6](tos)2 (Table 4.1).[10] In addition to the previously mentioned characteristics, compound 3 is the first 4d representantive of the hexahydrite mineral group. As shown in Table 4.2, the unit-cell parameters and the number of units in the unit cell are in good accordance with the given values. 
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Table 4.1: Comparison between published and obtained crystal structure data of [Ru(H2O)6](tos)2 (1).[10]   [Ru(H2O)6](tos)2  Reference 10 obtained 1 space group 1  C2/c a/Å 6.318(1) 14.0088(7) b/Å 7.287(2) 6.2999(3) c/Å 12.423(4) 24.9685(14) α/° 92.22(2) 90 β/° 94.82(2) 100.545(5) γ/° 107.13(2) 90 V/Å3 527.9(4) 2166.3(2)  Table 4.2: Representatives of the hexahydrite mineral group including compound 3. (crystallographic information files obtained from the ICSD database). The mentioned structures were solved in the C2/c space group.  chemical formula common name a/Å b/Å c/Å β/° Z [Mg(H2O)6]SO4[191] Hexa- hydrite 10.11(5) 7.212(4) 24.41(1) 98.30(5) 8 [Co(H2O)6]SO4[192] Moor- houseite  10.022(3) 7.217(2) 24.224(3) 98.42(2) 8 [Ni(H2O)6]SO4[193] Nickelhexa-hydrite 9.878(2) 7.214(2) 24.065(6) 98.37(2) 8 [Zn(H2O)6]SO4[194] Bianchite 9.981(2) 7.250(9) 24.280(3) 98.45(7) 8 [V(H2O)6]SO4[195] – 10.081(3) 7.286(2) 24.445(7) 98.78(2) 8 FeSO4 ∙6(H2O)[196] a) Ferrohexa-hydrite 10.08 7.28 24.59 98.37 8 [Ru(H2O)6]SO4 (3) – 9.6832(4) 7.3250(3) 24.023(1) 98.113(1) 8 a) cif without standard deviation   4.2 Phosphaneruthenium ligands – between strong σ-donors and σ*-acceptors As described in the introduction, phosphanes are capable of either σ*-back donation or strong covalent contributions, resulting in two different energy level schemes shown in Scheme 4.2. It is unlikely that a triphenylphosphane complex with no strong acceptors attached to the phenyl rings is capable of π-backbonding, more likely this and similar ligands interact as σ-donors with the metal centre. This argument is supported by DFT calculations. Since PPh3 mainly classified as σ-donor, the HOMO orbitals of the complex [Ru(H2O)2(PPh3)2(tos)2] (18) display metal-centred non-bonding t2g orbitals (Figure 4.2).[187] An observation of metal-ligand π-bonds and intraligand π-antibonds which would indicate a 
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π-acid activity is not made. The σ-donor activity is similarly observed for the phosphanes and bisphosphanes with pure carbon moieties attached to the phosphorus atom.[187] In contrast, the bisphosphanes with nitrogen moieties show a substantial amount of σ*-backbonding (Figure 4.3).  Scheme 4.2: Qualitative energy level scheme of strong σ-donors on the left side and π-acids capable of π*-backdonation on the right side. For strong σ-donors the splitting of eg and eg* is increased, while for π-acids the previous non-bonding t2g orbitals are splitted due to interaction with the empty π*-orbitals (σ*-orbitals) of the ligand. The electron distribution of e.g. [Ru(dppe)2(tos)]2+ is a	 t	 et , therefore in both cases only the energetically is favoured t2g orbital occupied.    Figure 4.2: Gabedit plot of the frontier orbitals (isovalue 0.02) of [Ru(H2O)2(PPh3)2(tos)2] (18).[197] HOMO−1 (xz) and HOMO (yz) as part of the t2g molecular orbital set. LUMO (unoccupied, z2) as part of the virtual eg orbitals. The occupied orbitals show mainly metal-centred, non-bonding orbital lobes. 
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82   Figure 4.3: Gabedit plot of the frontier orbitals (isovalue 0.04) of [Ru(dppbza)2(tos)]+ (9).[197] HOMO−1 (z2-like shaped)  and HOMO (yz) as part of the t2g molecular orbital set. LUMO (unoccupied, xy) as part of the virtual eg orbitals. The occupied orbitals show metal-ligand π-bonds with intraligand π-antibonding.   It is evident that the occupied HOMO and HOMO−1 orbitals show π-bonding between the ruthenium centre and the bisphosphane (dppbz, 21) ligand. The LUMO which is part of the virtual eg orbitals has a metal-centred orbital that is antibonding to the phosphane ligand. A similar behaviour can be expected for the complexes with the other aminophosphane ligands dpppha (22) and dpppra (23) as σ*-acceptors. As in Scheme 4.2, an increased ΔO and therefore an increased LFSE is the result of both strong σ-donors and σ*-acceptors. A classification using the bite angle PRu–P is not significant (Table 4.3). Even though a classification of the complexes obtained is desirable, the combination of electronic and steric effects (bite angle and steric hindrance) of the phosphane ligands are not suitable for an overall explanation of the complex formation of 7–20. Nonetheless, these complexes can be used as powerful precursors due to the labile water and tosylato ligands they bear. 
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Table 4.3: P–Ru–P bite angles in the phosphane complexes 7–20.   sulfonato-κ2O,O′ complexes disulfonato-κ2O,O′ complexes  P–Ru–P angle α/° 7 8 10 11 12 81.42(3), 81.80(3) 88.55(3), 89.40(3) 81.44(3), 82.07(3) 96.66(2) 95.85(2) diaqua complexes aqua-tosylato-κO complexes 14 15 16 18 19 72.34(4) 80.44(3) 82.34(1) 98.05(2) 88.71(2)  aminephosphane complexes: 20 9 (sulfonato-κ2O,O′) 13 (diaqua) 17 (aqua-tosylato-κO) 97.92(2) 69.96(3), 69.24(3) 69.02(2) 69.60(2), 69.34(2)  4.3 Treatment of [Ru(dppe)(tos)]2+ (7) with NO Since there is a broad interest in literature for reductive coupling of nitric oxide at model complexes of the nitric oxide reductase, the previously mentioned phosphane complexes were treated with NO.[95, 97, 103, 198] Compound [Ru(dppe)2(tos)]2+ (7) was chosen as the model complex, whereby the two other compounds (8 and 16) that are capable of binding a hydrogenhyponitrito or hyponitrito ligand (chapter 4.4) were treated with nitric oxide as well. However, they did not crystallise which was necessary for a deeper and profound understanding of the reaction pathways. As previously shown, in the absence of a reductive agent, two products form over time. Compound [Ru(dppe)2(NO)](tos) (25) which is obtained in the absence of a BF4− anion and [Ru(dppe)2(NO)F](SbF6)2 (26) which is obtained in the presence of BF4− or SbF6−. It is clearly evident, that compound 26 is a derivative of 25, as the latter is obtained exclusively in the absence of a fluoride donor. It is likely that the remaining NO acts thereby as oxidant, but since the amount of complex consumed is small and the reaction itself lengthy, no spectroscopic evidence was found. In the presence of a reductive agent, compound [Ru(dppe)2(H)(NO2)] (24) is formed, but only in the simultaneous presence of water. Different apparatuses with and without wash bottles were used, whereby 24 was obtained only with the first and 25 in the latter. It is likely that the H2O impurities are deprotonated by the tetrakisdimethylaminoethylene (tden) reductive agent and the hydroxide ion reacts as nucleophile with the NO+ ligand of the ruthenium complex as known in literature.[199] The vacant trans position of 
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the nitrite ligand is then occupied by a hydrido ligand, which can be confirmed by a Difference-Fourier analysis. An overview of the tentative, simplified reaction mechanism is given in Scheme 4.3.  Scheme 4.3: Reaction pathway from [Ru(H2O)6]2+, over [Ru(dppe)2(tos)]+ to different NO derivatives.  Finally, the question arises, whether there is a hyponitrito ligand present or not. Since both a hydrogenhyponitrito and a hyponitrito complex could be obtained, the characteristic orange/yellow colour of such compounds was not visible at any time. Additionally, the crystalline products (with powdery residue) showed no sign of hyponitrite in the respective IR spectra. No crystallisation occurred beside the previously mentioned products, although the hydrogenhyponitrito/hyponitro complexes are stable and tend to crystallise easily. Nonetheless, as there is no negative proof, it is only an indication of the absence of a hyponitrite moiety. In literature, the metal-centred reduction of nitric oxide is favoured. Most of the time, two low-valent metal centres provide two electrons for the reductive coupling of gaseous nitric oxide.[95, 97, 103] The ruthenium centre of the phosphane complexes used in this work is probably too stable in the oxidation state of +II, especially since the examples of hyponitrite formation using gaseous nitric oxide at ruthenium centres were Ru(I) complexes.[99, 105] As shown in Scheme 4.3, the reactivity towards NO is also given for hexaaquaruthenium which forms in the presence of PPh3 and NO the {Ru(NO)2}10 complex [Ru(PPh3)2(NO)2]. In terms of its electronic status the formation of a hyponitrito ligand is possible ([Ru(PPh3)2(NO)2] → [Ru(PPh3)2(N2O2)]) as shown for [Pt(PPh3)2(N2O2)], but it is evidently not favoured.[98] It has to be mentioned that in general, the reactivity of the phosphane complexes and [Ru(H2O)6]2+ towards NO is of a rather chaotic nature. A broad range of products was obtained which are not displayed in this work due to rather poor data sets. This concerns dinitrosyl complexes with or without oxidised phosphane ligands (e.g. with PPh3 or PtBuPh2), and mononitrosyl complexes (e.g. with dpppha).  
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4.4 Hydrogenhyponitrito and hyponitrito complexes — products of salt metathesis  To avoid product mixtures which are hard to purify for obtaining hyponitrito complexes, a different approach was taken. As already shown, silver hyponitrite or hyponitrous acid were successfully used to generate hyponitrito complexes.[103-104] Therefore, the triphenylstannyl hyponitrite compounds which were originally synthesised by Beck et al., reacted well with the phosphane complexes in this work (7, 8, 16), but only with these three.[175, 200] Experiments with the remaining phosphane complexes were unsuccessful. Nonetheless, the hydrogenhyponitrito complexes are exceptionally stable and can flexibly be protonated and deprotonated. A tentative reason for this could be the sterically demanding phenyl groups which form, thereby, a protective pocket that encases the hydrogenhyponitrite/hyponitrite moiety (Figure 4.4).   Figure 4.4: Space-filling models of compounds 28, 29, 30 (Gabedit).[39, 197] Additionally, the “pocket” is visualised by a comparison between the starting complex and the hydrogenhyponitrite product. As seen in Figure 4.5, the hydrogenhyponitrito and tosylato ligands are, in terms of bond distances and angles, similar. Also, the hydrogenhyponitrito and hyponitrite complexes (28–33) form hydrogen bond networks as seen in Figure 4.5, which are discussed in literature as key components for the formation of hyponitrito complexes in general.[103, 201] It is likely that this combination of steric protection, steric similarity and hydrogen bond networks favours the formation and crystallisation of these complexes.  A classification of the hyponitrite moiety as weak-field or strong-field ligand was part of our publication.[39] The frontier orbitals show characteristics of σ-donors and π-bases. Figure 4.6, in which z lays on the P–Ru–P axis (left), shows the LUMO (centre) and the HOMO (right). The virtual LUMO consists of the eg-derived N/O–Ru σ-antibond and the Ru-d(x2−y2) orbital as the metal part. Two of the three occupied frontier MOs, specifically the HOMO−1 and the HOMO−2, show mainly Ru-d-character in agreement with the σ-character of the Ru–P interactions. The HOMO is made up from the HOMO−1 of the free hydrogenhyponitrito ligand in an antibond to the remaining t2g-derived orbital. Specifically, 
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with the axes chosen in Figure 4.6 (left), the HOMO was a linear combination of d(xz) and d(yz) (Figure 4.6, right). Thus, with its antibond between the metal orbital and an occupied ligand-MO, the HOMO reflects π-donor properties of the HN2O2− ligand. The intraligand-π-MO contribution to the HOMO is N–N bonding but has nodes to both participating oxygen-p-AOs.).[39]    Figure 4.5: Comparison between selected bond angles and distances of the labile tosylato ligand of 7 (left) and the hydrogenhyponitrito ligand of 28 (right) which replaces it.   Figure 4.6: Gabedit plot of the frontier orbitals of 28 (isovalue: 0.05).[197] Top: choice of the Cartesian axes (z towards the observer); centre: the LUMO; bottom: the HOMO.[39] The irradiation of the hyponitrite complexes 28, 29, 30 and their corresponding hyponitrite complexes 31 and 32 with ultraviolet light showed that these complexes can react to a nitric oxide species (confirmed by the crystallised compounds 25, 36) and release N2O as well. The proposed mechanism described previously reveals a plausible pathway. Therefore, the compounds react on the one hand like trans-hyponitrite salts which release N2O if irradiated (investigated by Chacón Villalba et al.) and, on the other hand, like diazoniumdiolates that release NO under the same conditions.[202-204]    
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4.5 Diazoniumdiolato complexes—a replacement for cis-N2O22−  Due to orbital interactions the cis-hyponitrous acid is less stable than the trans analogue. As seen in Figure 4.7, the donation of the nitrogen lone pair into the σ*(N–O) lowers kinetic stability due to the weakening of the N–O bond favouring N2O release.[94]  N NHO N N OHHO N2p*(NO)OH*(NO)N2pcis form trans form  Figure 4.7: Interaction of the nitrogen lone-pair with the σ*(N–O) orbital in hyponitrous acid.[94, 201]  As a consequence of this intramolecular lability, cis-hyponitrite salts exhibit explosive behaviour which is probably triggered by impact or shock. Also, there are no substituted derivatives of cis-hyponitrite known.[94] Therefore, a safer method for using diazoniumdiolato ligands was performed to get insight to see whether a cis-hyponitritoruthenium complex is possible.    Figure 4.8: Gabedit plot of the frontier orbitals (isovalue 0.05) of [Ru(dppe)2(bdd)]+ (39).[197] HOMO−1 (x2–y2-like shaped) and HOMO (xz) as part of the t2g molecular orbital set. LUMO (unoccupied, z2-like shaped) as part of the virtual eg orbitals.  A classification of the diazoniumdiolato ligand, as made for trans-hyponitrite, is given in Figure 4.8. The occupied orbitals are metal-centred with metal-ligand π-antibonds as well. Any π-acceptor characteristics are not observable. Similar observations are made for compounds 37, 40, 41. Therefore, the diazoniumdiolato ligands can be characterised as mainly σ-donors with π-donor capability (weak-field ligands).   
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Most C- and N-diazoniumdiolates are formed under basic conditions due to instant decomposition under acidic conditions.[107] In general, the decomposition of diazoniumdiolates can be accomplished either by photoexcitation or by the addition of an electron pair acceptor such as H+ for example.[203, 205] Therefore, the reaction and crystallisation of the starting complexes 7, 8, 16 was successful only, if these compounds were crystallised before in the presence of tetrafluoroboric acid. In comparison, C-diazoniumdiolates are far more stable than N-diazoniumdiolates due to the better stabilisation of the N2O2 moiety. Also, the substitution of the terminal oxygen atoms is more established with even protonated C-diazoniumdiolates obtainable as in compound 42.[107, 206] In contrast to their unstable behaviour in their salt form, the N-diazoniumdiolato ligands are as stable in their corresponding complexes (35, 37) as their C-diazoniumdiolato counterparts (39–41), which could also result from the phenylgroup protection (Figure 4.9).  Figure 4.9: Space-filling model of compounds 37 (Gabedit).[197] With the dppp co-ligand, compound [Ru(dppp)2(NO)]BF4 (36) was obtained instead of the N-diazoniumdiolato complex. Nitric-oxide release of diazoniumdiolates is well known in literature, but formation of a nitrosyl complex after adding a diazoniumdiolato ligand probably represents a novelty.[117, 204] The reactivity of compound 8 towards the N-diazoniumdiolate 38 is probably explained best by the higher σ-donor capability as indicated by the high-field-shifted 31P{1H} NMR signals compared to 7 and 16. The higher electron density presumably promotes the reverse reaction from pyrrolidinediazoniumdiolate back to nitric oxide (pdd → 2NO + pyrrolidine). The involved antibonding orbitals of the NN double bond of compound 37 (as model for 36) which have to be occupied are part of the LUMO+3 and therefore, as a tentative part of the energetically disfavoured t1u* orbital sets, unavailable. Shaik et al. emphasised the stabilisation of the N2O2-moiety through the substituent on the nitrogen and the bond cleavage as the rate-determining step for the decomposition.[205] Therefore, it is more likely that the antibonding orbitals between the pyrrolidine and the N2O2 moiety which are part of the HOMO of 37 (Figure 4.10) are affected by the previously mentioned higher basicity of the dppp ligand, resulting in a borderline situation between the dppe and dppv compounds 35, 37 and NO 
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compound 36. The remaining N2O2 moiety decomposes and the emitted nitric oxide coordinates to the ruthenium centre.  Figure 4.10: Gabedit plot of the HOMO (isovalue 0.04) of [Ru(dppv)2(pdd)]+ (37).[197]     
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5 Summary The first part of this work deals with the descriptive analysis of hexaaquaruthenium salts. An alteration of the original work made a synthesis possible which is best described as an avoidance of the ion-chramatography step in order to obtain [Ru(H2O)6](tos)2 (1).[10] A reproduction of the 17O NMR signal of the complex cation was possible whereby the signal of the tosylate anion was added. A comparison of solid-state and solution UV/VIS spectroscopy—in solution with or without toluenesulfonic-acid addition—revealed that in all three cases the hexaaquaruthenium cation is present as shown in Figure 5.1.   Figure 5.1: Hexaaquaruthenium tosylate (1); visualisation of the hydrogen bond saturation. Five new hexaaquaruthenium compounds 2–6 such as the highly soluble hexaaquaruthenium triflate (2) and hexaaquaruthenium sulphate (3) being the first 4d version of the hexahydrite mineral group have been synthesised. Graph-set analysis revealed similar patterns for the hexaaquaruthenium compounds confirming the assumption on full occupation of all hydrogen bond positions. The mesitylsulfonate compound 6 was tested beside compound 1 for two phosphane complexes and resulted with respect to the coordination in identical complexes (7 and 10, 11, 12). The treatment of hexaaquaruthenium tosylate (1) (or 6) as a precursor resulted in six phosphane compounds with tosylato-κ2O,O′ ligand (7–12), four diaquaphosphane complexes (13–16) and four borderline complexes with aqua and tosylato ligands (17–20). As introduced, compounds 7–12 are the first crystal structures of tosylato-κ2O,O′ ruthenium complexes synthesised representing the rare compounds with chelating sulfonato ligands in general. It was possible to obtain two mononuclear ruthenium compounds (10 and 12) with two chelating tosylato ligands which had been unknown in this coordination form. Compound 14, the trans-diaqua form of the  originally published cis-[Ru(dppen)2(H2O)2] by Bickley et al. was obtained as a tosylate salt.[47] Compounds 13, 15, 16 are tetrafluoridoborate salt analogues of 14. Apart from X-ray-crystallographic analysis, the comparison between calculated and empirical IR spectra confirmed the formation of all these compounds and 
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made an illustration of the respective vibrations possible. 31P{1H} NMR and UV/VIS spectroscopy were further used to complete the analytic data for the newly synthesised compounds. The synthesis of hyponitrito complexes by the treatment of compound 7 as the model complex with nitric oxide was not possible in the context of the experiments shown. The {RuNO}8 complex [Ru(dppe)2(NO)]BF4 (25) is the main derivative of this reaction and is formed independently of the NO concentration. In the presence of excess nitric oxide and a fluoride donor, compound 26 is formed. Compound 24 was obtained by adding a reducing agent to the mentioned NO set-up whereby this nitrite hydride complex emerges. Compound 24 is obtained solely in the presence of traces of water indicating a reaction taking place of both, hydroxide with the NO+ ligand and a reaction of the ruthenium centre as hydride catalyst with the resulting hydrogen. A reaction of the more reactive hexaaquaruthenium with nitric oxide in the presence of PPh3 results in a {Ru(NO)2}10 compound 27, which is theoretically able to form a hyponitrite complex in terms of the electronic state (Scheme 5.1) such as the reaction of [Pt(PPh3)2(NO)2] to [Pt(PPh3)2(N2O2)].[98] A Difference-Fourier analysis was performed for compound 24 to ensure the assignment of the hydrido ligand. For compounds 25–27 IR spectroscopy and 31P{1H} NMR spectroscopy complete the analytical data of the compounds.  Scheme 5.1: Possible, simplified formation of a ruthenium hyponitrite complex from compound 27. In contrast to the previous reactions, it was possible to obtain the first mononuclear trans-hydrogenhyponitrito ruthenium compounds with dppe (bis(diphenylphosphanyl)ethane), dppp (bis(diphenylphosphanyl)propane) and dppv (bis(diphenylphosphanyl)ethene) (28a–30) by using salt metathesis and subsequent protonation (example 29 in Figure 3.41 and 5.2 left). The previously formed four-ring-tosylato chelate is substituted by a trans-hydrogenhyponitro ligand. The deprotonation with imidazole led to two hyponitrito compounds (28a→31, 30→33). The deprotonation of compound 29 using imidazole was not possible resulting in compound 32 with a hydrogenhyponitrito imidazole hydrogen bridge. The imidazole/imidazolium replaces, thereby, the diethyl ether/TBME (tert-butylmethyl ether) moiety. X-ray diffraction analysis was performed as the main analysis. Difference-Fourier analyses of the very good crystallographic data enabled the assignment of the hydrogenhyponitrito hydrogen and its migration to the imidazole in case of deprotonation. A comparison of solid-state and solution UV/VIS spectra of 28a–30 confirmed that the chromophore is, in both cases, identical. Solid-state 31P{1H} NMR spectroscopy confirmed the 
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formation of the complexes delivering a tentative explanation for the unaltered protonation of compound 29 due to higher basicity of the dppp ligands indicated by a high-field shift. The comparison of calculated and empirical IR spectra made an assignment of the hyponitrito-ligand vibrations possible which were then illustrated. The computational calculations (RI-DFT level using def2-TZVP basis sets and the functionals BP-86 which is used for the calculations in general in this thesis) made a classification of the hydrogenhyponitrito/hyponitrito ligand as a weak-field ligand possible using orbital considerations. These obtained results were published.[39] Irradiation experiments in the ultraviolet region (365 nm) broke down compounds 28a–32 resulting in both N2O release and the formation of nitrosyl complexes regardless whether the hyponitrite was protonated or deprotonated. Compounds 25 and 36 were identified by comparing IR vibrations as likely decomposition products, i.e. nitrosyl products obtained in the process of irradiation for compounds 28a,b/31 and 29/32. A reasonable, irradiation induced reaction pathway could be assigned.  Figure 5.2: Examples of complexes obtained from starting complex 8 (ORTEP-3 plot). Left: complex cation [Ru(dppp)2(N2O2H)]+ in 29 with hydrogen bridge to diethyl ether; centre: complex cation [Ru(dppp)2(bdd)]+ in 40; right: complex cation [Ru(dppp)2(NO)]+ in 36. Due to the explosive behaviour of cis-sodium hyponitrite, C- and N-diazoniumdiolates (benzyldiazoniumdiolate (bdd, 42) and pyrrolidinediazoniumdiolate (pdd, 38)) were both used as replacements. The main reason for this was to prove that cis-hyponitrite can bind to the starting complexes 7, 8, 16 with respect to bond distances and angles. It was possible to obtain three C-diazoniumdiolato ruthenium compounds (39–41) including their crystal structures with the co-ligands dppe, dppp and dppv of 28–30 (see example 40 in Figure 5.2). Also, the two N-diazoniumdiolato compounds 35 and 37 were obtained, whereby 37 was identified by X-ray diffractometry. In general, a comparison of calculated and empirical infrared spectra made an assignment of the diazoniumdiolato vibrations possible, which were then illustrated. UV/VIS and 31P{1H} NMR spectroscopy complete the analytic information. Apart from the one example of a diazoniumdiolatoruthenium complex shown in chapter 1.5, all illustrated compounds are the first diazoniumdiolatoruthenium complexes synthesised 
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with these ligand forms ever. Compound 36 [Ru(dppp)2(NO)]BF4 is a nitrosyl complex obtained when the starting complex 8 is treated with pdd (Figure 5.2). Both the complex cation [Ru(dppe)2(NO)]+ (25) and [Ru(dppp)2(NO)]+ (36) were already published, but their synthetic routes are different.[166, 177] The supposed mechanism of the reaction provides an explanation for compound 36, whose existence was confirmed by infrared and 31P{1H} NMR spectroscopy.    Future work should include intensive testing of the newly synthesised hexaaquaruthenium compounds as already shown for compound 6 on a minor scale. As already stated in this work, the phosphane complexes (especially 7, 8 and 16) are able to stabilise the hyponitrite ligand and diazoniumdiolato complexes as well. Even if these complexes are incapable of metal centred reduction of nitric oxide, the phosphane complexes are able to serve as crystallisation-anchor complexes for ligands which are unstable or whose crystallisation is difficult. The reactivity of diazoniumdiolato ruthenium complexes remains unexplored. Therefore, the question of whether or not an irradiation of these compounds leads to nitrosyl complexes such as compound 36 is of particular interest.       
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6 Experimental Part 6.1 Common working techniques All reactions, as far as not explicitly described otherwise, were carried out under inert-gas atmosphere using standard Schlenk techniques.  The syringes and cannulas which were used to transfer reagents and solvents, were purged three times with argon prior to use. Diethyl ether which was used for the purification of the raw products was dried by heating to reflux, cooled and stored under argon flow over 4 Å molecular sieves. The solvents, as well as the air-sensitive phosphanes, were stored under argon atmosphere. For crystallisation, several techniques were applied: hexaaquaruthenium(II) salts were obtained by concentrating the solution with different sulfonic acids. As far as possible, the phosphane-precursor complexes were obtained by layering a methylene chloride or chloroform solution with the corresponding antisolvent (toluene, diethyl ether, cyclohexane). The hydrogenhyponitrite, hyponitrite and diazoniumdiolate complexes were obtained in the same manner layering DCM solutions with diethyl ether, TBME and cyclohexane. Adjusting of various concentrations enhanced the crystal quality and yield. Additional rinsing with diethyl ether is obligatory in the case of the hydrogen hyponitrite complexes to obtain a clean product. As far as possible, high-resolution mass spectra were recorded. In other cases, data of elemental analysis and powder-X-ray diffraction are shown.  The absorption bands of the infrared spectra were reported in wave numbers (cm−1). NMR spectra were recorded on solutions in:[207]  D2O:   residual water: δ 4.79 for 1H NMR; δ 0.0 ppm for 17O NMR CD2Cl2:   residual dichlormethane: δ 5.32 ppm for 1H NMR; δ 53.84 ppm for 13C{1H} NMR CDCl3:  residual chloroform: δ 7.26 ppm for 1H NMR; δ 77.16 ppm for 13C{1H} NMR THF-d8: residual THF: δ 3.58, 1,72 ppm for 1H NMR, δ 67.21, 25.31 ppm for 13C{1H} NMR CD3OD:  residual methanol: δ 3.31 ppm for 1H NMR; δ 49.00 ppm for 13C{1H} NMR Chemical shifts were reported as δ values in ppm relative to the solvent peak, if possible. Solid-state NMR were recorded from finely powdered material using a 4 mm rotor (rotation around the “magic angle” of 54.74° with respect to the external magnetic field).   
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Crystallography Crystals were selected using a Leica MZ6 polarisation microscope. Suitable crystals were measured with Bruker D8 Venture diffractometer and Oxford XCalibur 3 using Mo-Kα irradiation (λ = 0.71073 Å). Multi-scan-absorption correction was applied. The structure solutions were carried out by direct methods using SHELXT. The structures were refined by full-matrix least-squares calculations on F2 using SHELXL-2014.[39, 208-209] Computational chemistry All quantum-chemical calculations at the DFT level were performed with Orca4 (version 4.0.1). Initial geometries were taken from crystal-structure analyses. Wave functions were calculated at the multipole-accelerated RI-DFT level using def2-TZVP basis sets and the functional BP86; dispersion correction was applied by using Grimme's DFT-D3 with BJ-damping as implemented in Orca4.[210] Frequency analyses were done numerically.[39]   
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6.2 Analytical methods Analytic method equipment Elemental analysis Elementar vario EL (C, H, N content) Infrared spectrometer Jasco FT/IR-4600 Fourier-Transform Infrared spectrometer with ATR Diamond plate Crystal selection microscope Leica MZ6 with polarisation filter  NMR spectrometer Jeol ECX 400 MHz  Jeol GSX 270  Bruker Avance III HD 400 MHz Solid-state NMR spectrometer Bruker Avance III 500 MHz X-ray diffractometer  Bruker D8 venture TXS  Oxford XCalibur3  STOE Stadi P powder diffractometer  UV/VIS spectrophotometer Varian Cary 50 Scales Mettler Toledo AG204  Sartorius BP410S  Sartorius ED124S Mass spectrometer Jeol JMS 700, Thermo Finnigan MAT 95, FAB  Thermo Finnigan LTQ FT, IonMax ion source, ESI    
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6.3 Reagents and solvents chemicals purity company Ba(OH)2 ≥98% Fluka N-benzylhydroxylamine hydrochloride puriss., ≥99% Aldrich chloroform 99% Kraft DCM 99.9% Kraft diethyl ether 99.5% Kraft dppbz >98% TCI dppe 99% ABCR dppen 98% Aldrich dppp ≥98% ABCR dppv 97% ABCR ethanol pA – ethyl acetate purum  – H2(1,5-NaphDS) >98% TCI H2(4,4′-BiphenDS) >98% TCI H2O de-ionised house installation H2SiF6 33.5–35% Aldrich H2SO4 96% – HOTf 99% ABCR HSbF6∙6H2O – Aldrich i-hexane purum – imidazole 99% ABCR MesSO3∙2H2O 97% Aldrich 
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methanol (dried over molecular sieve) 99.8% Aldrich Na2N2O2∙xH2O – Aldrich NaIO4 – Normapur NaNO2 pA Grüssing NaOH puriss. ABCR nitric oxide 99.5% Air Liquide n-pentane puriss. – Pb ≥99% Aldrich PBnPh2 99% Alfa Aesar PPh2iPr 99% ABCR PPh3 99% Acros pyrrolidine ≥99.5% Aldrich RuCl3∙xH2O 99.9%, 36% Ru ABCR silver nitrate puriss. VWR sodium – Aldrich tetrafluoroboric acid (in water) 50% Fluka tetrakis(dimethylamino) ethylene (tden) ≥95% TCI THF (dried over molecular sieve) ≥99.9% Aldrich toluene technical – triphenyltin chloride 95% ABCR p-toluene sulfonic acid ≥98% Aldrich  
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6.4 Syntheses of hexaaquaruthenium(II) salts  6.4.1 Preparation of “RuO2·xH2O”   Literature: C. Fellay, G. Laurenczy, S. M. Bischof, R. A. Periana, Inorganic Syntheses, Vol. 35, John Wiley & Sons, Inc., Hoboken, New Jersey, 2010. Starting materials: RuCl3 ∙xH2O, NaOH pellets, H2O (de-ionized), AgNO3 solution (2% in H2O) Procedure: A solution of NaOH (1.23 mol, 49.2 g) in H2O (250 mL) was prepared and heated up to 60 °C. The RuCl3∙ xH2O (28.9 mmol, 6.00 g, statement abcr: 207.43 g/mol) was added and the suspension stirred for 1 h. After that, the solution was cooled down to room temperature and stirred again for 2 d. The black solid was filtered off and washed several times with H2O until a test with AgNO3 solution (2% in H2O) was negative. The solid was dried at room temperature for 2 days.  Empirical formula: “RuO2∙xH2O” (ill-defined) Yield: ca. 9–10 g of black scales. Please note: The product is ill-defined. The water content varies strongly depending on the drying process. The product was directly used without any further analytics. Nonetheless, following the route mentioned above the yield of the hexaaquaruthenium(II) salts stays nearly the same. Great care has to be taken in the washing process to avoid any chloride contamination, otherwise this will result in the formation of chlorine gas in the following syntheses and the subsequent decomposition of the ruthenium(II) species.    
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6.4.2 Setup for the synthesis of hexaaquaruthenium(II)   Figure 6.1: Set-up of the apparatus for the synthesis of the [Ru(H2O)6]2+ cation. Arrows indicate the way of the Ar flow. Washing flask C was omitted due to photographic limitations.  Figure 6.2: Set-up plan of the apparatus. The inlet tube is sealed at one side and the glass bridge has an integrated inlet tube to ensure a tightness of the apparatus. A stopcock with PTFE-key was used in the dropping funnel. Black residues, visible on the glass, occur, if organic impurities are on the glass or the surface is rough.   
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6.4.3 Hexaaquaruthenium(II) tosylate (1)   According to: C. Fellay, G. Laurenczy, S. M. Bischof, R. A. Periana, Inorganic Syntheses, Vol. 35, John Wiley & Sons, Inc., Hoboken, New Jersey, 2010. Starting materials: RuO2∙xH2O (ill-defined), NaIO4, H2SO4 (50% a. 2.0 M), H2O (de-ionized), Pb (dust), HOTf (98%), Htos (98%), neutralising solution (Pb in 1.0 M H2SiF6). Procedure: A solution of NaIO4 (10.5 g, 49.0 mmol) (A) in water (85 ml), a suspension of Pb (20.0 g, 96.4 mmol) in HOTf (2.40 mM, 140 mL) (B) and a suspension Pb (3.00 g, 14.5 mmol) in H2SiF6 (1.0 M, 60 mL) (C) were prepared. After placing the solutions in the intended reaction flasks (Fig. 6.1 and 6.2), they were degassed with Ar for 1 h. After that, the H2SO4 solution (50%, 42 mL) (D) was prepared and degassed separately. The NaIO4 solution was cooled to 0 °C, the RuO2∙xH2O (2.1 g, ≈ 17 mmol) was added to solution A, the dropping funnel was filled with the H2SO4 solution and the apparatus was scrutinized to ensure leak tightness. The acid was dropped slowly (ca. 1 drop per second) into solution A and a constant flow of Ar (2 bubbles per second) was maintained. The ice bath was not removed and allowed to melt over time to ensure a slow emission of RuO4 (please read instructions below). Stirring was continued for 3–4 d under constant Ar flow until solution A was clear. To the dark pink solution B H2SO4 (2.0 M, 42 mL) was added and stirred for 15 min. After sedimentation of the PbSO4, the solution was filtered off with a Schlenk-frit with cotton wool (placed above the glass disc). To this solution Htos (35.0 g, 184 mmol) was added and immediately put in a rotary evaporator. The bath was heated to 45 °C and the pressure was reduced in small steps from 65 mbar to 30 mbar. The operational steps had to be done quickly otherwise the oxidation of Ru(II) to Ru(III) would result in preferential crystallisation of the Ru(III) product.  When the first crystals appeared the evaporation was stopped, the crystal slurry was put under an Ar atmosphere and kept for 3 h at 4 °C in the refrigerator. The crystals were filtered off with a Schlenk-frit, washed with ethyl acetate (3 ∙ 20 mL) and diethyl ether (3 ∙ 20 mL) and dried in vacuo. The crystals were kept away from light and air. 
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Empirical formula: C14H26O12RuS2 (551.55 g/mol) Yield: 4.7 g (8.5 mmol, 61% of th. (14 mmol RuCl3)) of pink platelets. Elemental Analysis: (calcd. for C14H26O12RuS2, 551.55 g/mol) found (calcd.): C 30.43% (30.48%), H 4.85% (4.75%), S 11.76% (11.62%). UV/VIS spectroscopy: 391.0, 533.0 (de-ionized water, pH 6); 392.5, 534.5 (H-tos solution, pH 1); 388.0, 521.0 (solid-state UV/VIS) nm 17O NMR spectroscopy: (D2O, 54 MHz):δ = 174.2 (s) (p-toluene sulfonate), −189.9 (s) (hexaaquaruthenium(II)) ppm. X-ray structure analysis: to008  Please note: RuO4 is a toxic and highly reactive gas. Due to safety hazards proper instructions for the work with it was attached to the appendix. The ion-exchange chromatography—as suggested in the literature—could not be reproduced, therefore, the more expensive triflic acid (HOTf) was used to avoid this step.   
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6.4.4 Hexaaquaruthenium(II) triflate (2)  According to: C. Fellay, G. Laurenczy, S. M. Bischof, R. A. Periana, Inorganic Syntheses, Vol. 35, John Wiley & Sons, Inc., Hoboken, New Jersey, 2010. Starting materials: RuO2∙xH2O (ill-defined), NaIO4, H2SO4 (50% a. 2.0 M), H2O (de-ionized), Pb (dust), HOTf (99%), neutralising solution (Pb in 1.0 M H2SiF6), Ba(OH)2.  Procedure: Variant I A solution of NaIO4 (10.5 g, 49.0 mmol) (A) in water (85 ml), a suspension of Pb (20.0 g, 96.4 mmol) in HOTf (2.40 mM, 140 mL) (B) and a suspension Pb (3.00 g, 14.5 mmol) in H2SiF6 (1.0 M, 60 mL) (C) were prepared. After placing the solutions in the intended reaction flasks (Fig. 6.1 and 6.2), they were degassed with Ar for 1 h. After that, the H2SO4 solution (50%, 42 mL) (D) was prepared and degassed separately. The NaIO4 solution was cooled to 0 °C, the RuO2∙xH2O (2.1 g, ≈ 17 mmol) was added to solution A, the dropping funnel was filled with the H2SO4 solution and the apparatus was scrutinized to ensure leak tightness. The acid was dropped slowly (ca. 1 drop per second) into solution A and a constant flow of Ar (2 bubbles per second) was maintained. The ice bath was not removed and allowed to melt over time to ensure a slow emission of RuO4. Stirring was continued for 3–4 d under constant Ar flow until solution A was clear. To the dark pink solution B H2SO4 (2.0 M, 42 mL) was added and stirred for 15 min. Separately, a solution of Ba(OH)2 (753 mg, 4.39 mmol) in H2O was neutralised with 
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HOTf (2.0 mL, 23 mmol) and degassed with Ar. The other solution was titrated with the Ba(OTf)2 solution until no visual precipitation of BaSO4 occurred. The suspension was stirred for another 15 min. After sedimentation, the solution was filtered off with a Schlenk-frit with cotton wool (placed above the glass disc). The clear solution was reduced in a rotary evaporator. The bath was heated to 45 °C and the pressure was reduced in small steps from 65 mbar to 30 mbar. The evaporation had to be maintained until no further distillate could be collected. After that, the solution was put under Ar and cooled down to 4 °C in a refrigerator. After 1–2 days, the pink crystals were filtered off, cautiously (see below) and carefully washed with dry n-pentane (2 ∙ 10 mL) and dried in vacuo. The crystals were kept away from air and light. Empirical formula: C2H12F6O12RuS2 (507,30 g/mol) Yield: 1.83 g (3.60 mmol, 24.8% of th. (14.5 mmol RuCl3)) of pink blocks. Elemental Analysis: (calcd. for C2H12F6O12RuS2, 507.30 g/mol) found (calcd.): C 4.88% (4.74%), H 2.65% (2.38%), S 12.85% (12.64%).  X-ray structure analysis: to024  Variant II  A solution of [Ru(H2O)6]SO4 (1.121 g, 3.7 mmol) in H2O (20 mL) was prepared and treated with a neutralised solution of Ba(OH)2 (750 mg, 4.0 mmol) with HOTf (2 mL, 22.6 mmol) in H2O (10 mL). After sedimentation, the solution was filtered through a syringe filter, and evaporated in a rotary evaporator. The following work steps were identical to variant I.   Yield: 1.43 g (2.8 mmol, 76% of th.) of pink blocks.  Please note: The [Ru(H2O)6](OTf)2 obtained in this synthesis is a highly soluble compound. Both ethyl acetate and diethyl ether are not suitable for the washing process. It is suspected that the solvent itself or trace impurities of water are enough to solve larger quantities of the product. Additionally, there is a possibility in variant I to obtain [Ru(H2O)6]SO4, if a decent amount of sulfate remains. Due to the characteristics of the synthesis an exact determination of the Pb2+ concentration in solution is not possible. The method of titrating the solution was the most sensible way to solve this problem and also to avoid contamination with larger quantities of Ba(OTf)2. Nonetheless, variant II offers the possibility to obtain a proper product.   
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6.4.5 Hexaaquaruthenium(II) sulfate (3)  According to: C. Fellay, G. Laurenczy, S. M. Bischof, R. A. Periana, Inorganic Syntheses, Vol. 35, John Wiley & Sons, Inc., Hoboken, New Jersey, 2010. Starting materials: RuO2∙xH2O (ill-defined), NaIO4, H2SO4 (50% a. 2.0 M), H2O (de-ionized), Pb (dust), HOTf (99%), neutralising solution (Pb in 1.0 M H2SiF6) Procedure: A solution of NaIO4 (10.5 g, 49.0 mmol) (A) in water (85 ml), a suspension of Pb (20.0 g, 96.4 mmol) in HOTf (2.40 mM, 140 mL) (B) and a suspension Pb (3.00 g, 14.5 mmol) in H2SiF6 (1.0 M, 60 mL) (C) were prepared. After placing the solutions in the intended reaction flasks (Fig. 6.1 and 6.2), they were degassed with Ar for 1 h. After that, the H2SO4 solution (50%, 42 mL) (D) was prepared and degassed separately. The NaIO4 solution was cooled to 0 °C, the RuO2∙xH2O (2.1 g, ≈ 17 mmol) was added to solution A, the dropping funnel was filled with the H2SO4 solution and the apparatus was scrutinized to ensure leak tightness. The acid was dropped slowly (ca. 1 drop per second) into solution A and a constant flow of Ar (2 bubbles per second) was maintained. The ice bath was not removed and allowed to melt over time to ensure a slow emission of RuO4. Stirring was continued for 3–4 d under constant Ar flow until solution A was clear. To the dark pink solution B H2SO4 (2.0 M, 42 mL) was added and stirred for 15 min. After sedimentation of the PbSO4, the solution was filtered off with a Schlenk-frit with cotton wool (placed above the glass disc). To this solution an additional amount of H2SO4 (10 mL, 2.0 M) was added and immediately put in a rotary evaporator. The bath was heated to 45 °C and the pressure was reduced in small steps from 65 mbar to 30 mbar. The evaporation had to be maintained until no further distillate could be collected. After that, the solution was put under Ar and cooled down to 4 °C in a refrigerator. After 1–2 days, the pink crystals were filtered off, carefully washed with ethyl acetate (2 ∙ 10 mL) and diethyl ether (2 ∙ 10 mL) and dried in vacuo. The crystals were kept away from air and light.  Empirical formula: H12O10RuS (305.23 g/mol) 
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Yield: 1.12 g (3.67 mmol, 25.3% of th. (14.5 mmol RuCl3)) of red platelets. Elemental Analysis: (calcd. for H12O10RuS, 305.23 g/mol) found (calcd.): H 3.83% (3.96%), S 10.45% (10.51%). X-ray structure analysis: tv140    
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6.4.6 Hexaaquaruthenium(II) naphthalenedisulfonate (4)  According to: C. Fellay, G. Laurenczy, S. M. Bischof, R. A. Periana, Inorganic Syntheses, Vol. 35, John Wiley & Sons, Inc., Hoboken, New Jersey, 2010. Starting materials: RuO2∙xH2O (ill-defined), NaIO4, H2SO4 (50% a. 2.0 M), H2O (de-ionized), Pb (dust), HOTf (99%), neutralising solution (Pb in 1.0 M H2SiF6), H2(1,5-NaphDS) (≥ 98%). Procedure: A solution of NaIO4 (10.5 g, 49.0 mmol) (A) in water (85 ml), a suspension of Pb (20.0 g, 96.4 mmol) in HOTf (2.40 mM, 140 mL) (B) and a suspension Pb (3.00 g, 14.5 mmol) in H2SiF6 (1.0 M, 60 mL) (C) were prepared. After placing the solutions in the intended reaction flasks (Fig. 6.1 and 6.2), they were degassed with Ar for 1 h. After that, the H2SO4 solution (50%, 42 mL) (D) was prepared and degassed separately. The NaIO4 solution was cooled to 0 °C, the RuO2∙xH2O (2.1 g, ≈ 17 mmol) was added to solution A, the dropping funnel was filled with the H2SO4 solution and the apparatus was scrutinized to ensure leak tightness. The acid was dropped slowly (ca. 1 drop per second) into solution A and a constant flow of Ar (2 bubbles per second) was maintained. The ice bath was not removed and allowed to melt over time to ensure a slow emission of RuO4 (please read instructions below). Stirring was continued for 3–4 d under constant Ar flow until solution A was clear. To the dark pink solution B H2SO4 (2.0 M, 42 mL) was added and stirred for 15 min. After sedimentation of the PbSO4, the solution was filtered off with a Schlenk-frit with cotton wool (placed above the glass disc). To this solution H2(1,5-NaphDS) (2.88 g, 8.00 mmol) was added and immediately put in a rotary evaporator. The bath was heated to 45 °C and the pressure was reduced in small steps from 65 mbar to 30 mbar. When the first crystals appeared the evaporation was stopped, the crystal slurry was put under an Ar atmosphere and kept for 3 h at 4 °C in the refrigerator. The crystals were filtered off with a Schlenk-frit, washed with methanol (3 ∙ 20 mL), ethyl acetate (3 ∙ 20 mL) and diethyl ether (3 ∙ 20 mL) and dried in vacuo. The crystals were kept away from light and air. Empirical formula: C10H18O12RuS2 (495.45 g/mol) 
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Yield: 3.13 g (6.32 mmol, 43.6% of th. (14.5 mmol RuCl3)) of pink platelets. Elemental Analysis: (calcd. for C10H18O12RuS2, 495.45 g/mol) found (calcd.): C 24.20% (24.24%), H 3.73% (3.66%), S 12.97% (12.94%). X-ray structure analysis: tv449    
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6.4.7 Hexaaquaruthenium(II) biphenyldisulfonate (5)  According to: C. Fellay, G. Laurenczy, S. M. Bischof, R. A. Periana, Inorganic Syntheses, Vol. 35, John Wiley & Sons, Inc., Hoboken, New Jersey, 2010. Starting materials: RuO2∙xH2O (ill-defined), NaIO4, H2SO4 (50% a. 2.0 M), H2O (de-ionized), Pb (dust), HOTf (99%), neutralising solution (Pb in 1.0 M H2SiF6), H2(4,4′-BiphenDS) (≥ 98%). Procedure: A solution of NaIO4 (10.5 g, 49.0 mmol) (A) in water (85 ml), a suspension of Pb (20.0 g, 96.4 mmol) in HOTf (2.40 mM, 140 mL) (B) and a suspension Pb (3.00 g, 14.5 mmol) in H2SiF6 (1.0 M, 60 mL) (C) were prepared. After placing the solutions in the intended reaction flasks (Fig. 6.1 and 6.2), they were degassed with Ar for 1 h. After that, the H2SO4 solution (50%, 42 mL) (D) was prepared and degassed separately. The NaIO4 solution was cooled to 0 °C, the RuO2∙xH2O (2.1 g, ≈ 17 mmol) was added to solution A, the dropping funnel was filled with the H2SO4 solution and the apparatus was scrutinized to ensure leak tightness. The acid was dropped slowly (ca. 1 drop per second) into solution A and a constant flow of Ar (2 bubbles per second) was maintained. The ice bath was not removed and allowed to melt over time to ensure a slow emission of RuO4 (please read instructions below). Stirring was continued for 3–4 d under constant Ar flow until solution A was clear. To the dark pink solution B H2SO4 (2.0 M, 42 mL) was added and stirred for 15 min. After sedimentation of the PbSO4, the solution was filtered off with a Schlenk-frit with cotton wool (placed above the glass disc). To this solution H2(4,4′-BiphenDS) (3.14 g, 10.0 mmol) was added and immediately put in a rotary evaporator. The bath was heated to 45 °C and the pressure was reduced in small steps from 65 mbar to 30 mbar. When the first crystals appeared the evaporation was stopped, the crystal slurry was put under an Ar atmosphere and kept for 3 h at 4 °C in the refrigerator. The crystals were filtered off with a Schlenk-frit, washed with ethyl acetate (3 ∙ 20 mL) and diethyl ether (3 ∙ 20 mL) and dried in vacuo. The crystals were kept away from light and air. Empirical formula: C12H24O14RuS2 (557.52 g/mol)  
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Yield: 3.90 g (7.00 mmol, 48.2% of th. (14.5 mmol RuCl3)) of pink platelets. Elemental Analysis: (calcd. for C12H20O12RuS2, 521.49 g/mol) found (calcd.): C 27.43% (27.64%), H 3.83% (3.87%), S 12.28% (12.31%) (Loss of two water of crystallization in the drying process). X-ray structure analysis: uo030   6.4.8 Hexaaquaruthenium(II) mesitylsulfonate (6)  According to: C. Fellay, G. Laurenczy, S. M. Bischof, R. A. Periana, Inorganic Syntheses, Vol. 35, John Wiley & Sons, Inc., Hoboken, New Jersey, 2010. Starting materials: RuO2∙xH2O (ill-defined), NaIO4, H2SO4 (50% a. 2.0 M), H2O (de-ionized), Pb (dust), HOTf (99%), neutralising solution (Pb in 1.0 M H2SiF6), HMesSO3∙2H2O (97%). Procedure: A solution of NaIO4 (10.5 g, 49.0 mmol) (A) in water (85 ml), a suspension of Pb (20.0 g, 96.4 mmol) in HOTf (2.40 mM, 140 mL) (B) and a suspension Pb (3.00 g, 14.5 mmol) in H2SiF6 (1.0 M, 60 mL) (C) were prepared. After placing the solutions in the intended reaction flasks (Fig. 6.1 and 6.2), they were degassed with Ar for 1 h. After that, the H2SO4 solution (50%, 42 mL) (D) was prepared and degassed separately. The NaIO4 solution was cooled to 0 °C, the RuO2∙xH2O (2.1 g, ≈ 17 mmol) was added to solution A, the dropping funnel was filled with the H2SO4 solution and the apparatus was scrutinized to ensure leak tightness. The acid was dropped slowly (ca. 1 drop per second) into solution A and a constant flow of Ar (2 bubbles per second) was maintained. The ice bath was not removed and allowed to melt over time to ensure a slow emission of RuO4 (please read instructions below). Stirring was continued for 3–4 d under constant Ar flow until solution A was clear. To the dark pink solution B H2SO4 (2.0 M, 42 mL) was added and stirred for 15 min. After sedimentation of the PbSO4, the solution was filtered off with a Schlenk-frit with cotton wool (placed above the glass disc). To this solution 
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HMesSO3∙2H2O (5.00 g, 20.6 mmol) was added and immediately put in a rotary evaporator. The bath was heated to 45 °C and the pressure was reduced in small steps from 65 mbar to 30 mbar. When the first crystals appeared the evaporation was stopped, the crystal slurry was put under an Ar atmosphere and kept for 3 h at 4 °C in the refrigerator. The crystals were filtered off with a Schlenk-frit, washed with ethyl acetate (3 ∙ 20 mL) and diethyl ether (3 ∙ 20 mL) and dried in vacuo. The crystals were kept away from light and air at 4 °C. Empirical formula: C18H34O12RuS2 (607.64 g/mol) Yield: 3.90 g (6.42 mmol, 44.3% of th. (14.5 mmol RuCl3)) of pink platelets. Elemental Analysis: (calcd. for C18H34O12RuS2, 607.64 g/mol) found (calcd.): C 34.24% (35.58%), H 5.51% (5.64%), S 10.25% (10.55%). X-ray structure analysis: uo031 Please note: The [Ru(H2O)6](MesSO3)2 obtained in this synthesis is more sensitive to air and temperature than the other salts. The lifespan of the product can be prolonged by storing at 4 °C. Nonetheless, the product will decompose over time showing a tentative surface of elemental ruthenium.      
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6.5 Syntheses of phosphane precursor complexes 6.5.1 Phosphane complexes with κ2O,O′-tosylato/mesitylsulfonato ligands  6.5.1.1 Bis{bis(diphenylphosphanyl)ethane}tosylatoruthenium(II) tetrafluoridoborate (7)   According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Literature: D. Beck, P. Klüfers, Chem. Eur. J.  2018, 24, 16019–16028. Starting materials: [Ru(H2O)6](tos)2, 1,2-bis(diphenylphosphanyl)ethane (99%, dppe), THF, tetrafluoroboric acid (50% in H2O), DCM, chloroform, toluene, diethyl ether. Procedure: A mixture of [Ru(H2O)6](tos)2  (275 mg, 0.498 mmol, 1.00 equiv.) and dppe (400 mg, 1.00 mmol, 2.01 equiv.) was prepared and suspended in THF (10 mL). The suspension was stirred for 1–2 d until a yellow-orange solution was formed. The solvent was removed in vacuo. The yellow crude product was resolved in DCM (3 mL), filtered off through a syringe filter and layered with diethyl ether. For the tetrafluoro-borate product HBF4 (0.13 mL, 2.1 equiv., 50% in H2O) was added to the DCM solution, filtered off and layered with toluene (variant I). To obtain crystals without intrinsic distortion a chloroform (4 mL) solution of the crude product was treated with HBF4 (0.065 mL, 1.0 equiv., 50% in H2O), filtered off through a syringe filter and layered with diethyl ether (variant II). In all cases orange crystals formed after few hours and after 1 d the crystallisation was finished. The solvent was removed, the crystals were washed with diethyl ether (10 mL) and dried in vacuo.   Empirical formula: C59H55BF4O3P4RuS (1155.92 g/mol) 
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Yield (a): 570 mg (0.493 mmol, 99.0% of th.) of orange platelets. Yield (b): 520 mg (0.449 mmol, 90.2% of th.) of orange platelets. Variant I:  IR spectroscopy: (RT, solid), (intensity):  = 1586vw, 1486w, 1435m, 1256s, 1192m, 1058s, 993s, 748m cm−1. UV/VIS spectroscopy: λmax/nm (εmax[M−1 cm−1]) (DCM) 342 (1952), 380 (2030). NMR spectroscopy:  13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 142.3 (C-CH3), 139.3 (C-SO3−), 128.2-135.1 (Ph + tos aromatic), 125.5 (C1 toluene), 31.3 (P-CH2), 25.4 (P-CH2), 21.6 (Ph-CH3) ppm. 31P{1H} NMR (162 MHz, CD2Cl2): δ 60.3 (t, dppe), 46.9 (t, dppe) ppm.  Elemental Analysis: (calcd. for C61.53H58.53BCl1.5F4O3P4RuS, 1211.65 g/mol, included DCM as crystal solvent) found (calcd.): C 58.90% (60.99%), H 4.84% (4.87%), S 2.90% (2.65%).[161]  Variant II:[39]  IR spectroscopy: (RT, solid), (intensity):  = 3027vw, 1600vw, 1487w, 1436m, 1256s, 1192w,1049s, 989s, 742m cm−1. UV/VIS spectroscopy: λmax/nm (εmax[M−1 cm−1]) (DCM) 338 (1396), 379 (1178). NMR spectroscopy:  13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 142.3 (C-CH3), 128.3-134.8 (Ph + tos aromatic), 30.9 (P-CH2), 25.3 (P-CH2), 21.6 (Ph-CH3) ppm. 31P{1H} NMR (162 MHz, CD2Cl2): δ 60.3 (t, 3JPP = 18.3 Hz), 46.9 (t, 3JPP = 18.3 Hz) ppm. Elemental Analysis: (calcd. for C60H56BCl3F4O3P4RuS, 1275.28 g/mol, included CHCl3 as crystal solvent) found (calcd.): C 56.38% (56.51%), H 4.57% (4.43%), S 2.88% (2.51%). HRMS (ESI+): m/z = 1069.11 (C59H55O3P4RuS)  X-ray structure analysis: uv252   
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 PXRD:  Graph 1: Powder-X-ray diffraction of 7b. Red: X-ray diffraction at 100 K, Black: Powder-X-ray diffraction at RT.[39]    
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6.5.1.2 Bis{bis(diphenylphosphanyl)propane}tosylatoruthenium(II) tetrafluoridoborate (8)    According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Literature: D. Beck, P. Klüfers, Chem. Eur. J.  2018, 24, 16019–16028. Starting materials: [Ru(H2O)6](tos)2, 1,3-bis(diphenylphosphanyl)propane (98%, dppp), THF, tetrafluoroboric acid (50% in H2O), DCM, diethyl ether. Procedure: A mixture of [Ru(H2O)6](tos)2  (275 mg, 0.498 mmol, 1.00 equiv.) and dppp (413 mg, 1.00 mmol, 2.01 equiv.) was prepared and suspended in THF (10 mL). The suspension was stirred for 1–2 d until a red-orange solution was formed. The solvent was removed in vacuo and the orange crude product was washed with diethyl ether (10 mL). The compound was resolved in DCM (3 mL), HBF4 (0.13 mL, 2.0 equiv., 50% in H2O) was added, stirred again, filtered off and layered with diethyl ether. Red crystals formed after 3 d. The solvent was removed, the crystals were washed with diethyl ether (10 mL) and dried in vacuo. Empirical formula: C61H59BF4O3P4RuS (1183.97 g/mol) Yield: 527 mg (0.445 mmol, 89.4%) of yellow-red rods. IR spectroscopy: (RT, solid), (intensity):  = 3059w, 2923w, 2878w, 1598vw, 1573vw, 1485w, 1433m, 1407w, 1317w, 1249s, 1191m, 1160m, 1117m, 1050s, 1025s, 992s, 972s, 921m, 837m, 777w, 790m, 744m cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 317 (sh), 400.  NMR spectroscopy:  31P{1H} NMR (162 MHz, CD2Cl2): δ 23.1 (t, 4JPP = 33.7 Hz), −2.9 (t, 4JPP = 33.7 Hz) ppm.  HRMS (ESI+): m/z = 1097.21 (C61H59O3P4RuS). 
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X-ray structure analysis: vv493  PXRD:  Graph 2: Powder-X-ray diffraction of 8. Red: X-ray diffraction at 100 K, Black: Powder-X-ray diffraction at room temperature.[39]   
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6.5.1.3 Bis{bis(diphenylphosphanyl)benzylamine}tosylatoruthenium(II) tetrafluoridoborate (9) [Ru(H2O)6](tos)2 P P+ 2 1. RT, THF, 24 h2. CH2Cl2, Et2O H+ + tos + 6 H2O +[Ru(dppbza)2(tos)]BF4N1 921+ HBF4 (additive)   According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](tos)2, 1,1’-bis(diphenylphosphanyl)benzylamine (dppbza), THF, tetrafluoroboric acid (50% in H2O), DCM, diethyl ether. Procedure: A mixture of [Ru(H2O)6](tos)2  (275 mg, 0.498 mmol, 1.00 equiv.) and dppbza (476 mg, 1.00 mmol, 2.01 equiv.) was prepared and suspended in THF (10 mL). The suspension was stirred for 1–2 d until an orange-brown solution was formed. The solvent was removed in vacuo and the orange crude product was washed with diethyl ether (10 mL). The compound was resolved in DCM (3 mL), HBF4 (0.13 mL, 2.0 equiv., 50% in H2O) was added, stirred again, filtered off and layered with diethyl ether. Yellow crystals formed after 2 d. The solvent was removed, the crystals were washed with diethyl ether (10 mL) and dried in vacuo. Empirical formula: C69H61BF4N2O3P4RuS (1310.09 g/mol). Yield: 431 mg (0.328 mmol, 65.9%) of dark-yellow prisms. IR spectroscopy: (RT, solid), (intensity):  = 3061vw, 2921vw, 1483w, 1436m, 1274m, 112m, 1050s, 989m, 750m, 695s, 680s cm−1. UV/VIS spectroscopy: (DCM) Expected signals reside in the solvent cut-off region. NMR spectroscopy:  13C{1H} NMR spectroscopy (101 MHz, CDCl3): δ 135.5 (C–CH3), 135.0 (Ph), 134.7 (Ph), 132.4 (Ph), 131.8 (Ph), 131.3 (Ph), 129.6 (Ph), 129.1 (Ph), 128.6 (Ph), 125.9 (C–SO3), 66.2 (CH3-CH2-O-Et), 53.2 (CH2), 21.7 (tos-CH3), 15.7 (CH3-CH2-O-Et) ppm. 
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31P{1H} NMR (162 MHz, CDCl3): δ 87.7 (t, 2JPP = 38.4 Hz), 66.2 (t, 2JPP = 38.4 Hz) ppm. Elemental Analysis: (calcd. for C69H62BF4N2O3P4RuS∙1.31C4H10O, 1408.20 g/mol, found (calcd.): C 62.19% (62.02%), H 4.82% (4.63%), N 2.18% (2.08%), S 2.84% (2.56%). HRMS (ESI+): m/z = 1310.30 (C69H61BF4N2O3P4RuS). X-ray structure analysis: uv279   
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6.5.1.4 Di(iso-propyldiphenylphosphane)ditosylatoruthenium(II) (10)    According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](tos)2, i-propyldiphenylphosphane (99%, PPh2iPr), THF, DCM, diethyl ether. Procedure: A mixture of [Ru(H2O)6](tos)2  (275 mg, 0.498 mmol, 1.00 equiv.) and diphenyl-iso-propylphosphane PPh2iPr (229 mg, 1.00 mmol, 2.01 equiv.) was prepared and suspended in THF (10 mL). The suspension was stirred for 2 d until a dark violet solution was formed. The solvent was removed in vacuo. The compound was resolved in DCM (3 mL), filtered off and layered with diethyl ether. Violet crystals formed after 2 d. The solvent was removed, the crystals were washed with cool diethyl ether (3 mL) and dried in vacuo. Empirical formula: C44H48O6P2RuS2, 899.95 g/mol. Yield: 368 mg (0.410 mmol, 82.3% of th.) of violet platelet. IR spectroscopy: (RT, solid), (intensity):  = 1598vw, 1485w, 1428w, 1267m, 982s, 672vs cm−1. UV/VIS spectroscopy: λmax/nm (εmax[M−1 cm−1]) (DCM) 383 (1028), 530 (467). NMR spectroscopy:  13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 143.3 (C-CH3), 139.2 (C-SO3−), 134.5 (P-C(Ph)), 129.6 (tos), 127.4 (tos), 27.5 (‘d’, CH-P), 21.9 (Ph-CH3), 18.5 (PCH-CH3) ppm. 31P{1H} NMR (162 MHz, CD2Cl2): δ 69.2 (s) ppm.  Elemental Analysis: (calcd. for C44H48O6P2RuS2, 899.95 g/mol) found (calcd.): C 58.11% (58.72%), H 5.36% (5.38%), S 7.18% (7.13%). HRMS (ESI+): m/z = 811.18.  X-ray structure analysis: uv107 
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6.5.1.5 Bis{bis(diphenylphosphanyl)ethane}mesitylsulfonatoruthenium(II) tetrafluoridoborate (11)   According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](MesSO3)2, 1,2-bis(diphenylphosphanyl)ethane (99%, dppe), THF, tetrafluoroboric acid (50% in H2O), DCM, diethyl ether. Procedure: A mixture of [Ru(H2O)6](MesSO3)2  (304 mg, 0.500 mmol, 1.00 equiv.) and dppe (400 mg, 1.00 mmol, 2.00 equiv.) was prepared and suspended in THF (10 mL). The suspension was stirred for 2 d until an orange solution was formed. The solvent was removed in vacuo. The compound was resolved in DCM (3 mL), HBF4 (0.13 mL, 2.0 equiv., 50% in H2O) was added, filtered off and layered with diethyl ether. Orange crystals formed after 1 d. The solvent was removed, the crystals were washed with diethyl ether (3 mL) and dried in vacuo. Empirical formula: C61H59BF4O3P4RuS (1183.97 g/mol) Yield: 534 mg (0.451 mmol, 90.6% of th.) of orange platelets.  IR spectroscopy: (RT, solid), (intensity):  = 3057w, 2970w, 2931w, 1604w, 1573w, 1485m, 1470w, 1434s, 1379w, 1310m, 1247vs, 1191s, 1150s, 1081vs, 1051vs, 984vs, 958s, 886m, 872m, 849m, 821m, 797m, 749vs cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 341, 379. NMR spectroscopy:  13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 140.9 (C-CH3), 138.5 (C-SO3−), 134.4–127.9 (MesSO3), 66.2, 22.2 (CH-P), 21.0 (Ph-CH3), 15.6 (PCH-CH3) ppm. 31P{1H} NMR (162 MHz, CD2Cl2, RT): δ 60.5 (bs) ppm (additional signals 50.8 (bs), 44.7 (bs) ppm) (bad signal-to-noise ratio).  
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31P{1H} NMR (162 MHz, CD2Cl2, 0 °C): δ 60.6 (br s), 57.8 (br s); 52.0, 50.1 (A = 51.0); 43.4, 41.6 (B = 42.6) ppm.  Elemental Analysis: (calcd. for C44H48O6P2RuS2, 899.95 g/mol) found (calcd.): C 59.25% (61.83%), H 5.08% (5.10%), S 2.38% (2.71%). HRMS (ESI+): m/z = 1183.28 (added BF4−). X-ray structure analysis: vv826    
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6.5.1.6 Di(iso-propyldiphenylphosphane)dimesitylsulfonatoruthenium(II) (12)    According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](MesSO3)2, iso-propyldiphenylphosphane (99%, PPh2iPr), THF, DCM, diethyl ether. Procedure: A mixture of [Ru(H2O)6](MesSO3)2  (304 mg, 0.50 mmol, 1.00 equiv.) and PPh2iPr (229 mg, 1.00 mmol, 2.00 equiv.) was prepared and suspended in THF (10 mL). The suspension was stirred for 2 d until a dark violet solution was formed. The solvent was removed in vacuo. The compound was resolved in DCM (3 mL), filtered off and layered with diethyl ether. Violet crystals formed after 2 d. The solvent was removed, the crystals were washed with cool diethyl ether (3 mL) and dried in vacuo. Empirical formula: C48H56O6P2RuS2 (956.12 g/mol) Yield: 313 mg (0.327 mmol, 65.7% of th.) of violet needles.  IR spectroscopy: (RT, solid), (intensity):  = 3047w, 2955w, 2928w, 2867w, 1604w, 1566w, 1486w, 1460w, 1435m, 1404w, 1379w, 1362w, 1249vs, 1189w, 1157w, 1084m, 1055m, 1034m, 979vs, 952s, 882w, 857m, 843m, 737m, 707m cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 379, 519. NMR spectroscopy:  13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 141.0 (C-CH3), 138.5 (C-SO3−), 137.3 (MesSO3), 134.3 (P-C(Ph)), 131.0 (MesSO3), 129.6 (MesSO3), 127.4 (“t”, MesSO3), 27.8 (m, CH-P), 22.37 (tos), 21.3 (Ph-CH3), 18.6 (PCH-CH3) ppm. 31P{1H} NMR (162 MHz, CD2Cl2): δ 70.2 (s) ppm.  Elemental Analysis: (calcd. for C48H56O6P2RuS2, 956.12 g/mol g/mol) found (calcd.): C 59.90% (60.17%), H 5.93% (6.10%), S 6.47% (6.69%). 
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HRMS (ESI+): m/z = 839.21. X-ray structure analysis: vv833   
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6.5.2 Phosphane complexes with aqua ligands 6.5.2.1 Diaqua-bis{bis(diphenylphosphanyl)phenylamine}ruthenium(II) tetrafluoridoborate (13)    According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](tos)2, 1,1’-bis(diphenylphosphanyl)phenylamin (dpppha), THF, tetrafluoroboric acid (50% in H2O), DCM, diethyl ether. Procedure: A mixture of [Ru(H2O)6](tos)2  (275 mg, 0.498 mmol, 1.00 equiv.) and dpppha (462 mg, 1.00 mmol, 2.01 equiv.) was prepared and suspended in THF (10 mL). The suspension was stirred for 1–2 d until a yellow-brown solution was formed. The solvent was removed in vacuo and the orange crude product was washed with diethyl ether (10 mL). The compound was resolved in DCM (3 mL), HBF4 (0.13 mL, 2.0 equiv., 50% in H2O) was added, stirred again, filtered off and layered with diethyl ether. Yellow crystals formed after 4 d. The solvent was removed, the crystals were washed with n-hexane (3 ∙ 10 mL), diethyl ether (10 mL) and dried in vacuo. Empirical formula: C60H54B2F8N2O2P4Ru (1233.68 g/mol) Yield: 297 mg (0.241 mmol, 48.4% of th.) of yellow crystal agglomerates. IR spectroscopy: (RT, solid), (intensity):  = 1590vw, 1495w, 1436w, 1212m, 1158m, 1100m, 928m, 876w, 814w, 741m, 689m cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 349.0, 423.1. NMR spectroscopy: 
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13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 132.3–122.5 (Ph) ppm. 31P{1H} NMR (162 MHz, CD2Cl2): δ 78.7 (s) (main signal), 90.1, 88.8, 87.4, 63.4, 52.9, 35.8 (several subsidiary signals) ppm.  HRMS (ESI+): m/z = 1082.20. X-ray structure analysis: uv275   
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6.5.2.2 Diaqua-bis{1,1’-bis(diphenylphosphanyl)ethene}ruthenium(II) tetrafluoridoborate (14)    According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](tos)2, 1,1’-bis(diphenylphosphanyl)ethene (99%, dppen), THF, tetrafluoroboric acid (50% in H2O), DCM, diethyl ether. Procedure: A mixture of [Ru(H2O)6](tos)2  (275 mg, 0.498 mmol, 1.00 equiv.) and dppen (397 mg, 1.00 mmol, 2.01 equiv.) was prepared and suspended in THF (10 mL). The suspension was stirred for 1–2 d until an orange solution was formed. The solvent was removed in vacuo and the orange crude product was washed with diethyl ether (10 mL). The compound was resolved in toluene (3 mL) was added, stirred again, filtered off and layered with diethyl ether. Yellow crystals formed after 5 d. The solvent was removed, the crystals were washed with n-hexane (3 ∙ 10 mL) and dried in vacuo. Empirical formula: C66H64O8P4RuS2 (1274.33 g/mol)  Yield: 343 mg (0.269 mmol, 54.0% of th.) of dark yellow crystal agglomerates. IR spectroscopy: (RT, solid), (intensity):  = 3056vw, 2084vw, 1653w, 1435m, 1055m, 729m cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 364.2, 427.5. NMR spectroscopy:  13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 142.7 (Ph), 134.3–126.18 (m) (Ph + C=CH2), subsidiary species: 66.2, 21.7, 15.7, 1.33 ppm. 31P{1H} NMR (162 MHz, CD2Cl2): δ 23.1 (s), 3.14 (s) (main species), 61.5, 33.8, 8.6, 6.5 (subsidiary species) ppm.  Elemental Analysis: (calcd. for C66H64O8P4RuS2(BF4)(tos), 956.12 g/mol g/mol) found (calcd.): C 59.78% (59.55%), H 4.92% (4.83%), S 2.16% (2.69%). 
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HRMS (ESI+): m/z = 1082.22. X-ray structure analysis: uv186    
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6.5.2.3 Diaqua-bis{1,2-bis(diphenylphosphanyl)benzene}ruthenium(II) tetrafluoridoborate (15)    According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](tos)2, 1,2-bis(diphenylphosphanyl)benzene (99%, dppbz), THF, tetrafluoroboric acid (50% in H2O), DCM, diethyl ether. Procedure: A mixture of [Ru(H2O)6](tos)2  (275 mg, 0.498 mmol, 1.00 equiv.) and dppbz (224 mg, 1.00 mmol, 2.01 equiv.) was prepared and suspended in THF (10 mL). The suspension was stirred for 1–2 d until a light-yellow solution was formed. The solvent was removed in vacuo and the yellow crude product was washed with diethyl ether (4 mL). The compound was resolved in DCM (3 mL), HBF4 (0.13 µL, 2.0 equiv., 50% in H2O) was added, stirred again, filtered off and layered with diethyl ether. Yellow crystals formed after 3 d. The solvent was removed, the crystals were washed with n-hexane (3 ∙ 10 mL) and dried in vacuo. Empirical formula: C60H52B2F8O2P4Ru (1203.65 g/mol) Yield: 370 mg (0.307 mmol, 61.6% of th.) of yellow rods. IR spectroscopy: (RT, solid), (intensity):  = 3524w, 3555br, 3066vw, 1636m, 1482m, 1434m, 1314w, 1277w, 1255w, 1189m, 1165m, 1146m, 1099vs, 1061vs, 983vs, 851m, 777s, 754vs, 742vs cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 434.1. NMR spectroscopy:  31P{1H} NMR (162 MHz, CD2Cl2): δ 50.66 (s) ppm.  
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Elemental Analysis: (calcd. for C60H52O2P4Ru, 1030.04 g/mol) found (calcd.):C 56.82% (59.87%), H 4.36% (4.35%).[161] HRMS (ESI+): m/z = 1054.20. X-ray structure analysis: vv399    
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6.5.2.4 Diaqua-bis{cis-1,2-bis(diphenylphosphanyl)ethene}ruthenium(II) tetrafluoridoborate (16)    According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Literature: D. Beck, P. Klüfers, Chem. Eur. J.  2018, 24, 16019–16028. Starting materials: [Ru(H2O)6](tos)2, 1,2-bis(diphenylphosphanyl)ethene (99%, dppv), THF, tetrafluoroboric acid (50% in H2O), DCM, diethyl ether. Procedure: A suspension of [Ru(H2O)6](tos)2 (275 mg, 0.498 mmol, 1.00 equiv.) and dppv (397 mg, 1.00 mmol, 2.01 equiv.) in THF (10 mL) was stirred for 24 h. The solvent was removed and the crude product was suspended in DCM (3 mL). To this suspension, HBF4 (126 µL, 2.00 equiv., 50% in water) was added. After filtration through a syringe filter, the solution was layered with diethyl ether. After crystallization and removal of the residual solvent, the crystals were washed three times with cyclohexane (10 mL each) and dried in vacuo.  Empirical formula: C52H48B2F8O2P4Ru (1103.53 g/mol)  Yield: 125 mg (0.113 mmol, 22.7% of th.) of yellow crystal agglomerates. IR spectroscopy: (RT, solid), (intensity):  = 3059w, 1633w, 1599w, 1483m, 1433s, 1404w, 1316m, 1267m, 1253s, 1190m, 1139m, 1098s, 1050vs, 1030vs, 1001vs, 921w, 847w, 816m, 740vs, 718m cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 274.0, 360.4  NMR spectroscopy:  31P{1H} NMR (162 MHz, CD2Cl2): δ 69.2 (t, 3JPP = 15 Hz), 54.2 (t, 3JPP = 15 Hz) ppm (additional signals 66.47 (t), 58.9 (br), 55.7 (s) ppm). HRMS (ESI+): m/z = 929.91 (C52H58O2P4Ru). 
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X-ray structure analysis: vv418 PXRD:  Graph 3: Powder-X-ray diffraction of 16. Red: X-ray diffraction at 100 K, Black: Powder-X-ray diffraction at RT.[39]   
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6.5.3 Borderline complexes between chelate and diaqua coordination 6.5.3.1 Aqua-bis{bis(diphenylphosphanyl)-n-propylamine}tosylatoruthenium(II) tetrafluoridoborate (17)   According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](tos)2, 1,2-bis(diphenylphosphanyl)propylamine, THF, DCM, toluene. Procedure: A suspension of [Ru(H2O)6](tos)2 (275 mg, 0.498 mmol, 1.00 equiv.) and dppv (428 mg, 1.00 mmol, 2.01 equiv.) in THF (10 mL) was stirred for 24 h. The solvent was removed and the crude product was suspended in DCM (3 mL). After filtration through a syringe filter, the solution was layered with toluene. After crystallization and removal of the residual solvent, the crystals were washed three times with n-hexane (5 mL each), three times with diethyl ether (5 mL each) and dried in vacuo.  Empirical formula: C68H72N2O7P4RuS2 (1318.42 g/mol) Yield: 288 mg (0.218 mmol, 43.8% of th.) of yellow platelets. IR spectroscopy: (RT, solid), (intensity):  = ≈ 3350, ≈ 3200, 3057w, 2997w, 2084vw, 1623w, 1485m, 1435m, 1282w, 1172–1036, 816m, 668vs cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 305.5, 362.0.  NMR spectroscopy:  13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 143.1 (C–CH3), 138.9 (C–SO3), 135.2–128.7 (m, Ph), 126.0 (Ph), 53.2 (CH2–CH2–CH3), 21.7 (CH2–CH2–CH3), 11.5 (CH2–CH2–CH3) ppm. 31P{1H} NMR (162 MHz, CD2Cl2): δ 83.6 (t, 2JPP = 37.6 Hz), 62.2 (t, 2JPP = 37.6 Hz) ppm.  Elemental Analysis: (calcd. for C68H72N2O7P4RuS2 ∙ 1.89 C7H8, 1492.57 g/mol) found (calcd.): C 67.91% (65.60%), H 5.62% (5.50%), N 1.98% (2.12%), S 3.76% (3.50%).[161] 
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HRMS (ESI+): m/z = 1127.24 or 1209.29. X-ray structure analysis: uv148    
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6.5.3.2 Diaqua-bis(triphenylphosphane)ditosylatoruthenium(II) (18)    According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](tos)2, triphenylphosphane (PPh3) (99%), THF, diethyl ether, DCM. Procedure: To a suspension of [Ru(H2O)6](tos)2 (275 mg, 0.498 mmol, 1.00 equiv.) in THF (5 mL) triphenylphosphane (PPh3) (263 mg, 1.00 mmol, 2.01 equiv.) was added. The mixture was stirred for 72 h, whereby the solution turned orange. The solvent was removed in vacuo, the solid was dried and resolved in DCM (2 mL). The solution was filtered through a syringe filter and the filtrate was layered with diethyl ether (4 mL) and stored at −20 °C. The obtained crystals were washed with n-hexane (3 ∙ 2.5 mL) and dried in vacuo. Empirical formula: C50H48O8P2RuS2, 1004.06 g/mol. Yield: 279 mg (0.278 mmol, 55.8% of th.) of red blocks. IR spectroscopy: (RT, solid), (intensity):  = 3060vw, 1599w, 1483m, 1436m, 1220m, 1145s, 979vs, 693vs cm−1. UV/VIS spectroscopy: λmax/nm (εmax[M−1 cm−1]) (DCM) 372 (1030), 474 (181). NMR spectroscopy:  13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 142.3 (C–CH3), 140.0 (C–SO3−), 134.9 (C–SO3−), 133.4 (m, P–C1), 126.2–129.9 (Ph – tos), 21.7 (tos–CH3) ppm. 31P{1H} NMR (162 MHz, CD2Cl2): δ 52.6 (s) ppm.  Elemental Analysis: (calcd. for C30H56O8P2RuS2, 771.87 g/mol) found (calcd.): C 59.75% (59.82%), H 4.87% (4.82%), S 6.50% (6.39%). HRMS (ESI+): m/z = 838.12  X-ray structure analysis: vv088 
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6.5.3.3 Diaqua-bis(di-tert-butylphosphane)ditosylatoruthenium(II) (19)    According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](tos)2, di-tert-butylphosphane (PHtBu2)(98%), THF, diethyl ether, DCM. Procedure: To a suspension of [Ru(H2O)6](tos)2 (275 mg, 0.498 mmol, 1.00 equiv.) in THF (5 mL) di-tert-butylphosphane (PHtBu2) (292 mg, 370 µL, 1.00 mmol, 2.01 equiv.) was added. The mixture was stirred for 24 h. The colour changed from yellowish to orange-red. The solvent was removed in vacuo, the solid was dried and resolved in DCM (2 mL). The solution was filtered through a syringe filter and the filtrate was layered with diethyl ether. The obtained crystals were washed with cyclohexane (3 ∙ 10 mL) and dried in vacuo. Empirical formula: C30H56O8P2RuS2, 771.87 g/mol. Yield: 210 mg (0.272 mmol, 54.6% of th.) of red platelets. IR spectroscopy: (RT, solid), (intensity):  = 2902br, 2314w, 1601vw, 1496vw, 1366m, 1150vs, 1221s, 984 cm−1. UV/VIS spectroscopy: λmax/nm (εmax[M−1 cm−1]) (DCM) 377 (1467), 516 (215). NMR spectroscopy:  13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 142.2 (C-CH3), 139.9 (C-SO3−), 129.3 (tos aromatic), 126.2 (tos), 36.6 (“t”, C(CH3)3), 32.3 (P-CCH3), 21.7 (Ph-CH3) ppm. 31P{1H} NMR (162 MHz, CD2Cl2): δ 75.0 (s) ppm.  Elemental Analysis: (calcd. for C30H56O8P2RuS2, 771.87 g/mol) found (calcd.): C 46.80% (46.68%), H 7.24% (7.31%), S 8.40% (8.31%). HRMS (ESI+): m/z = 606.19. X-ray structure analysis: 
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6.5.3.4 Diaqua-di(benzyldiphenylphosphane)ditosylatoruthenium(II) (20)   According to: O. H. Bailey, A. Ludi, Inorg. Chem. 1985, 24, 2582–2585. Starting materials: [Ru(H2O)6](tos)2, benzyldiphenylphosphane (PPh2Bn) (98%), THF, diethyl ether, DCM. Procedure: To a suspension of [Ru(H2O)6](tos)2 (275 mg, 0.498 mmol, 1.00 equiv.) in THF (5 mL) benzyldiphenylphosphane (PPh2Bn) (277 mg, 1.00 mmol, 2.00 equiv.) was added. The mixture was stirred for 36 h. The solvent was removed in vacuo, the solid was dried and resolved in DCM (2 mL). The solution was filtered through a syringe filter and the filtrate was layered with diethyl ether (8 mL). The obtained crystals were washed with diethyl ether (3 ∙ 2.5 mL) and dried in vacuo. Empirical formula: C52H52O8P2RuS2, 1032.13 g/mol. Yield: 133 mg (0.129 mmol, 25.9% of th.) of dark-yellow blocks. IR spectroscopy: (RT, solid), (intensity):  = 3059vw, 1600vw, 1494w, 1438w, 1452vw, 1216m, 1151s, 1103, 989vs, 694vs cm−1. UV/VIS spectroscopy: λmax/nm (εmax[M−1 cm−1]) (DCM) 360 (3478), 463 (805). NMR spectroscopy: 13C{1H} NMR spectroscopy (101 MHz, CD2Cl2): δ 142.4 (C-CH3), 139.9 (C-SO3−), 135.8 (Bn-C1), 134.2, 131.8 (Ph-C1), 126.9–131.4 (tos aromatic), 66.8 (Et–O–CH2–CH3), 35.3 (“t”, (P-CH2)), 21.7 (tos-CH3), 15.7 (Et–O–CH2–CH3) ppm. 31P{1H} NMR (162 MHz, CD2Cl2): δ 59.8 (s) ppm.  Elemental Analysis: (calcd. for C56H62O9P2RuS2, 1106.19 g/mol) found (calcd.): C 60.80% (60.94%), H 5.65% (5.48%), S 5.80% (5.81%). HRMS (ESI+): m/z = 866.16. X-ray structure analysis: vv193  
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6.5.4 Syntheses of bisphosphanes 6.5.4.1 dppbza, bis(diphenylphosphanyl)benzylamine (21)  Literature: Y. Wang, Z. Li, X. Zeng, X. Wang, C. Zhan, Y. Liu, Q. Luo, X. Liu, New J. Chem. 2009, 33, 1780.  Starting materials: acetonitrile, benzylamine, DCM, chlorodiphenylphosphane, magnesium sulfate, sodium hydroxide, triethylamine.  Procedure: Benzylamine (2.44 mL, 22.4 mmol) was solved in DCM (100 mL). An equivalent chlorodiphenylphosphane (4.02 mL, 22.4 mmol) and triethylamine (30 mL) were added and the solution was stirred for 30 min at RT. Then, another equivalent of chlorodiphenylphosphane was added and stirred for 18 h. The solvent was removed in vacuo and the residue was resolved in DCM (50 mL). The solution was washed with saturated NaOH solution and dried over MgSO4. The solid was filtered off, the solvent removed in vacuo and the residue was recrystallised from DCM/acetonitrile (1:2) at 4 °C. The solvent was decanted and the crystals were washed with acetonitrile (5 mL) and dried in vacuo. Empirical formula: C31H27NP2, 475.50 g/mol. Yield: 3.84 g (8.07 mmol, 36.0% of th.) of colourless blocks. NMR spectroscopy: 13C{1H} NMR spectroscopy (101 MHz, THF-d8): δ 141.2 (Ph), 141.0 (Ph), 140.8 (Ph), 134.1 (Ph), 134.0 (Ph), 133.9 (Ph), 130.0 (Ph), 129.6 (Ph), 128.7 (Ph), 127.6 (Ph), 57.1 (CH2) ppm. 31P{1H} NMR (162 MHz, THF-d8): δ 61.2 (s) ppm.  Elemental Analysis: (calcd. for C31H27NP2, 475.50 g/mol) found (calcd.): C 78.12% (78.30%), H 5.73% (5.72%), N 2.96% (2.95%).   
Experimental Part 
138  
6.5.4.2 dpppha, bis(diphenylphosphanyl)phenylamine (22)  Literature: W. Seidel, M. Alexiev, Z. Anorg. Allg. Chem. 1978, 438, 68–74. Mayer Tobias, Dinukleare Nitrosyl- und Hyponitrito-Komplexe, Ph.D. thesis, LMU München, 2012. Starting materials: aniline, acetonitrile, DCM, chlorodiphenylphosphane, magnesium sulfate, sodium hydroxide, triethylamine. Procedure: Aniline (1.00 mL, 11.2 mmol) was solved in DCM (30 mL). An equivalent chlorodiphenylphosphane (2.07 mL, 11.2 mmol) and triethylamine (15 mL) were added and the solution was stirred for 30 min at RT. Then, another equivalent of chlorodiphenylphosphane was added and stirred for 18 h. The solvent was removed in vacuo and the residue was resolved in DCM (30 mL). The solution was washed with saturated NaOH solution and dried over MgSO4. The solid was filtered off, the solvent removed in vacuo and the residue was recrystallised from DCM/acetonitrile (1:2) at 4 °C. The solvent was decanted and the crystals were washed with acetonitrile (5 mL) and dried in vacuo. Empirical formula: C30H25NP2, 461.48 g/mol. Yield: 3.68 g (7.97 mmol, 71.1% of th.) of colourless powder. NMR spectroscopy: 13C{1H} NMR spectroscopy (101 MHz, THF-d8): δ 149.0 (Ph), 140.8 (Ph), 134.2 (Ph), 130.0 (Ph), 129.0 (Ph), 125.9 (Ph), 111.1 (Ph) ppm. 31P{1H} NMR (162 MHz, THF-d8): δ 69.1 (s) ppm.  Elemental Analysis: (calcd. for C30H25NP2, 461.48 g/mol) found (calcd.): C 77.93% (78.08%), H 5.46% (5.46%), N 3.07% (3.04%).   
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6.5.4.3 dpppra, bis(diphenylphosphanyl)propylamine (23)  According to: T. Mayer, H.-C. Böttcher, Z. Naturforsch. B 2012, 67, 504–506. Starting materials: n-propylamine, acetonitrile, DCM, chlorodiphenylphosphane, magnesium sulfate, sodium hydroxide, triethylamine. Procedure: n-Propylamine (0.90 mL, 11.2 mmol) was solved in DCM (30 mL). An equivalent chlorodiphenylphosphane (2.07 mL, 11.2 mmol) and triethylamine (15 mL) were added and the solution was stirred for 30 min at RT. Then, another equivalent of chlorodiphenylphosphane was added and stirred for 18 h. The solvent was removed in vacuo and the residue was resolved in DCM (30 mL). The solution was washed with saturated NaOH solution and dried over MgSO4. The solid was filtered off, the solvent removed in vacuo and the residue was recrystallised from DCM/acetonitrile (1:2) at −20 °C. The solvent was decanted and the crystals were washed with ice-cold acetonitrile (5 mL) and dried in vacuo. Empirical formula: C27H27NP2, 427.47 g/mol Yield: 2.93 g (6.85 mmol, 61.1% of th.) of colourless blocks. NMR spectroscopy: 13C{1H} NMR spectroscopy (101 MHz, THF-d8): δ 140.4 (Ph), 140.3 (Ph), 133.4 (Ph), 133.3 (Ph), 133.1 (Ph), 129.3 (Ph), 128.6 (Ph), 128.5 (Ph), 55.4 (CH2–CH2–CH3), 25.2 (CH2–CH2–CH3), 11.2 (CH2–CH2–CH3) ppm. 31P{1H} NMR (162 MHz, THF-d8): δ 63.2 (s) ppm.  Elemental Analysis: (calcd. for C30H25NP2, 461.48 g/mol) found (calcd.): C 75.67% (75.86%), H 6.37% (6.35%), N 3.28% (3.28%). HRMS (ESI+): m/z = 428.16 ([M–H]+, C27H28NP2).   
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6.6 Reactions with gaseous nitric oxide 6.6.1 Bis{bis(diphenylphosphanyl)ethane}hydridonitritoruthenium(0) (24)   Starting materials: [Ru(dppe)2(tos)]BF4, toluene, tetrakisdiamino ethylene, nitrogen monoxide, DCM, diethyl ether. Procedure: The previously synthesised product [Ru(dppe)2(tos)](BF4) (7) was solved in refluxing toluene (40 mL). tetrakis(dimethylamino)ethylene (tden; 200 µL, excess) was added. After cooling the solution to −72 °C using a dry-ice/i-propanol cooling bath, the solution was treated with nitrogen monoxide for 1.5 h. The solution turned red. The solution was brought to room temperature whereby the colour changed from red to ocher. The solvent was decanted, the solid dried and resolved in DCM. The solution was filtered through a syringe filter and layered with diethyl ether. The obtained yellow-red crystal agglomerates were analysed without further work-up because of their sensitivity. Empirical formula: C52H49NO2P4Ru, 944.93 g/mol. Yield: Few agglomerates of yellow platelets. X-ray structure analysis: vv099 Please note: The compound is water and oxygen sensitive. Therefore, successful analytics were not possible due to fast decomposition (melting of the crystals within few minutes). Nonetheless, the synthesis is repeatable.  
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6.6.2 Bis{bis(diphenylphosphanyl)ethane}nitrosylruthenium tosylate (25)  Starting materials: [Ru(dppe)2(tos)](tos), DCM, nitrogen monoxide, diethyl ether. Procedure: The previously synthesised product [Ru(dppe)2(tos)](tos) (7) was solved in DCM (20 mL). The solution was treated with nitrogen monoxide for 1.5 h at RT. The solution turned brown-red. The solution was filtered through a syringe filter and layered with diethyl ether. The obtained brown-red crystals were filtered off and dried in vacuo. Empirical formula: C59H55NO4P4RuS, 1099.12 g/mol Yield: Few agglomerates of red blocks (≈ 100 mg). IR spectroscopy: (RT, solid), (intensity):  = 3054 vw, 1665 (NO-stretch vib.) m, 1598vw, 1573 vw, 1483w, 1434s, 1252m, 1173s, 1158s, 1119vs, 1096vs, 1027m, 991s, 814s, 741vs cm−1. UV/VIS spectroscopy: λmax/nm (DCM) ≈ 350 (sh), ≈ 425 (sh) NMR spectroscopy:  31P{1H} NMR (162 MHz, CD2Cl2): δ 61.4, 31.8. ppm.  HRMS (FAB+): m/z = 928.17 (12C52H48ONP4102Ru). X-ray structure analysis: vv142  
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6.6.3 Bis{bis(diphenylphosphanyl)ethane}fluoridonitrosylruthenium tetrafluoridoborate (26a)  Starting materials: [Ru(dppe)2(tos)]BF4, nitric oxide, DCM, CHCl3, NOBF4, diethyl ether, HSbF6∙6H2O. Procedure: Variant I The previously synthesised product [Ru(dppe)2(tos)](BF4) (7) was solved in DCM (20 mL). To this solution crystalline HSbF6 ∙ xH2O (ca. 250 mg) was added. The solution was treated with nitrogen monoxide for 1 h at RT. The solution turned brown-orange. The solution was stirred overnight, filtered through a syringe filter and layered with diethyl ether. The obtained yellow crystals were filtered off and dried in vacuo. Variant II The previously synthesised product [Ru(dppe)2(tos)](tos) (7) was solved in CHCl3 (5 mL). To this solution crystalline HSbF6 ∙ xH2O (ca. 400 mg) was added. The solution was treated with NOBF4 (175 mg, 1.5 mmol). The solution turned brown-orange. The solution was stirred overnight, filtered through a syringe filter and layered with diethyl ether. The obtained yellow crystals were filtered off and dried in vacuo. Empirical formula: C52H48F13NOP4RuSb2, 1418.40 g/mol.  Yield: 320 mg (0.225 mmol, 45.1% of th.) of yellow platelets. IR spectroscopy: (RT, solid), (intensity):  = 3059w, 1846m, 1585w, 1485w, 1436m, 1417w, 1315w, 1273w, 1193w, 1098m, 1025m, 997m, 916m, 877m, 808 s, 758s cm−1. NMR spectroscopy: 31P{1H} NMR (162 MHz, CD2Cl2): δ 41.5 (d, J = 34.6 Hz) ppm. HRMS (ESI+): m/z = 1052.15 (C51H58OFP4RuSb). X-ray structure analysis: uv352  
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6.6.4 Dinitrosylbis(triphenylphosphane)ruthenium(0) (27) (using NO)   Starting materials: [Ru(H2O)6](tos)2, nitrogen monoxide, EtOH, triphenylphosphane. Procedure: The previously synthesised product [Ru(H2O)6](tos)2 (1) (275 mg, 0.498 mmol) was suspended in EtOH (10 mL). The solution was treated with nitrogen monoxide for 1.5 h at RT whereby the solution turned brown-red. To this solution PPh3 (263 mg, 1.00 mmol, 2.01 equiv.) was added and the suspension was treated with NO for another 20 min. The solution was filtered through a syringe filter and layered with diethyl ether. The obtained brown-red crystals were filtered off and dried in vacuo. Empirical formula: C36H30N2O2P2Ru, 685.66 g/mol.  Yield: 101 mg (0.147 mmol, 29.5% of th.) of red blocks. IR spectroscopy: (RT, solid), (intensity):  = 3200vw, 3250vw, 1651s (NO), 1605vs (NO), 1569sh, 1478s, 1432s, 1305m, 1184w, 1156w, 1091vs, 1027w, 997w, 846w, 740vs cm−1. NMR spectroscopy:  31P{1H} NMR (162 MHz, CD2Cl2): δ 54.8 (s) ppm.  Elemental Analysis: (calcd. for C36H30N2O2P2Ru, 685.66 g/mol) found (calcd.): C 62.71% (63.06%), H 4.39% (4.41%), N 4.13% (4.09%). X-ray structure analysis: vv487   
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6.7 Hydrogenhyponitrito ruthenium complexes and hyponitrite derivatives 6.7.1 Bis{bis(diphenylphosphanyl)ethane}hydrogenhyponitritoruthenium(II) tetrafluoridoborate (28)  Literature: D. Beck, P. Klüfers, Chem. Eur. J.  2018, 24, 16019–16028. Starting materials: [Ru(dppe)2(tos)](tos), triphenylstannyl hyponitrite, DCM, tetrafluoroboric acid (50% in H2O), diethyl ether. Procedure: a) Crude [Ru(dppe)2(tos)](tos) (7) was dissolved in DCM (15 mL) and cooled to −72 °C. Bis(triphenylstannyl) hyponitrite (34) was dissolved in DCM (20 mL) and added dropwise to the solution of (1). The light-yellow solution was stirred for 2 h and brought to room temperature afterwards. To the well-stirred solution, 600 µL HBF4 (excess, 50% in water) was added and stirred until the solution became a suspension (ca. 15 min). The suspension was concentrated to 4 mL. The colourless solid was removed by filtration through a syringe filter, the solution was layered with diethyl ether and stored in the absence of any disturbance. Within 5 days, red blocks of 28 have formed as well as colourless precipitate of, tentatively, tin-containing side-products. The mother liquor was pipetted off and the colourless solid was removed by washing with diethyl ether (3 × 10 mL). The crystals were recrystallized with the same composition of DCM and diethyl ether, washed and dried in vacuo. b) solvent-free crystals The crystals were recrystallized with DCM and toluene, washed with diethyl ether and dried in vacuo.  Empirical formula: C56H59BF4N2O3P4Ru (1119.81 g/mol) Yield 28a: 439 mg (0.392 mmol, 78.7% of th.) of yellow blocks. IR spectroscopy: (ATR, solid-state): 3059w, 2971w, 1572w, 1484s, 1450shp, 1433vst, 1411w, 1383w, 1345w, 1311w, 1278 w, 1242w, 1192 w, 1100shp, 1050vst, 1032vs, 1002s, 928w, 871m, 841m, 815 m, 802m, 744vs, 715m cm−1.   UV/VIS spectroscopy: λmax/nm (DCM) 357.6. UV/VIS spectroscopy: λmax/nm (solid-state): 378.0, 532.9. 
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NMR spectroscopy: 31P{1H} NMR (MAS, 202 MHz): δ 63.7 (s), 62.8 (s), 55.8 (s), 54.6 (s) ppm.  HRMS (FAB+): m/z = 959.18 (C52H49N2O2P4102Ru)  X-ray structure analysis: uv616 (with solvent), vv389 (without crystal-solvent)    
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6.7.2 Bis{bis(diphenylphosphanyl)propane}hydrogenhyponitritoruthenium(II) tetrafluoridoborate (29)  Literature: D. Beck, P. Klüfers, Chem. Eur. J.  2018, 24, 16019–16028. Starting materials: [Ru(dppp)2(tos)](tos), triphenylstannyl hyponitrite, DCM, tetrafluoroboric acid (50% in H2O), diethyl ether. Procedure: Crude [Ru(dppp)2(tos)](tos) (8) was dissolved in DCM (15 mL) and cooled to −72 °C. Bis(triphenylstannyl) hyponitrite (34) was dissolved in DCM (20 mL) and added dropwise to the solution of 7. The light-yellow solution was stirred for 2 h and brought to room temperature afterwards. To the well-stirred solution, 600 µL HBF4 (excess, 50% in water) was added and stirred until the solution became a suspension (ca. 15 min). The suspension was concentrated to 4 mL. The colourless solid was removed by filtration through a syringe filter, the solution was layered with diethyl ether and stored in the absence of any disturbance. Within 5 days, brown blocks of 29 have formed as well as colourless precipitate of, tentatively, tin-containing side-products. The mother liquor was pipetted off and the colourless solid was removed by washing with diethyl ether (3 × 10 mL). The crystals were recrystallized with the same composition of DCM and diethyl ether, washed and dried in vacuo.  Empirical formula: C54H53BF4N2O2P4Ru (1073.80 g/mol) Yield: 482 mg (0.449 mmol, 90.2% of th.) of dark-red blocks. IR spectroscopy: (ATR, solid-state): 3052w, 2019vw, 1572w, 1483m, 1453vw, 1433.82s, 1377m, 1313w, 1271w, 1245w, 1189w, 1163w, 1115w, 1090s, 1048vs, 1034vs, 1023shp, 999s, 970s, 935w, 834m, 791m, 742s, 730m cm−1.  UV/VIS spectroscopy : λmax/nm (DCM): 371.5, 453.2 (sh). UV/VIS spectroscopy: λmax/nm (solid-state): 386.0, 445.3, 545.3. NMR spectroscopy: 31P{1H} NMR (MAS, 202 MHz): δ 29.85 (s), 26.04 (s), 6.83 (s), −4.79 (s) ppm.  HRMS (FAB+): m/z = 987.21 (C54H53N2O2P4102Ru)  X-ray structure analysis: vv413 
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6.7.3 Bis{bis(diphenylphosphanyl)ethene}hydrogenhyponitritoruthenium(II) tetrafluoridoborate (30)  Literature: D. Beck, P. Klüfers, Chem. Eur. J.  2018, 24, 16019–16028. Starting materials: [Ru(dppv)2(H2O)2](tos)2, triphenylstannyl hyponitrite, DCM, tetrafluoroboric acid (50% in H2O), diethyl ether. Procedure: Crude [Ru(dppv)2(H2O)2](tos)2 16 was dissolved in DCM (15 mL) and cooled to −72 °C. Bis(triphenylstannyl) hyponitrite (34) was dissolved in DCM (20 mL) and added dropwise to the solution of 16. The light-yellow solution was stirred for 2 h and brought to room temperature afterwards. To the well-stirred solution, 600 µL HBF4 (excess, 50% in water) was added and stirred until the solution became a suspension (ca. 15 min). The suspension was concentrated to 4 mL. The colourless solid was removed by filtration through a syringe filter, the solution was layered with diethyl ether and stored in the absence of any disturbance. Within 5 days, yellow rods of 31 have formed as well as colourless precipitate of, tentatively, tin-containing side-products. The mother liquor was pipetted off and the colourless solid was removed by washing with diethyl ether (3 × 10 mL). The crystals were recrystallized with the same composition of DCM and diethyl ether, washed and dried in vacuo.  Empirical formula: C52H45BF4N2O2P4Ru (1041.71 g/mol). Yield: 145 mg (0.139 mmol, 27.9% of th.) of yellow rods. IR spectroscopy: (ATR, solid-state): 3054w, 1633vw, 1483m, 1453vw, 1434st, 1379w, 1313m, 1286w, 1189w, 1164w, 1112shp, 1087vs, 1051vs, 1035shp, 997vs, 847w, 787w, 741w, 718m cm−1.  UV/VIS spectroscopy: λmax/nm (DCM) 358. UV/VIS spectroscopy: λmax/nm (solid-state): ≈ 388. NMR spectroscopy: 31P{1H} NMR (MAS, 202 MHz): δ 64.93 (s), 63.36 (s), 59.63 (s), 53.62 (s) ppm.  HRMS (FAB+): m/z = 955.15 (C52H45N2O2P4102Ru)  X-ray structure analysis: vv423  
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6.7.4 Bis{bis(diphenylphosphanyl)ethane}hyponitritoruthenium(II) (31)   Literature: D. Beck, P. Klüfers, Chem. Eur. J.  2018, 24, 16019–16028. Starting materials: [Ru(dppe)2(N2O2H)](BF4), imidazole, DCM, diethyl ether. Procedure: Crystals of [Ru(dppe)2(N2O2H)](BF4) (28) (432 mg, 0.386 mmol) were dissolved in DCM (5 mL) and imidazole (100 mg, excess) was added. The solution was filtered and layered with diethyl ether. After the colour of the mother liquor remained constant (ca. 4 days), the mother liquor was pipetted off and the product was washed with diethyl ether (3 × 10 mL).  Empirical formula: C55H53N4O2P4Ru (1027.02 g/mol). Yield: 361 mg (0.352 mmol, 91.2% of th.) of light-yellow blocks. IR spectroscopy: (ATR, solid-state): 3066w, 2358w, 2333w, 1572w, 1485m, 1433s, 1413m, 1390shp, 1315w, 1272w, 1252vw, 1189w, 1161w, 1053vs, 997s, 974s, 943shp, 917w, 872m, 814m, 802m, 749s, 717m cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 367.4. HRMS (FAB+): m/z = 961.18 (C52H49N2O2P4102Ru) [M+H]+ X-ray structure analysis: vv017    
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6.7.5 Bis{bis(diphenylphosphanyl)propane}hydrogenhyponitritoruthenium(II) tetrafluoridoborate (32)  Literature: D. Beck, P. Klüfers, Chem. Eur. J.  2018, 24, 16019–16028. Starting materials: [Ru(dppp)2(N2O2H)](BF4), imidazole, DCM, diethyl ether. Procedure: Crystals of [Ru(dppp)2(N2O2H)](BF4) 29 (131 mg, 0.121 mmol) were dissolved in DCM (5 mL) and imidazole (100 mg, excess) was added. The solution was filtered and layered with diethyl ether. After the colour of the mother liquor remained constant (ca. 4 days), the mother liquor was pipetted off and the product was washed with diethyl ether (3 × 10 mL).  Empirical formula: C54H53BF4N2O2P4Ru (1073.80 g/mol). Yield: 95 mg (0.089 mmol, 74% of th.) of yellow platelets. Please note: Regarding the crystal structure, no deprotonation occurred.   IR spectroscopy: (ATR, solid-state): 3288w, 3054w, 2360m, 1531w, 1484m, 1453vw, 1433s, 1386w, 1323w, 1313w, 1269w, 1269w, 1196w, 1166w, 1131vw, 1115w, 1051vs, 1020s, 974s, 935m, 842s, 797m, 745vs, 734m cm−1.  UV/VIS spectroscopy: λmax/nm (DCM) 312.0 (shoulder), 373.5. HRMS (FAB+): m/z = 987.21 (C54H53N2O2P4102Ru) [M+H]+ X-ray structure analysis: vv427    
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6.7.6 Bis{bis(diphenylphosphanyl)ethene}hyponitritoruthenium(II) (33)   Literature: D. Beck, P. Klüfers, Chem. Eur. J.  2018, 24, 16019–16028. Starting materials: [Ru(dppv)2(N2O2H)](BF4), imidazole, DCM, diethyl ether. Procedure: Crystals of [Ru(dppv)2(N2O2H)](BF4) 30 (125 mg, 0.120 mmol) were dissolved in DCM (5 mL) and imidazole (100 mg, excess) was added. The solution was filtered and layered with diethyl ether. After the colour of the mother liquor remained constant (ca. 4 days), the mother liquor was pipetted off and the product was washed with diethyl ether (3 × 10 mL).  Empirical formula: C52H44N2O2P4Ru (953.90 g/mol) Yield: 100 mg (0.104 mmol, 86.7% of th.) of light-yellow rods. IR spectroscopy (ATR, solid-state): 3326w, 3146w, 3049w, 1587w, 1535w, 1483w, 1433s, 1385w, 1325w, 1285w, 1253shp, 1190w, 1159w, 1090s, 1051vs, 999s, 935m, 844w, 822w, 737vs, 716m cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 305.5 (shoulder), 362.0. HRMS (ESI+): m/z = 957.14 (C52H48O2P4Ru) [M+H]+ X-ray structure analysis: vv772    
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6.7.7 Bis(triphenylstannyl) hyponitrite (34)   Literature: G. Brauer, Handbuch der präparativen Anorganischen Chemie, Vol. 1, Stuttgart, 1960, W. Beck, H. Engelmann, H. S. Smedal, Z. Anorg. Allg. Chem. 1968, 357, 134–138. T. Mayer, W. Beck, H.-C. Böttcher, Z. Anorg. Allg. Chem. 2011, 637, 345–347.  Starting materials: i-hexane, silver nitrate, Na2N2O2∙xH2O, water, toluene, triphenyltin chloride. Procedure: Ag2N2O2 The work has to be done in absence of light. A solution of sodium trans-hyponitrite∙xH2O (4.00 g, 37.7 mmol) was solved in 150 mL H2O and cooled to 1 °C. To this solution AgNO3 (7.70 g, 45.3 mmol) solved in H2O (10 mL) was dropped. The bright green-yellow precipitate was sucked off, washed with ethanol (2 ∙ 10 mL) and diethyl ether (3 ∙ 10 mL) and dried in vacuo.  Empirical formula: Ag2N2O2 (275.75 g/mol) Yield: 7.28 g (26.4 mmol, 70.0% of th.) of green-yellow scales. Please note: Ag2N2O2 was used for the following set-up without further analytics.  Ph3Sn(N2O2)SnPh3 (34) A suspension of Ag2N2O3 (1.01 g, 3.67 mmol) and Ph3SnCl (2.94 g, 7.63 mmol) in toluene (60 mL) was stirred for 24 h. The AgCl precipitate was filtered off through a filter paper with cotton wool. The clear solution was reduced using an rotary evaporator, resolved in toluene (40 mL) and layered with i- hexane (80 mL). The colourless solid was washed with i-hexane (3 ∙ 10 mL), dried in vacuo and resolved in DCM (20 mL). The amount of triphenyltin hyponitrite was directly used for the previous syntheses of 28–30. Empirical formula: C36H30N2O2Sn2 (760,07 g/mol) 
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Yield: ≈ 350 mg of colourless crystals. The product was resolved and directly used for syntheses of the products 28–30. IR spectroscopy (ATR, solid-state): 3065w, 3020w, 1578w, 1479m, 1428s, 1332m, 1303m, 1263m, 1178m, 1159m, 1076s, 1023w, 996vs, 914m, 894m, 850m, 727vs cm−1. NMR spectroscopy:  119Sn{1H} NMR spectroscopy (149 MHz, toluene-d8): δ −87.9 (s) ppm.  Elemental Analysis: (calcd. for C36H30N2O2Sn2, 760,07 g/mol) found (calcd.): C 56.95% (56.89%), H 4.07% (3.98%), N 3.42% (3.69%). HRMS (EI+): m/z = 715.9 [M+−N2O]+   
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6.8 Diazoniumdiolato complexes as models for cis-hyponitrito complexes 6.8.1 Bis{bis(diphenylphosphanyl)ethane}pyrrolidinediazoniumdiolatoruthenium(II) tetrafluoridoborate (35)  Starting materials: [Ru(dppe)2(tos)]BF4, pdd, DCM, diethyl ether. Procedure: Crystallised [Ru(dppe)2(tos)]BF4 (7) was dissolved in DCM (5 mL) and cooled to −72 °C. A soluson of sodium pyrrolidinediazoniumdiolate (85 mg, 0.56 mmol) in MeOH (5 mL) was prepared and dropped in the other solution. The solution was stirred for 1 h at −72 °C and 1 h at RT. The colour changes from red to red brown. After that, the volume of the solution was reduced to 2.5 mL, filtered through a syringe filter and layered with diethyl ether. The mother liquor was decanted and the crystals were dried in vacuo.  Empirical formula: C56H56BF4N3O2P4Ru (1114.85 g/mol) Yield: 264 mg (0.237 mmol, 48.1% of th.) of yellow crystals. IR spectroscopy: (RT, solid), (intensity):  = 3057vw, 2939vw, 1682vw, 1586w, 1573w, 1484m, 1433s, 1409m, 1378w, 1313w, 1282w, 1257w, 1190w, 1167m, 1083s, 1053vs, 1026vs, 999vs, 874m, 810m, 745s cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 371. HRMS (ESI+): m/z = 944.17 (C52H48O2NP4Ru)   
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6.8.2 Bis{bis(diphenylphosphanyl)propane}nitrosylruthenium(II) tetrafluoridoborate (36)  Starting materials: [Ru(dppp)2(tos)]BF4, pdd, DCM, diethyl ether. Procedure: Crystallised [Ru(dppp)2(tos)]BF4 (8) was dissolved in DCM (5 mL) and cooled to −72 °C. A soluson of sodium pyrrolidinediazoniumdiolate (85 mg, 0.56 mmol) in MeOH (5 mL) was prepared and dropped in the other solution. The solution was stirred for 1 h at −72 °C and 1 h at RT. The colour changes from red to dark brown. After that, the volume of the solution was reduced to 2.5 mL, filtered through a syringe filter and layered with diethyl ether. The mother liquor was decanted and the crystals were dried in vacuo.  Empirical formula: C54H52BF4NOP4Ru (1042.78 g/mol) Yield: 120 mg (0.115 mmol, 23.3% of th.) of yellow blocks. IR spectroscopy: (RT, solid), (intensity):  = 3054vw, 2669vw, 2869vw, 1656s (NO), 1586w, 1573w, 1484m, 1433s, 1406w, 1379w, 1344w, 1309w, 1277w, 1184w, 1162m, 1087s, 1045vs, 998s, 970s, 914m, 831s, 793s, 757s cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 373, 432, 573. NMR spectroscopy:  31P{1H} NMR (162 MHz, CD2Cl2): δ 16.0, 10.6 (3JPP = 39.1 Hz, first isomer), 29.2, 0.8 (3JPP = 31.0 Hz, second isomer), 34.0, 1.4 (3JPP = 32.4 Hz, third isomer) ppm. HRMS (ESI+): m/z = 956.20 (C54H52ONP4Ru)  X-ray structure analysis: wv165 
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6.8.3 Bis{bis(diphenylphosphanyl)ethene}pyrrolidinediazoniumdiolatoruthenium(II) tetrafluoridoborate (37)  Starting materials: [Ru(dppv)2(H2O)2](BF4)2, pdd, DCM, diethyl ether. Procedure: Crystallised [Ru(dppv)2(H2O)](BF4)2 (16) was dissolved in DCM (5 mL) and cooled to −72 °C. A soluson of sodium pyrrolidinediazoniumdiolate (85 mg, 0.56 mmol) in MeOH (5 mL) was prepared and dropped in the other solution. The solution was stirred for 1 h at −72 °C and 1 h at RT. The colour changes from yellow to pale yellow. After that, the volume of the solution was reduced to 2.5 mL, filtered through a syringe filter and layered with diethyl ether. The mother liquor was decanted and the crystals were dried in vacuo.  Empirical formula: C56H52BF4N3O2P4Ru (1110.82 g/mol) Yield: 182 mg (0.164 mmol, 33.3% of th.) of yellow rods. IR spectroscopy: (RT, solid), (intensity):  = 3055w, 2969w, 1707m, 1587w, 1572w, 1482m, 1459m, 1434m, 1308w, 1217m, 1187m, 1090s, 1046vs, 997s, 885w, 848w, 813w, 741vs cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 364. HRMS (ESI+): m/z = 1024.21 (C56H52O2N3P4Ru)  X-ray structure analysis: wv182   
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6.8.4 pdd, pyrrolidinediazoniumdiolate (38)  Literature: J. E. Saavedra, T. R. Billiar, D. L. Williams, Y.-M. Kim, S. C. Watkins, L. K. Keefer, J. Med. Chem. 1997, 40, 1947–1954. Starting materials: sodium, methanol, pyrrolidine, diethyl ether, acetonitrile, nitric oxide. Procedure: To sodium (0.92 g, 0.040 mol) methanol (14.5 mL) was dropped under constant stirring using a metal-reflux condenser under an argon atmosphere. The developing hydrogen was removed by a constant argon flow. In a high-pressure bottle pyrrolidine (2.82 g, 3.31 mL, 0.04 mol) was solved in diethyl ether (10 mL) and acetonitrile (10 mL). The NaOMe solution was dropped slowly into the other solution and the flask was sealed. The bottle was flushed with nitric oxide (1 h, without pressure) after appearance of the colourless precipitate the outlet of the bottle was closed and the NO flow was kept at around 1.5 bar for 2 h. After formation of a colourless slurry, the inlet was closed, the apparatus flushed with Ar and the suspension was stirred for 2 further days under NO atmosphere. The solid was sucked off, washed with diethyl ether and dried in vacuo. Empirical formula: C4H8N3NaO2 (153.12 g/mol) Yield: 3.10 g (20.2 mmol, 50.5% of th.) of colourless crystals (ill-defined).  Please note: The product is stable for a short time. Steady decomposition is visible in brown fumes and yellow discolouration. Therefore, the yield described for 35–37 is estimated. 
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6.8.5 Bis{bis(diphenylphosphanyl)ethane}benzyldiazoniumdiolatoruthenium(II) tetrafluoridoborate (39)  Starting materials: [Ru(dppe)2(tos)]BF4, bdd, DCM, diethyl ether. Procedure: Crystallised [Ru(dppe)2(tos)]BF4 (7) was dissolved in DCM (5 mL) and cooled to −72 °C. A soluson of hydrogen benzyldiazoniumdiolate (Hbdd (42)) (100 mg, 0.657 mmol) in DCM (5 mL) was prepared and dropped in the other solution. The solution was stirred for 1 h at −72 °C and 1 h at RT. Ater that, the volume of the solution was reduced to 2.5 mL, filtered through a syringe filter and layered with diethyl ether. The mother liquor was decanted and the crystals were dried in vacuo.  Empirical formula: C59H55BF4N2O2P4Ru (1135.87 g/mol) Yield: 420 mg (0.370 mmol, 75.1% of th.) of yellow platelets. IR spectroscopy: (RT, solid), (intensity):  = 3058vw, 1584vw, 1571vw, 1498w, 1483w, 1460w, 1433s, 1345w, 1322w, 1274w, 1238w, 12171, 1192m, 1162w, 1146w, 1084s, 1048vs, 997s, 948w, 923m, 868m, 848m, 810m, 793w, 748vs cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 370. NMR spectroscopy:  31P{1H} NMR (162 MHz, CD2Cl2): δ 55.8, 55.6 (dd, 11.6 Hz, 21.1 Hz), 55.1, 54.9 (dd, 13.3 Hz, 21.1 Hz), 50.3, 48.3 (dd, 11.7 Hz, 21.9 Hz), 44.6 (dd, 13.3 Hz, 21.2 Hz) ppm. HRMS (ESI+): m/z = 1049.23 (C59H55O2N2P4Ru)  X-ray structure analysis: wv167 
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6.8.6 Bis{bis(diphenylphosphanyl)propane}benzyldiazoniumdiolatoruthenium(II) tetrafluoridoborate (40)  Starting materials: [Ru(dppp)2(tos)]BF4, bdd, DCM, diethyl ether. Procedure: Crystallised [Ru(dppp)2(tos)]BF4 (8) was dissolved in DCM (5 mL) and cooled to −72 °C. A soluson of hydrogen benzyldiazoniumdiolate (Hbdd (42)) (100 mg, 0.657 mmol) in DCM (5 mL) was prepared and dropped in the other solution. The solution was stirred for 1 h at −72 °C and 1 h at RT. Ater that, the volume of the solution was reduced to 2.5 mL, filtered through a syringe filter and layered with diethyl ether. The mother liquor was decanted and the crystals were dried in vacuo.  Empirical formula: C61H59BF4N2O2P4Ru (1163.92 g/mol) Yield: 471 mg (0.405 mmol, 82.2% of th.) of yellow prisms. IR spectroscopy: (RT, solid), (intensity):  = 3059w, 2921w, 2868w, 1572w, 1484w, 1455w, 1433m, 1347w, 1305m, 1230vs, 1197vs, 1153vs, 1092vs, 1049vs, 997s, 980vs, 920m, 836m, 793m, 749s cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 379. HRMS (ESI+): m/z = 1077.26 (C61H59O2N2P4Ru)  X-ray structure analysis: wv172 
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6.8.7 Bis{bis(diphenylphosphanyl)ethene}benzyldiazoniumdiolatoruthenium(II) tetrafluoridoborate (41)  Starting materials: [Ru(dppp)2(H2O)2](BF4)2, bdd, DCM, diethyl ether. Procedure: Crystallised [Ru(dppp)2(H2O)](BF4) (8) was dissolved in DCM (5 mL) and cooled to −72 °C. A soluson of hydrogen benzyldiazoniumdiolate (Hbdd (42)) (100 mg, 0.657 mmol) in DCM (5 mL) was prepared and dropped in the other solution. The solution was stirred for 1 h at −72 °C and 1 h at RT. Ater that, the volume of the solution was reduced to 2.5 mL, filtered through a syringe filter and layered with diethyl ether. The mother liquor was decanted and the crystals were dried in vacuo.  Empirical formula: C59H51BF4N2O2P4Ru (1131.84 g/mol) Yield: 320 mg (0.283 mmol, 57.4% of th.) of yellow platelets. IR spectroscopy: (RT, solid), (intensity):  = 3057w, 1599w, 1572w, 1483w, 1457w, 1433s, 1415m, 1340w, 1313w, 1209w, 1191s, 1146m, 1119m, 1090s, 1051vs, 1036vs, 998s, 910m, 846w, 814m, 786m, 740vs cm−1. UV/VIS spectroscopy: λmax/nm (DCM) 365. NMR spectroscopy:  31P{1H} NMR (162 MHz, CD2Cl2): δ 66.1, 65.9 (dd, 7.0 Hz, 19.6 Hz), 65.5, 65.3 (dd, 8.3 Hz, 20.3 Hz), 56.3, 54.1 (dd, 6.9 Hz, 20.2 Hz), 53.3, 51.2 (dd, 8.1 Hz, 19.8 Hz) ppm. HRMS (ESI+): m/z = 1045.20 (C59H51O2N2P4Ru)  X-ray structure analysis: wv179 
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6.8.8 bdd, benzyldiazoniumdiolate (42)  Literatur: H. Maskill, W. P. Jencks, J. Am. Chem. Soc. 1987, 109, 2062–2070. Starting materials: NaNO2, N-benzylhydroxylamine hydrochloride, HCl (2 M), methanol, water. Procedure: An ice-cold solution of NaNO2 (0.960 g, 13.9 mmol) in H2O (2.4 mL) was added to a solution of benzylhydroxylamine hydrochloride (1.00 g, 6.27 mmol) in HCl (2.0 M, 6.6 mL) and MeOH (3.6 mL) over a time of 5 min. A foaming suspension was obtained. The solid was sucked off, washed with ice-cold water (3 ∙ 10 mL) and dried in vacuo. Empirical formula: C7H8N2O2 (152.15 g/mol) Yield: 749 mg (4.93 mmol, 78.6% of th.) of colourless crystals. IR spectroscopy: (RT, solid), (intensity):  = 3034w, 1807vw, 1632vw, 1493m, 1471m, 1454m, 1429m, 1395m, 1348m, 1330m, 1312m, 1268s, 1211m, 1186w, 1159w, 1101w, 1078s, 1057s, 1029m, 1002m, 970m, 947m, 911m, 829 m, 775m, 702s cm−1. Elemental Analysis: (calcd. for C7H8N2O2, 152.15 g/mol g/mol) found (calcd.): 55.32% (55.26%), H 5.11% (5.30%), N 18.13% (18.41). HRMS (ESI−): m/z = 151.05 (C7H7O2N2).     
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7 Appendix  7.1 Packing diagrams of the moleculare structures    Figure 7.1: Mercury packing diagram of [Ru(H2O)6](tos)2 (1) in the monoclinic space group P21/c with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), ruthenium (turquoise), sulphur (yellow). 
Appendix 
162    Figure 7.2: Mercury packing diagram of [Ru(H2O)6](OTf)2 (2) in the monoclinic space group C2/c with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), fluorine (light green), oxygen (red), ruthenium (turquoise), sulphur (yellow).   
Appendix 
163    Figure 7.3: Mercury packing diagram of [Ru(H2O)6]SO4 (3) in the monoclinic space group C2/c with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: hydrogen (white), oxygen (red), ruthenium (turquoise), sulphur (yellow).   
Appendix 
164    Figure 7.4: Mercury packing diagram of [Ru(H2O)6](1,5-NaphDS) (4) in the monoclinic space group P21/c with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), ruthenium (turquoise), sulphur (yellow).   
Appendix 
165    Figure 7.5: Mercury packing diagram of [Ru(H2O)6](4,4′-BiphenDS)∙2H2O (5) in the triclinic space group P1 with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), ruthenium (turquoise), sulphur (yellow). The disorder of the biphenyl moiety is omitted.    
Appendix 
166   Figure 7.6: Mercury packing diagram of [Ru(H2O)6](MesSO3)2 (6) in the monoclinic space group P21/c with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), ruthenium (turquoise), sulphur (yellow).   
Appendix 
167   Figure 7.7: Mercury packing diagram of [Ru(dppe)2(tos)(BF4)]∙0.985CHCl3 (7) in the triclinic space group P1 with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), chlorine (green), fluorine (green-yellow), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow).   
Appendix 
168   Figure 7.8: Mercury packing diagram of [Ru(dppp)2(tos)(BF4)]∙xEt2O (8) in the monoclinic space group P21/c with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), fluorine (green-yellow), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow). Phenyl-groups and diethyl ether were illustrated as wireframe.   
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169   Figure 7.9: Mercury packing diagram of [Ru(dppbza)2(tos)(BF4)]∙2.9Et2O (9) in the orthorhombic space group Fdd2 with view along [0 0 1]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow). Phenyl-groups, diethyl ether and tetrafluoride borate were illustrated as wireframe.   
Appendix 
170   Figure 7.10: Mercury packing diagram of [Ru(PiPrPh2)2(tos)2] (10) in the monoclinic space group P21/c with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow).    
Appendix 
171   Figure 7.11: Mercury packing diagram of [Ru(dppe)2(MesSO3)(BF4)]∙DCM (11) in the triclinic space group P1 with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), chlorine (green), fluorine (green-yellow), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow).   
Appendix 
172   Figure 7.12: Mercury packing diagram of [Ru(PiPrPh2)2(MesSO3)2]∙0.826DCM (12) in the monoclinic space group P21/c with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), chlorine (green), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow).   
Appendix 
173   Figure 7.13: Mercury packing diagram of [Ru(dpppha)2(H2O)2](BF4)2∙1.948DCM (13) in the triclinic space group P1 with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), chlorine (green), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise).   
Appendix 
174   Figure 7.14: Mercury packing diagram of [Ru(dppen)2(H2O)2](tos)2∙1.506DCM (14) in the monoclinic space group P21/n with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), chlorine (green), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow).   
Appendix 
175   Figure 7.15: Mercury packing diagram of [Ru(dppbz)2(H2O)2](BF4)2 (15) in the monoclinic space group C2/c with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), fluorine (green-yellow), oxygen (red), phosphorus (orange), ruthenium (turquoise).   
Appendix 
176   Figure 7.16: Mercury packing diagram of [Ru(dppv)2(H2O)2](BF4)2 (16) in the triclinic space group P1 with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), fluorine (green-yellow), oxygen (red), phosphorus (orange), ruthenium (turquoise).   
Appendix 
177   Figure 7.17: Mercury packing diagram of [Ru(dpppra)2(H2O)(tos)](tos)∙1.891C7H8 (17) in the monoclinic space group P21/n with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow).   
Appendix 
178   Figure 7.18: Mercury packing diagram of [Ru(PPh3)2(H2O)2(tos)2]∙2C4H10O (18) in the triclinic space group P1 with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow).   
Appendix 
179   Figure 7.19: Mercury packing diagram of [Ru(PHtBu2)2(H2O)2(tos)2] (19) in the monoclinic space group C2/c with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow).   
Appendix 
180   Figure 7.20: Mercury packing diagram of [Ru(PPh2Bn)2(H2O)2(tos)2]∙C4H10O (20) in the monoclinic space group P21/n with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow). Diethyl ether was illustrated as wireframe.   
Appendix 
181   Figure 7.21: Mercury packing diagram of [Ru(dppe)2(H)(NO2)] (24) in the monoclinic space group P21/n with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise).   
Appendix 
182   Figure 7.22: Mercury packing diagram of [Ru(dppe)2(NO)](tos)∙0.955DCM (25) in the triclinic space group P1 with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), chlorine (green), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise), sulphur (yellow).   
Appendix 
183   Figure 7.23: Mercury packing diagram of [Ru(dppe)2(NO)F](SbF6) (26) in the triclinic space group P1 with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise), antimony (lavender).   
Appendix 
184   Figure 7.24: Mercury packing diagram of [Ru(PPh3)2(NO)2] (27) in the monoclinic space group P21/n with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise).   
Appendix 
185   Figure 7.25: Mercury packing diagram of [Ru(dppe)2(N2O2H)]BF4∙Et2O (28a) in the orthorhombic space group Pbca with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise). Phenyl groups, diethyl ether (except oxygen) and tetrafluorido borate were illustrated as wireframe.   
Appendix 
186   Figure 7.26: Mercury packing diagram of [Ru(dppe)2(N2O2H)]BF4 (28b) in the monoclinic space group P21/n with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise).    
Appendix 
187   Figure 7.27: Mercury packing diagram of [Ru(dppp)2(N2O2H)]BF4∙Et2O∙DCM (29) in the monoclinic space group P21/n with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), chlorine (green), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise). Phenyl groups, diethyl ether (except oxygen), dichlormethane and tetrafluorido borate were illustrated as wireframe.   
Appendix 
188   Figure 7.28: Mercury packing diagram of [Ru(dppv)2(N2O2H)]BF4∙0.81TBME∙DCM (30) in the monoclinic space group P21/c with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), chlorine (green), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise). Phenyl groups, TBME (except oxygen), dichlormethane and tetrafluorido borate were illustrated as wireframe.   
Appendix 
189   Figure 7.29: Mercury packing diagram of [Ru(dppe)2(N2O2)]∙HImiBF4 (31) in the orthorhombic space group P212121 with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise). Phenyl groups, imidazole (except the protonated nitrogen) and tetrafluorido borate were illustrated as wireframe.   
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190   Figure 7.30: Mercury packing diagram of [Ru(dppp)2(N2O2H)]BF4∙Imi∙0.856DCM (32) in the monoclinic space group P21/n with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), chlorine (green), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise). Phenyl groups, imidazole (except the basic nitrogen), dichlormethane and tetrafluorido borate were illustrated as wireframe.   
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191   Figure 7.31: Mercury packing diagram of [Ru(dppv)2(N2O2)]∙HImiBF4∙Imi∙0.804DCM (33) in the monoclinic space group P21/n with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), chlorine (green), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise). Phenyl groups, imidazole (except both nitrogens), dichlormethane and tetrafluorido borate were illustrated as wireframe.   
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192   Figure 7.32: Mercury packing diagram of [Ru(dppp)2(NO)]BF4∙Et2O (36) in the monoclinic space group P21 with view along [1 0 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise).    
Appendix 
193   Figure 7.33: Mercury packing diagram of [Ru(dppv)2(pdd)]BF4∙0.601DCM (37) in the monoclinic space group P21/c with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), chlorine (green), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise). Phenyl groups, dichlormethane and tetrafluorido borate were illustrated as wireframe.   
Appendix 
194   Figure 7.34: Mercury packing diagram of [Ru(dppe)2(bdd)]BF4 (39) in the monoclinic space group P21 with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise). Phenyl groups and tetrafluorido borate were illustrated as wireframe.    
Appendix 
195   Figure 7.35: Mercury packing diagram of [Ru(dppp)2(bdd)]BF4 (40) in the monoclinic space group P21/n with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise). Phenyl groups and tetrafluorido borate were illustrated as wireframe.    
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196   Figure 7.36: Mercury packing diagram of [Ru(dppv)2(bdd)]BF4∙0.867DCM (41) in the monoclinic space group P21/n with view along [0 1 0]. The symmetry elements of the space group are overlaid. Atoms: carbon (grey), hydrogen (white), boron (rose), chlorine (green), fluorine (green-yellow), nitrogen (blue), oxygen (red), phosphorus (orange), ruthenium (turquoise). Phenyl groups, dichlormethane and tetrafluorido borate were illustrated as wireframe.     
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7.2 Crystallographic Tables Table 7.1: Crystallographic data of [Ru(H2O)6](tos)2 (1), [Ru(H2O)6](OTf)2 (2), [Ru(H2O)6](SO4) (3).  1*), **) 2*), **) 3**) sum formula C14H26O12RuS2 C2H12F6O12RuS2 H12O10RuS Mr/g mol−1 551.54 507.31 305.23 color and habit pink platelet pink block red platelet crystal system monoclinic monoclinic monoclinic space group P21/c C2/c C2/c a/Å 14.0088(7)  9.5224(4) 9.6832(4)  b/Å 6.2999(3) 9.2316(4) 7.3250(3) c/Å 24.9685(14) 17.6491(9) 24.0235(10) β/° 100.545(5) 91.299(4) 98.1130(10) V/Å3 2166.3(2) 1551.08(12) 1686.92(12) Z 4  4 8 ρ/g cm−3 1.691 2.172 2.404 μ(MoKα)/mm−1 0.973 1.401 2.136 crystal size/mm  0.16 × 0.10 × 0.04 0.18 × 0.11 × 0.1 0.10 × 0.09 × 0.05 temperature/K 100(2) 293(2) 293(2) θrange/° 4.36–28.66 4.56–28.47 3.50–27.15 refls. measured 8005 2737 9660 independent refls. 4829 1718 1862 Rint 0.0430 0.0242 0.0207 mean σ(I)/I 0.0901 0.0396 0.0156 diffractometer  Oxford XCalibur Bruker D8Venture reflexes with I≥2σ(I) 3224 1521 1752 parameters 300 125 148 R(Fobs) 0.0547 0.0316 0.0192 Rw(F2) 0.1317 0.0785 0.0471 S 1.046 1.032 1.076 max. shift/error 0.001 0.001 0.001 max. electron density in e Å−3 1.320 (1.056 Å from Ru1)  0.519 0.662 min. electron density in e Å−3 −1.027 −0.762 −0.714 x, y (weighting scheme) 0.0409, 0.000 0.0363, 1.1818 0.0199, 4.4904 *) C-bonded H: constrained, **) O-bonded H: O–H fixed to 0.82 Å, H...H fixed to 1.31 Å   
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Table 7.2: Crystallographic data of [Ru(H2O)6](1,5-NaphDS) (4), [Ru(H2O)6](4,4′-BiphenDS)∙2H2O  (5), [Ru(H2O)6](MesSO3)2 (6).  4*), **) 5*), **), ***) 6*), **) sum formula C10H18O12RuS2 C12H24O14RuS2 C18H34O12RuS2 Mr/g mol−1 495.43 557.50 607.64 color and habit pink platelet pink platelet pink platelet crystal system monoclinic  triclinic monoclinic  space group P21/c P1 P21/c a/Å 13.2776(6)  6.3148(4)  8.4108(3) b/Å 6.5560(3) 6.7346(3) 30.6658(13) c/Å 9.5892(4) 13.5126(9) 9.4564(4) α/° 90 90.475(4) 90 β /° 92.344(2) 102.302(5) 93.023(3) γ/° 90 114.935(5) 90 V/Å3 834.02(6) 506.00(6) 2435.64(17) Z 2 1 4 ρ/g cm−3 1.973 1.830 1.657 μ(MoKα)/mm−1 1.252 1.050 0.874 crystal size/mm  0.08 × 0.05 × 0.02 0.46 × 0.25 × 0.02 0.42 × 0.21 × 0.04 temperature/K 100(2) 100(2) 100(2) θ range/° 3.07–27.13 4.20–27.48 4.13–26.37 refls. measured 16757 3211 13426 independent refls. 1821 2266 4970 Rint 0.0614 0.0226 0.0289 mean σ(I)/I 0.0429 0.0424 0.0348 diffractometer  Bruker D8Venture Oxford XCalibur Oxford XCalibur reflexes with I≥2σ(I) 1553 2134 3978 parameters 133 194 343 R(Fobs) 0.0411 0.0313 0.0334 Rw(F2) 0.0918 0.0730 0.0818 S 1.130 1.032 1.084 max. shift/error 0.001 0.001 0.001 max. electron density in e Å−3 0.728 0.993 0.826 min. electron density in e Å−3 −1.043 −0.872 −0.693 x, y (weighting scheme) 0.0081, 6.3318 0.0306, 0.5339 0.0267, 3.5678 *) C-bonded H: constrained, **) O-bonded H: O–H fixed to 0.82 Å, H...H fixed to 1.31 Å, ***) Disordered biphenyl moiety 
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Table 7.3: Crystallographic data of [Ru(dppe)2(tos)]BF4∙0.985CHCl3 (7), [Ru(dppp)2(tos)]BF4∙xEt2O (8), [Ru(dppbza)2(tos)]BF4∙2.9Et2O (9).  7*) 8*) 9*) sum formula C59.97H55.97BCl2.97F4O3P4Ru C126.28H118B2F8O7P8Ru2S2 C149.66H151.14B2F8N4O9P8Ru2S2 Mr/g mol−1 1273.90 2435.22 2837.39 color and habit orange platelet yellow rod dark-yellow prism crystal system triclinic monoclinic orthorhombic space group P1 P21/c Fdd2 a/Å 13.9552(5) 20.4360(9)  34.8309(19) b/Å 15.4053(5) 15.3302(6) 46.815(3) c/Å 16.1482(6) 20.9705(8) 16.9247(10) α/° 115.552(1) 90 90 β /° 110.580(1) 119.062(1) 90 γ/° 95.805(1) 90 90 V/Å3 2797.8(2) 5742.6(4) 27598(3) Z 2  2  8 ρ/g cm−3 1.512 1.408 1.366 μ(MoKα)/mm−1 0.634 0.481 0.413 crystal size/mm  0.1 × 0.05 × 0.02 0.10 × 0.02 × 0.02 0.10 × 0.10 × 0.05 temperature/K 100(2) 97(2) 100(2) θ range/° 2.937–26.44 2.892–27.12 3.043–25.72 refls. measured 50568 116853 181917 independent refls. 11326 12657 13146 Rint 0.0421 0.0647 0.0288 mean σ(I)/I 0.0513 0.0442 0.0181 diffractometer Bruker D8Venture Bruker D8Venture Bruker D8Venture refls. with I≥2σ(I) 9636 10215 12957 parameters 715 696 820 Flack parameter – – −0.017(3) R(Fobs) 0.0389 0.0447 0.0319 Rw(F2) 0.0966 0.0973 0.0838 S 1.114 1.048 1.049 max. shift/error 0.001 0.001 0.002 max. electron density in e Å−3 0.847 2.375 (1.180 Å from Ru1) 0.734 min. electron density in e Å−3 −0.726 −1.410 −0.446 x, y (weighting scheme) 0.0000, 9.0622 0.0276, 13.0291 0.0375, 77.1749 *) C-bonded H: constrained   
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Table 7.4: Crystallographic data of [Ru(PiPrPh2)2(tos)2] (10), [Ru(dppe)2(MesSO3)]BF4∙DCM  (11), [Ru(PiPrPh2)2(MesSO3)2]∙0.826DCM (12).  10*) 11*) 12*) sum formula C44H48O6P2RuS2 C62H61BCl2F4O3P4RuS C48.83H57.65Cl1.65O6P2RuS2 Mr/g mol−1 899.95 1268.82 1026.21 color and habit violet platelet orange platelet violet needle crystal system monoclinic triclinic monoclinic space group P21/c P1 P21/c a/Å 10.1812(8) 12.2709(5)  10.5758(3) b/Å 18.8518(13) 13.6469(5) 40.3791(10) c/Å 21.5726(16) 17.5092(7) 22.7217(6) α/° 90 93.876(2) 90 β /° 95.855(3) 102.976(2) 90.8920(10) γ/° 90 97.578(2) 90 V/Å3 4118.9(5) 2817.88(19) 9701.9(4) Z 4 2 8 ρ/g cm−3 1.451 1.495 1.405 μ(MoKα)/mm−1 0.607 0.584 0.613 crystal size/mm  0.08 × 0.06 × 0.03 0.10 × 0.08 × 0.01 0.10 × 0.01 × 0.01 temperature/K 100(2) 100(2) 100(2) θ range/° 2.84–26.40 3.00–27.91 2.17–27.88 refls. measured 160645 58544 190730 independent refls. 8407 13423 23074 Rint 0.0498 0.0622 0.0437 mean σ(I)/I 0.0240 0.0720 0.0371 diffractometer  Bruker D8Venture Bruker D8Venture Bruker D8Venture reflexes with I≥2σ(I) 7698 9772 19296 parameters 502 725 1139 R(Fobs) 0.0244 0.0439 0.0397 Rw(F2) 0.0603 0.1101 0.0825 S 1.044 1.010 1.071 max. shift/error 0.002 0.001 0.004 max. electron density in e Å−3 0.407 1.120 (1.231 Å from B1) 1.505 (0.947 Å from Cl2) min. electron density in e Å−3 −0.499 −0.875 −0.563 x, y (weighting scheme) 0.0202, 4.3592 0.0473, 1.7856 0.0231, 15.3053 *) C-bonded H: constrained    
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Table 7.5: Crystallographic data of [Ru(dpppha)2(H2O)2](BF4)2∙1.948DCM (13), [Ru(dppen)2(H2O)2](BF4)2∙1.506DCM (14), [Ru(dppbz)2(H2O)2](BF4)2 (15).  13*), **) 14*), **) 15*), **) sum formula C61.95H57.90B2Cl3.90F8N2O2P C67.51H65.01Cl3.01O8P4RuS2 C60H52B2F8O2P4Ru Mr/g mol−1 1399.09 1400.02 1203.58 color and habit yellow rod dark-yellow block yellow block crystal system triclinic monoclinic monoclinic space group P1 P21/n C2/c a/Å 11.2628(3) 13.2765(5) 24.9957(10) b/Å 11.6441(3) 15.5607(5) 11.5994(4) c/Å 12.8451(4) 15.6970(6) 21.2476(9) α/° 110.2550(10) 90 90 β /° 94.9400(10) 96.9190(10) 120.4480(10) γ/° 103.6610(10) 90 90 V/Å3 1509.43(7) 3219.3(2) 5310.8(4) Z 1 2 4 ρ/g cm−3 1.539 1.444 1.505 μ(MoKα)/mm−1 0.609 0.588 0.489 crystal size/mm  0.1 × 0.05 × 0.02 0.50 × 0.40 × 0.10 0.02 × 0.02 × 0.01 temperature/K 100(2) 100(2) 100(2) θ range/° 3.093–26.39 2.509–27.13 1.994–26.37 refls. measured 37740 85474 49632 independent refls. 6117 7096 5427 Rint 0.0258 0.1171 0.0751 mean σ(I)/I 0.0239 0.0661 4298 diffractometer  Bruker D8Venture Bruker D8Venture Bruker D8Venture reflexes with I≥2σ(I) 5796 5694 0.0572 parameters 392 402 355 R(Fobs) 0.0264 0.0684 0.0446 Rw(F2) 0.0738 0.1292 0.0849 S 1.253 1.114 1.042 max. shift/error 0.001 0.001 0.001 max. electron density in e Å−3 0.623 0.753 0.586 min. electron density in e Å−3 −0.715 −0.827 −0.870 x, y (weighting scheme) 0.0450, 0.9798 0.0211, 13.6085 0.0192, 17.8828 *) C-bonded H: constrained, **) O-bonded H: O–H fixed to 0.82 Å, H...H fixed to 1.31 Å   
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Table 7.6: Crystallographic data of [Ru(dppv)2(H2O)2](BF4)2 (16), [Ru(dpppra)2(H2O)(tos)](tos)∙1.891C7H8 (17), [Ru(PPh3)2(H2O)2(tos)2]∙2C4H10O (18).  16*), **) 17*), **) 18*), **) sum formula C52H48B2F8O2P4Ru C81.24H85.13N2O7P4RuS2 C58H68O10P2RuS2 Mr/g mol−1 1103.47 1490.53 1152.25 color and habit yellow block yellow platelet red block crystal system triclinic monoclinic triclinic space group P1 P21/n P1 a/Å 10.3088(3)  12.8014(7) 10.8950(5) b/Å 11.0702(4) 31.8789(17) 12.1360(5) c/Å 11.5073(4) 18.3168(8) 22.2528(11) α/° 101.346(1) 90 103.563(2) β /° 102.254(1) 96.778(2) 101.945(2) γ/° 106.826(1) 90 93.294(2) V/Å3 1180.64(7) 7422.7(7) 2780.9(2) Z 1 4 2 ρ/g cm−3 1.552 1.334 1.376 μ(MoKα)/mm−1 0.542 0.409 0.472 crystal size/mm  0.10 × 0.08 × 0.05 0.12 × 0.06 × 0.03 0.20 × 0.15 × 0.10 temperature/K 100(2) 100(2) 100(2) θ range/° 2.994–28.74 2.67–27.13 3.02–26.39 refls. measured 37607 297562 53787 independent refls. 6095 16357 11331 Rint 0.0378 0.0565 0.0481 mean σ(I)/I 0.0305 0.0272 0.0517 diffractometer  Bruker D8Venture Bruker D8Venture Bruker D8Venture reflexes with I≥2σ(I) 5457 14470 9454 parameters 319 867 713 R(Fobs) 0.0275 0.0420 0.0398 Rw(F2) 0.0640 0.1095 0.0886 S 1.090 1.036 1.044 max. shift/error 0.001 0.001 0.001 max. electron density in e Å−3 0.507 2.080 (1.000 Å from C71) 0.702 min. electron density in e Å−3 −0.674 −1.111 −0.664 x, y (weighting scheme) 0.0141, 1.2618 0.0433, 18.5327 0.0245, 3.9358 *) C-bonded H: constrained, **) O-bonded H: O–H fixed to 0.82 Å, H...H fixed to 1.31 Å   
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Table 7.7: Crystallographic data of [Ru(PHtBu)2(H2O)2(tos)2] (19), [Ru(PPh2Bn)2(H2O)2(tos)2]∙C4H10O (20), [Ru(dppe)2(H)(NO2)] (24).  19*), **) 20*), **) 24*), ***) sum formula C30H56O8P2RuS2 C56H62O9P2RuS2 C52H49NO2P4Ru Mr/g mol−1 771.87 1106.18 944.87 color and habit red platelet dark-yellow block yellow platelet crystal system monoclinic monoclinic monoclinic space group C2/c P21/n P21/n a/Å 21.1944(10) 17.8180(14) 10.5618(3) b/Å 8.3783(4) 15.9422(12) 24.5648(8) c/Å 20.4169(10) 18.7631(14) 17.1283(6) α/° 90 90 90 β /° 91.703(2) 96.778(2) 99.2210(10) γ/° 90 90 90 V/Å3 3623.9(3) 5299.3(7) 4386.5(2) Z 4  4 4 ρ/g cm−3 1.415 1.387 1.431 μ(MoKα)/mm−1 0.680 0.491 0.547 crystal size/mm  0.09 × 0.08 × 0.06 0.10 × 0.09 × 0.04 0.10 × 0.08 × 0.01 temperature/K 100(2) 293(2) 100(2) θ range/° 3.27–27.16 2.94–30.53 2.925–25.73 refls. measured 70609 110510 114840 independent refls. 4002 16129 8325 Rint 0.0430 0.0738 0.0829 mean σ(I)/I 0.0169 0.0620 0.0454 diffractometer  Bruker D8Venture Bruker D8Venture Bruker D8Venture reflexes with I≥2σ(I) 3861 13091 6605 parameters 212 645 545 R(Fobs) 0.0207 0.0449 0.0552 Rw(F2) 0.0769 0.1178 0.1008 S 1.296 1.011 1.129 max. shift/error 0.001 0.001 0.001 max. electron density in e Å−3 0.571 1.310 (0.890 Å from C54b) 0.798 min. electron density in e Å−3 −0.585 −0.690 −0.950 x, y (weighting scheme) 0.0396, 3.7975 0.0450, 6.4209 0.0203, 12.9942 *) C-bonded H: constrained, **) O-bonded H: O–H fixed to 0.82 Å, H...H fixed to 1.31 Å, ***) Ru-bonded H: x, y, z and Uiso refined freely   
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Table 7.8: Crystallographic data of [Ru(dppe)2(NO)](tos)∙0.955DCM (25), [Ru(dppe)2(NO)F](SbF6) (26), [Ru(PPh3)2(NO)2] (27).  25*) 26*), **) 27*) sum formula C59.96H56.91Cl1.91NO4P4RuS C52H48F13.02N0.98O0.98P4RuSb C36H30N2O2P2Ru Mr/g mol−1 1180.12 1418.11 685.63 color and habit red block yellow platelet red platelet crystal system triclinic triclinic monoclinic space group P1 P1 P21/n a/Å 12.3785(3) 10.8263(3) 9.2255(5) b/Å 14.2057(4) 11.3656(4) 36.5078(18) c/Å 17.2074(5) 12.1778(4) 9.9088(5) α/° 86.8550(10) 62.6220(10) 90 β /° 69.6940(10) 88.4480(10) 111.201(2) γ/° 73.6980(10) 74.2360(10) 90 V/Å3 2720.66(13) 1272.14(7) 3111.4(3) Z 2 1 4 ρ/g cm−3 1.441 1.851 1.464 μ(MoKα)/mm−1 0.587 1.562 0.642 crystal size/mm  0.10 × 0.08 × 0.04 0.10 × 0.05 × 0.01 0.10 × 0.08 × 0.01 temperature/K 98(2) 100(2) 100(2) θ range/° 2.991–26.40 3.119–26.44 3.082–26.42 refls. measured 100712 55262 28609 independent refls. 11129 5225 6271 Rint 0.0331 0.0447 0.0348 mean σ(I)/I 0.0192 0.0265 0.0545 diffractometer  Bruker D8Venture Bruker D8Venture Bruker D8Venture reflexes with I≥2σ(I) 9994 4687 5430 parameters 660 335 388 R(Fobs) 0.0277 0.0532 0.0733 Rw(F2) 0.0668 0.1209 0.1423 S 1.070 1.148 1.333 max. shift/error 0.004 0.001 0.001 max. electron density in e Å−3 0.748 1.275 (0.373 Å from Ru1) 1.495 (0.935 Å from Ru1) min. electron density in e Å−3 −0.545 −1.611 −1.625 x, y (weighting scheme) 0.0194, 3.4304 0.0232, 12.0432 0.0000, 18.4555 *) C-bonded H: constrained, **) disorder of NO and F (inversion centre)   
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Table 7.9: Crystallographic data of [Ru(dppe)2(N2O2H)]BF4∙Et2O (28a), [Ru(dppe)2(N2O2H)]BF4 (28b), [Ru(dppp)2(N2O2H)]BF4∙Et2O∙DCM (29).  28a*), **) 28b*), **) 29*), **) sum formula C56H59BF4N2O3P4Ru C52H49BF4N2O2P4Ru C59H65BCl2F4N2O3P4Ru Mr/g mol−1 1119.81 1045.69 1232.79 color and habit red block yellow block dark-red block crystal system orthorhombic monoclinic monoclinic space group Pbca P21/n P21/n a/Å 15.2572(6)  12.0831(4)  11.5983(3) b/Å 24.3348(10) 15.3194(4) 14.5177(4) c/Å 27.3115(11) 25.2725(7) 33.0980(8) α/° 90 90 90 β /° 90 91.250(1) 96.484(1) γ/° 90 90 90 V/Å3 10140.2(7) 4677.0(2) 5537.4(2) Z 8  4  4  ρ/g cm−3 1.467 1.485 1.479 μ(MoKα)/mm−1 0.498 0.532 0.557 crystal size/mm  0.10 × 0.05 × 0.01 0.10 × 0.04 × 0.03 0.10 × 0.06 × 0.05 temperature/K 100(2) 100(2) 100(2) θ range/° 2.794–25.73 2.978–25.78 3.048–27.15 refls. measured 291839 98288 76948 independent refls. 9634 8853 12241 Rint 0.0836 0.0497 0.0356 mean σ(I)/I 0.0249 0.0289 0.0313 diffractometer  Bruker D8Venture Bruker D8Venture Bruker D8Venture reflexes with I≥2σ(I) 8281 7668 10665 parameters 644 598 684 R(Fobs) 0.0318 0.0344 0.0506 Rw(F2) 0.0834 0.0809 0.1267 S 1.074 1.082 1.081 max. shift/error 0.002 0.001 0.001 max. electron density in e Å−3 0.550 1.657 (2.391 Å from O2) 1.402 (1.186 Å from C56) min. electron density in e Å−3 −0.531 −0.474 −0.849 x, y (weighting scheme) 0.0308, 16.714 0.0266, 8.5015 0.0424, 18.9393 *) C-bonded H: constrained, **) O-bonded H: x, y, z refined, Uiso constrained 
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Table 7.10: Crystallographic data of [Ru(dppv)2(N2O2H)]BF4∙0.81TBME∙DCM (30), [Ru(dppe)2(N2O2)]∙HImiBF4 (31), [Ru(dppp)2(N2O2H)]BF4∙Imi∙0.856DCM (32).  30*), **) 31*), ****) 32*), ***), ****) sum formula C57.05H56.72BCl2F4N2O2.81P C55H53BF4N4O2P4Ru C57.86H58.71BCl1.71F4N4O2P Mr/g mol−1 1197.99 1113.77 1214.54 color and habit yellow rod yellow block yellow platelet crystal system monoclinic orthorhombic monoclinic space group P21/c P212121 P21/n a/Å 18.3784(9)  12.0407(3)  17.2207(5)  b/Å 12.6393(6) 14.7601(4) 18.7259(6) c/Å 24.9339(12) 27.8330(8) 18.2062(5) α/° 90 90 90 β /° 104.375(2) 90 109.701(1) γ/° 90 90 90 V/Å3 5610.6(5) 4946.5(2) 5527.3(3) Z 4  4 4 ρ/g cm−3 1.418 1.496 1.459 μ(MoKα)/mm−1 0.547 0.510 0.543 crystal size/mm  0.10 × 0.03 × 0.02 0.10 × 0.08 × 0.02 0.10 × 0.08 × 0.01 temperature/K 100(2) 100(2) 100(2) θ range/° 2.96–27.18 2.86–26.38 3.15–27.89 refls. measured 104640 157844 123188 independent refls. 12336 10089 13124 Rint 0.0802 0.0541 0.0445 mean σ(I)/I 0.0632 0.0241 0.0320 diffractometer  Bruker D8Venture Bruker D8Venture Bruker D8Venture reflexes with I≥2σ(I) 9423 9800 10989 parameters 678 642 694 Flack parameter – −0.012(6) – R(Fobs) 0.0589 0.0221 0.0393 Rw(F2) 0.1540 0.0519 0.0951 S 1.057 1.059 1.047 max. shift/error 0.001 0.003 0.001 max. electron density in e Å−3 1.515 (1.267 Å from O1) 0.372 1.688 (0.983 Å from Cl1) min. electron density in e Å−3 −1.421 −0.318 −0.820 x, y (weighting scheme) 0.0633, 19.9090 0.0224, 2.2851 0.0334, 11.5784 *) C-bonded H: constrained, **) O-bonded H: x, y, z refined, Uiso constrained, ***) O-bonded H: x, y, z and Uiso refined freely, ****) N-bonded H: constrained   
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Table 7.11: Crystallographic data of [Ru(dppv)2(N2O2)]∙HImiBF4∙Imi∙0.804DCM (33), [Ru(dppp)2(NO)]BF4∙Et2O (36), [Ru(dppv)2(pdd)]BF4∙0.601DCM (37).  33*), **), ***) 36*) 37*) sum formula C58.80H54.61BCl1.61F4N6O2P4Ru C58H62BF4NO2P4Ru C56.5H54BCl2F4N3O2P4Ru Mr/g mol−1 1246.10 1116.84 1183.73 color and habit yellow rod yellow block yellow rod crystal system monoclinic monoclinic monoclinic space group P21/n P21 P21/c a/Å 11.8299(5) 11.5161(4) 18.0796(11) b/Å 23.4827(9) 14.9621(5) 12.3722(7) c/Å 20.3765(8) 15.1677(5) 24.8831(15) α/° 90 90 90 β /° 97.709(2) 98.6130(10) 103.400(2) γ/° 90 90 90 V/Å3 5609.4(4) 2584.00(15) 5414.4(6) Z 4 2 2 ρ/g cm−3 1.476 1.435 1.425 μ(MoKα)/mm−1 0.533 0.486 0.526 crystal size/mm  0.10 × 0.03 × 0.02 0.10 × 0.08 × 0.04 0.10 × 0.03 × 0.01 temperature/K 97(2) 100(2) 100(2) θ range/° 3.129–27.90 3.258–26.45 3.012–26.41 refls. measured 89602 38193 104617 independent refls. 13362 10462 11042 Rint 0.0442 0.0266 0.0677 mean σ(I)/I 0.0386 0.0412 0.0484 diffractometer  Bruker D8Venture Bruker D8Venture Bruker D8Venture reflexes with I≥2σ(I) 10854 9968 8812 parameters 725 642 668 Flack parameter – 0.000(8) – R(Fobs) 0.0354 0.0288 0.0567 Rw(F2) 0.0900 0.0621 0.1469 S 1.027 1.064 1.059 max. shift/error 0.001 0.002 0.001 max. electron density in e Å−3 0.959 0.459 2.120 (1.140 Å from C3) min. electron density in e Å−3 −0.487 −0.367 −0.850 x, y (weighting scheme) 0.0361, 6.7539 0.0198, 1.3745 0.0590, 21.1059 *) C-bonded H: constrained, **) N-bonded H: N–H fixed to 0.88 Å (hydrogen between hyponitrite and imidazole), ***) N-bonded H: constrained   
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Table 7.12: Crystallographic data of [Ru(dppe)2(bdd)]BF4 (39), [Ru(dppp)2(bdd)]BF4 (40), [Ru(dppv)2(bdd)]BF4∙0.867DCM (41).  39 40 41 sum formula C59H55BF4N2O2P4Ru C61H59BF4N2O2P4Ru C59.87H52.73BCl1.73F4N2O2P Mr/g mol−1 1135.81 1163.86 1205.41 color and habit yellow platelet yellow prism yellow platelet crystal system monoclinic  monoclinic monoclinic space group P21 P21/n P21/n a/Å 12.4187(4) 18.1272(4) 21.2955(5) b/Å 14.7256(4) 15.6549(3) 12.5255(3) c/Å 14.0644(4) 18.8405(4) 21.3100(5) α/° 90 90 90 β/° 98.5210(10) 97.7170(10) 108.9640(10) γ/° 90 90 90 V/Å3 2543.61(13) 5298.13(19) 5375.6(2) Z 2 4 4 ρ/g cm−3 1.483 1.459 1.489 μ(MoKα)/mm−1 0.496 0.478 0.558 crystal size/mm  0.10 × 0.05 × 0.01 0.10 × 0.06 × 0.03 0.10 × 0.08 × 0.02 temperature/K 100(2) 100(2) 100(2) θ range/° 3.130–27.89 2.614–27.93 2.870–26.40 refls. measured 53672 83988 114636 independent refls. 12142 12618 10988 Rint 0.0323 0.0522 0.0648 mean σ(I)/I 0.0374 0.0470 0.0359 diffractometer  Bruker D8Venture Bruker D8Venture Bruker D8Venture reflexes with I≥2σ(I) 11502 9950 9043 parameters 658 676 680 Flack parameter −0.026(7) – – R(Fobs) 0.0303 0.0400 0.0484 Rw(F2) 0.0725 0.0969 0.1167 S 1.040 1.032 1.032 max. shift/error 0.001 0.001 0.002 max. electron density in e Å−3 0.669 0.749 2.656 (0.715 Å from C60) min. electron density in e Å−3 −0.536 −0.771 −1.382 x, y (weighting scheme) 0.0341, 1.2765 0.0322, 7.8096 0.0373, 21.3304 *) C-bonded H: constrained   
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7.3 Safety data sheets (in german) Betriebsanweisung für die Herstellung von [Ru(H2O)6]tos2  Daniel Beck, Datum: 27.11.2015  Arbeitssicherheit, Chemikalien, Geräte  Die allgemeine Betriebsanweisung des Arbeitskreises sowie die Betriebsanweisungen und/oder Sicherheitsdatenblätter der einzelnen Gefahrstoffe müssen gelesen, beachtet und bereitgehalten werden.  Spezifikation der Ausgangsstoffe, Formel (Synonyme; Abkürzungen):  (C. Fellay, G. Laurenczy, Inorg. Synth. 2010, 35, 152-155.)  - RuCl3 * xH2O (99.9%, ABCR, 40%)  - NaOH (Plätzchen, Chemikalienausgabe)  - NaIO4 (Chemikalienausgabe, 99%)  - RuO2 (Darstellung s.Publikation)  - Pb (Sigma-Aldrich, 99%)  - RuO4 (Einstufung fehlt: R: 8-36/38; S: 7/8-26-28-37/39)  - H2SO4 (Chemikalienausgabe)  - H2SiF6 (1L, Sigma-Aldrich, 33.5-35%)  - KHSO4 (Chemikalienausgabe, 99%)  - Nur perfluoriertes Schlifffett verwenden    Gefahren für Mensch und Umwelt:   H: 314, 335, 290, 319, 360D, 360F, 332, 302, 373, 410   P: 201, 273, 308+313, 280, 305+351+338, 310, 301+330+331, 309+310    Ruthenium(III)-chlorid * xH2O: gesundheitsschädlich, verursacht Verätzungen  NaOH, KHSO4, H2SO4: ätzend  Hexafluorokieselsäure: ätzend, giftig (geringe Mengen HF)  Natriumperiodat: brandfördernd  Rutheniumtetraoxid: sehr giftig beim Einatmen, beim Verschlucken und bei Berührung mi der  Haut; leichtflüchtig; entwickelt bereits unter 100°C sehr giftige Dämpfe; verursacht schwerste Verätzungen; brandfördernd; stark wassergefährdend, in Kontakt mit organischen Stoffen explosiv.  
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Pb (Staub): giftig, teratogen, steht im Verdacht nachhaltig das Nervensystem zu schädigen, umweltgefährdend                                Bereitzuhaltende persönliche Schutzausrüstung:   Nitrilhandschuhe, Atemschutzmaske für Stäube, Schutzbrille, Laborkittel  Bereitzuhaltende Löschmittel:   ■ Wasser im Sprühstrahl einsetzen und Druckknopfmelder betätigen!   Feuerwehr auf giftige Gase aufmerksam machen. Atemschutz: Kombinationsfilter ABEK   Ansatzgröße:   ■ 2,1 g (■ ≈17 mmol) RuO2 auf 11 g (0.049 mol) NaIO4                        
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Apparatur:     Die Reaktion muss im Abzug durchgeführt werden! Der Fortgang der Reaktion ist mit Zeitangaben im Laborjournal zu dokumentieren! Entsorgung:  ■ nach 4 Tagen Reaktionslösung A in separatem Müllkanister entsorgen (als „sauer“ kennzeichnen), sollte Flüssigkeit weiterhin gelben Stich haben: Zugabe von Methanol (Nebenprodukt: elementares Iod)  Blei nach Filtration (Granalienform) in Feststofftonne entsorgen.  Verhalten im Gefahrfall:  ■ Behälter dicht geschlossen an einem gut gelüfteten Ort aufbewahren.   Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.   Bei Unfall oder Unwohlsein sofort Arzt hinzuziehen und diese Betriebsanweisung vorzeigen.   Immer im Abzug arbeiten (spezieller Platz Nachtlabor)   Bei Gefahr des Hautkontaktes Neopren- bzw. Nitril-Schutzhandschuhe benutzen.   Beschäftigungsverbot für Jugendliche unter 16 Jahren.   Beschäftigungserlaubnis für Jugendliche über 16 Jahren nur, wenn das Ausbildungsziel den  Umgang notwendig macht und eine fachkundige Aufsicht gewährleistet ist.   Erste Hilfe  Immer:   
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Notarzt holen: siehe Alarmplan und diese Betriebsanweisung vorzeigen   Nach Einatmen:   Frischluft zuführen, Atemwege freihalten, ggf. Atemspende   Nach Verschlucken:   Wiederholt reichlich Wasser mit A-Kohle-Zusatz trinken lassen. Als  Laxans Na2SO4  (1 Esslöffel auf 1 Glas Wasser) verabreichen. Kein Erbrechen!   Nach Hautkontakt:   Sofort mit viel Wasser abwaschen,  dann mit PEG 400 abtupfen und mit  sterilem Verbandmaterial abdecken. Mit viel Wasser und Seife abwaschen.   Nach Kleidungskontakt:  Kleidung entfernen und Haut wie oben behandeln.   Nach Augenkontakt:  10–15 Minuten bei geöffnetem Lidspalt unter fließendem Wasser  spülen. Danach lockeren Verband anlegen. Sofort Augenarzt hinzuziehen!  Ersthelfer:  siehe Alarmplan  Gefährliche Reaktionen  Allgemeines: mit leichtoxidierbaren Stoffen, z.B. organischen Lösungsmitteln heftige bis  explosive Reaktion möglich; kräftiges Oxidationsmittel: setzt aus Salzsäure Chlor (giftiges  Gas) frei; leichtflüchtig Explosive Reaktion mit Ammoniak, Ethanol und Iodwasserstoff   Arbeitsvorschrift  Reaktionsgleichung:       Mr: 4.5 g, 8.2 mmol, 48% (551.55 g/mol)  Literatur:  C. Fellay, G. Laurenczy, Inorg. Synth. 2010, 35, 152–155.  Achtung:    RuO4 zersetzt sich am Magnetrührstab, Teflonfett, Silikonstopfen und Silikon-Schlauch zu schwarzem RuO2 (Ru).    Ausführung:  
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Die Anlage wird mit Ar auf Dichtigkeit geprüft. Zugabe von Rutheniumdioxid (2.1 g) zu einer Lösung aus Natriumperiodat (11 g) in Wasser (85 mL). Vorsicht: Bereits leichte Gelbverfärbung durch Rutheniumtetroxid. Zutropfen von H2SO4 (42 mL) mittels Tropftrichter. Überleitung durch Argonstrom (1Tropfen in der Waschflasche pro Sekunde). Reduktion des Tetroxids durch anwesendes Blei (20 g) in 1M H2SiF6 (140 mL). Die Reaktion für 4 Tage unter zuverlässigem Rühren laufen lassen. Reaktion wird erst gestoppt, wenn im 1. Kolben keine Gelbverfärbung zu erkennen ist (nach 4 Tagen meistens keine Gefahr mehr). Aufarbeitung: Entweder Zugabe von Kaliumtosylat (aus KOH (280 mmol, 15.71 g) und HTos (280 mmol, 53.26 g) oder Zugabe von KHSO4 (280 mmol, 38,12 g) und 1.5 eq. der gewünschten Sulfonsäure. Fritten unter Argon (zwei Wattebäusche auf den Frittenboden, ansonsten dauert die Filtration mind. 5 Stunden). Einrotieren und im Kühlschrank kristallisieren.  (Weitere Informationen in der Publikation).   Betriebsanweisung für die Herstellung von cis-Natriumhyponitrit, cis-Na2N2O2  Beck Daniel, Datum: 15.05.2017  Arbeitssicherheit, Chemikalien, Geräte  Die allgemeine Betriebsanweisung des Arbeitskreises sowie die Betriebsanweisungen und/oder Sicherheitsdatenblätter der einzelnen Gefahrstoffe müssen gelesen, beachtet und bereitgehalten werden.  Spezifikation der Ausgangsstoffe, Formel (Synonyme; Abkürzungen):  Natrium (Na): H: 260‐ 314; P: 223‐ 231+232‐ 280‐ 305+351+338‐ 370+378‐ 422  Ammoniak (gasförmig): H: 221‐ 280‐ 331‐ 314‐ 400; P: 210‐ 260‐ 280‐ 273‐ 304+340303+361+353‐ 305+351+338‐ 315‐ 377‐ 381‐ 405‐ 403  Stickstoffmonoxid (gasförmig): H: 270‐ 280‐ 330‐ 314; P: 260‐ 280‐ 244‐ 220‐ 304+340303+361+353‐ 305+351+338‐ 370+376‐ 315‐ 405‐ 403     Gefahren für Mensch und Umwelt:  Ammoniak (gasförmig):     
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 Natrium (Na):            Stickstoffmonoxid (gasförmig):         Bereitzuhaltende persönliche Schutzausrüstung:   Schutzbrille, Labormantel, Gesichtsvisier, Nitrilhandschuhe, Kevlarhandschuhe,    Gehörschutz  Bereitzuhaltende Löschmittel:   Sand bei Metallbrand.  Maximale Ansatzgröße: bei größerem Ansatz muss eine neue BA verfasst werden.  122 mg (5.5 mmol) Natrium.  Apparatur:   Trockeneiskühler, Dreihalsrundkolben 100 mL, Blasenzähler mit zwei abschließbaren Hähnen-Schlaucholive-Schliffkern, zweifach geklammert (bei der Einkondensierung NH3 und Einleitung NO) ; Hahnaufsatz 14.5, Standard-NO-Apparatur.   Die Reaktion muss im Abzug durchgeführt werden! Der Fortgang der Reaktion ist mit Zeitangaben im Laborjournal zu dokumentieren! Umsetzung bei erhöhtem Luftzug durchführen (Abzug 10 cm geöffnet). Ersthelfer bitten dabei zu sein (bei Zugabe des Lösungsmittels), dass er im Falle eines Unfalls direkt eingreifen kann.     
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Entsorgung:  Falls Produkt nicht vollständig mit Eduktkomplex abreagiert hat, dann die Reste mit Wasser quenchen und Entsorgung im wässrigen Metallsalzkanister.    Verhalten im Gefahrfall:  Da das Produkt explosive Eigenschaften besitzt, muss generell mit Schutzscheibe und Schutzschild gearbeitet werden. Im trockenen Zustand ist Produkt generell gefährlich. Vermutung: Der ursprüngliche Ansatz (3g Natrium) ist schlagempfindlich. Deswegen dürfen nur geringe Mengen für einen Ansatz verwenden (5.5 mmol Natrium hat sich als brauchbar herausgestellt)  Bei Freiwerden von Gasen und Dämpfen umgehend den Raum verlassen Erste-Hilfe-Maßnahmen:  Verbandskasten bereit stellen.  Bei Explosion: Unter fließendem Wasser (Augendusche, Notdusche) abwaschen, Blutung stillen, Arzt rufen.   Austritt NO: Raum verlassen und warten bis NO/NO2 Atmosphäre verschwunden.  Austritt NH3: In Abzug ausgasen lassen und Raum verlassen.  Arbeitsvorschrift  Reaktionsgleichung:   Literatur:  Claus Feldmann, Martin Jansen, Z. Anorg. Allg. Chem. 1997, 623, 1803–1809.  J. Goubeau, K. Laitenberger, Z. Anorg. Allg. Chem. 1963, 320, 78–85.    Ausführung:  Wichtig direkt weiterverwenden:  Natrium (122 mg) vorlegen und mit verflüssigtem Ammoniak (50 mL) lösen. Dazu wird das Ammoniakgas bei – 72°C einkondensiert (Zugang über den Schlenkstutzen am Kolben). Die Lösung wird mit Überschuss an gasförmigem Stickstoffmonoxid behandelt (−72 °C). Die Lösung entfärbt sich ca. nach einer dreiviertel Stunde. Vor der Reaktionsanlage befindet sich dabei grundsätzlich ein Schutzschild (wie für Autoklaven zu positionieren), zusätzlich ist die Schutzscheibe des Abzuges heruntergelassen. Man arbeitet durch geöffnete Seitenschieber. Der Ammoniak wird bei RT abdestilliert, wobei unbedingt der Rührer ausgeschalten sein muss (Stecker muss gezogen werden). Der Hahn des Blasenzählers wird leicht geöffnet, so dass Ammoniak mit Argon (Zuleitung über Schlaucholive) in den Abzug ausgetragen wird.  Nach 2 Stunden ist das Lösungsmittel abdestilliert und kleine farblose Schuppen von cisNatriumhyponitrit liegen im Gefäß (ab hier besonders aufpassen). Zu dem trockenen Produkt wird nun unter Trockeneis-Kühlung (+ iso-Propanol)  der gewünschte Eduktkomplex gegeben (hier gelöst in DCM (20 mL)) (danach kann der Rührer wieder in Betrieb genommen werden, 
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(−72 °C)). Sobald das Hyponitrit von Flüssigkeit umgeben ist, sollte keine Explosionsgefahr mehr bestehen (trotzdem Vorsicht). Die Schutzscheibe bleibt weiter positioniert. Eine Farbänderung zeigt die Komplexierung und damit eine Inaktivierung von Hyponitrit an. Beim Einengen des DCM ist darauf zu achten, dass kein farbloser Feststoff sichtbar ist. (Falls Rückstände sichtbar sind mit Wasser quenchen!)  Generell sollte die oben angegebene Schutzkleidung von Anfang an verwendet werden.   Ausbeute: – Analyse: direkt weiterverwenden! (Ist am sichersten)  Eigenschaften: weißer bzw. farbloser Feststoff.    
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